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Abstract 
The routine use of regenerative medicine products in patients requires cost-effective 
manufacturing processes and products that meet business and customer needs. The 
dermal skin substitute lCX-SKN, produced by lntercytex for the treatment of acute 
wounds, completed Phase I clinical trials in 2007. lCX-SKN is manufactured by 
seeding neonatal human dermal fibroblasts in a fibrin matrix and culturing for 49 days 
to form a collagen matrix synthesised by the cells. 
The results captured by this thesis demonstrate an integrated engineering and biological 
science approach to improve the current lCX-SKN process model and identify methods 
for process and product improvement. Measurement of the changes in the biochemical, 
mechanical and physical properties of lCX-SKN during the 49 day manufacturing 
period produced an improved four-phase process model describing cell proliferation, 
matrix compaction, fibrin degradation, collagen synthesis and matrix remodelling. 
Ultrasound was identified as a scalable form of mechanical stimulation for product 
improvement particularly as it does not require physical coupling to the constructs. A 
custom-built ultrasound device was used to investigate the effect of ultrasound on 
collagen synthesis and mechanical properties. A design of experiments showed that 
different combinations of ultrasound intensity (0.5-2.5W/cm2), duty cycle (5-80%) and 
duration (5-30minutes) affected the shear storage modulus (G') and collagen content. 
However, a significant effect on G' only resulted from combinations of duty cycle and 
duration. Further experiments to improve the properties of the construct, using 
0.5W/cm2 intensity, 50% duty cycle and 14 minute duration resulted in a 73% increase 
in G' primarily through increased collagen deposition. 
The results showed that further work is required to minimise process variation through 
control of the input raw materials. Optimisation of the fibrin matrix and diffusion of the 
culture media were identified as key areas to improve manufacturing cost-effectiveness. 
Enhanced understanding of the physical and molecular mechanisms by which 
ultrasound elicits cell responses will enable further optimisation of the ultrasound 
process for product improvement. 
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Chapter 1 Introduction 
1.0. Regenerative Medicine 
The vision of regenerative medicine or tissue engineering to provide therapies for the 
regeneration, repair and replacement of failing tissues and organs led to investment and 
rapid growth of the industry between the early 1990s and 2000. Large investment in the 
industry resulted in a number of commercially available tissue-engineered products 
such as those for skin and cartilage regeneration. However, the limited efficacy of the 
products over existing gold standard treatments and the high cost of production 
contributed to a downturn in the industry between 2000 and 2002. During this period, 
there was a reduction in the availability of funding and a number of the leading 
companies filed for bankruptcy. The need to address both scientific and commercial 
challenges to provide commercially viable products and further growth of the industry 
was apparent. Since 2002, the focus of regenerative medicine companies has been 
redirected from scientific research to commercialisation of products. Particular 
emphasis has been placed on addressing the challenges posed by reimbursement, 
regulation, manufacturing, marketing and distribution to realise the routine use of 
regenerative medicine products in patients. 
The manufacturing challenges facing regenerative medicine products is the focus of this 
thesis and are described in the next section. The skin graft replacement product, ICX-
SKN produced by Intercytex will be used in this thesis as a demonstrator regenerative 
medicine product for addressing the manufacturing challenges. 
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1.1. Problem Statement 
The current manufacturing challenges for regenerative medicine products include 
firstly, the development of cost-effective processes that allow for profitable 
reimbursement. Secondly, the repeatable manufacture of product to pre-determined 
specifications according to Good Manufacturing Practice (GMP) as required by 
regulation. Finally, the development of systems for repeatable and reproducible 
measurement of product properties and processing parameters is required for 
compliance with GMP. 
The use of cells in the production of regenerative medicine products presents additional 
challenges as the processing conditions required to elicit the desired cell responses are 
not fully understood. The development of product specification presents financial 
challenges as te-sting of the efficacy of the products in human clinical trials is very 
costly. The successful development of manufacturing processes to produce products 
which meet business and customer needs requires an integrated approach which 
combines manufacturing engineering and life science skills. 
Intercytex is an emerging healthcare company based in the UK and North America 
using proprietary cell therapy to develop products to restore and regenerate skin 
(www.intercytex.com). A current product in development is ICX-SKN, a skin graft 
replacement for burns and acute wounds. ICX-SKN comprises of allogeneic neonatal 
human dermal fibroblasts in a human collagen matrix and completed Phase I clinical 
trials in 2007. ICX-SKN is manufactured by seeding fibroblast cells in a fibrin matrix. 
During the 49 day manufacturing process, the cells breakdown the fibrin matrix and 
synthesise a collagen matrix which forms the basis ofthe final product. 
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The processes that occur during the remodelling of fibrin matrices and secretion of a 
collagen matrix by cells has been widely reported by researchers developing in-vitro 
wound healing models and tissue-engineered constructs for dermal, arterial and valve 
replacements. However, these studies have typically been carried out over a 21 day 
period and there is limited data about the changes in physical, biochemical and 
mechanical properties over a 49 day period as used for the manufacture of ICX-SKN. 
An improved understanding of the 49 day ICX-SKN manufacturing process would 
enable identification of areas for process and product improvement and provide a 
benchmark for the assessment of process changes. In addition, the ICX-SKN construct 
has gel-like properties which present difficulties when handling as they are prone to 
tearing and difficulties with characterisation of their properties due to the high volume 
fraction of water. Developments of repeatable and reproducible measurement 
techniques suitable for testing ICX-SKN are required. 
Identification of methods to increase collagen deposited in the matrix and improve the 
mechanical properties is also required for product improvement. Biochemical and 
mechanical stimulation has been used to increase collagen synthesis and mechanical 
properties of tissue-engineered constructs formed from cell seeded fibrin matrices. The 
current manufacturing process for ICX-SKN uses a culture media supplemented with 
growth factors to stimulate collagen synthesis from the cells. However, the use of 
mechanical stimulation to improve the properties of ICX-SKN has not been 
investigated. Application of tensile, compressive and shear forces to tissue-engineered 
construct has been shown to improve the properties of a number of tissue-engineered 
constructs. However, these methods typically required physical coupling to the 
constructs which would be problematic for ICX-SKN constructs which are prone to 
tearing due to their gel-like properties. 
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Ultrasound stimulation provides a form of mechanical stimulation which can be 
coupled to the constructs through a liquid path such as the culture media. Ultrasound 
stimulation in the therapeutic range has been used in-vivo to accelerate wound healing 
in bone and soft tissue. Ultrasound has been used in-vitro to increase collagen synthesis 
in tissue-engineered constructs for cartilage and intervertebral disc regeneration. 
However, the effect of ultrasound on dermal fibroblast seeded fibrin matrices has not 
been reported in the public domain. In addition, there are many combinations of 
ultrasound parameters such as the frequency, magnitude and duration that can be used 
to stimulate cell seeded constructs. The optimum combination of ultrasound parameters 
to stimulate collagen synthesis has not yet been determined. 
In summary, an integrated biological, manufacturing and process engineering approach 
is used in this thesis to develop the early-stage ICX-SKN product. This thesis focuses 
on firstly, the repeatable and reproducible measurement of the changes in physical, 
biochemical and mechanical properties of the ICX-SKN construct during the 49 day 
manufacturing process to provide an improved process model and identify areas for 
process improvement. Secondly, the identification of the range and combinations of 
ultrasound intensity, duty cycle and duration for increasing collagen synthesis and 
improvement of mechanical properties of the ICX-SKN construct. 
4 
1.2. Thesis Structure 
The literature review in Chapter 2 describes firstly, the current gold standard of skin 
grafting for the treatment of acute wounds and the need for skin substitutes. Secondly, 
the processes that occur when cells remodel a fibrin matrix and secrete a collagen 
matrix in-vivo during wound healing and in-vitro. Thirdly, current characterisation 
techniques to qualify and quantify the physical, biochemical and mechanical properties 
of cell seeded matrices. Finally, the effect of ultrasound on cell seeded matrices and the 
mechanisms by which ultrasound elicits cell responses is described. 
Chapter 3 describes the materials and methods used to characterise the physical, 
structural, biochemical and mechanical properties of SKN constructs during 
manufacturing. Characterisation techniques suitable for measurement of cell-seeded 
matrices with gel-like properties developed from established techniques and novel 
application of non-destructive testing techniques are described. This approach provided 
an increased understanding of the processes that occurred during the manufacturing of 
ICX-SKN and identified four key phases in the manufacturing process. 
Chapter 4 describes the experimental arrangement of the custom-built ultrasound 
stimulation device for the reproducible and repeatable stimulation of the ICX-SKN 
constructs. The design of experiments (DOE) study to investigate the effect of different 
combinations of ultrasound parameters on the structural, biochemical and mechanical 
properties of ICX-SKN constructs is also described. Chapter 5 describes the use of 
ultrasound stimulation for the improvement of the properties of the ICX-SKN 
constructs based on suitable ultrasound parameters identified in the DO E. 
The conclusions in Chapter 6 integrate and expand on the conclusions of the 
characterisation and ultrasound studies. Areas of further work to improve the efficiency 
of the manufacturing process and reduce batch-to-batch variation are described in 
Chapter 7. Further work to improve the effect of ultrasound on the properties of the 
ICX-SKN constructs, and to improve understanding of the mechanisms by which 
ultrasound stimulates cell responses are also described. 
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1.3. Thesis Contributions 
• Identification of four key phases in the 49 day ICX-SKN manufacturing process 
which increased the understanding of processes that occur in cell-seeded fibrin 
matrices in-vitro. 
• Demonstration of methodologies for repeatable quantification and qualification 
of the biochemical and mechanical properties of the ICX-SKN constructs and 
tissue-engineered constructs with gel-like properties. 
• Demonstration of the novel application of non-destructive 3D Surface profiling 
and Raman spectroscopy for the characterisation of the changes in physical and 
biochemical properties of the ICX-SKN constructs. 
• Design and build of a novel ultrasound device for repeatable and reproducible 
delivery of ultrasound to tissue-engineered constructs. 
• Application of a design of experiments methodology to efficiently assess the 
effects of ultrasound in the therapeutic range on the collagen synthesis and 
mechanical properties ofICX-SKN. 
• Evidence to show that the combination of ultrasound duty cycle and duration 
have a significant effect on the mechanical properties ofICX-SKN constructs in 
comparison to other combinations of ultrasound intensity, duty cycle and 
duration which had no significant effect. 
• Demonstration of the use of ultrasound stimulation to achieve a step change in 
mechanical properties ofICX-SKN for product improvement. 
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Chapter 2 Literature Review 
2.0. Introduction 
This chapter reviews the clinical, commercial and scientific issues associated with the 
development of an early stage tissue-engineered constructs for treatment of acute 
wounds. The composition, structure and function of skin and wound healing events that 
occur when the skin suffers injury or insult are described in sections 2.1 and 2.2. The 
advantages and disadvantages of the current gold standard skin grafting treatment for 
secondary intention acute wounds and benefits of development of skin substitutes are 
discussed in section 2.3. 
ICX-SKN, a dermal skin substitute currently being developed by healthcare company 
Intercytex will be used in this thesis as a demonstrator product for improvement of the 
manufacturing process and product properties. The production of ICX-SKN is 
described in detail in section 2.4 together with the current understanding of the 
processes that occur during the manufacturing period to produce the collagen matrix 
which forms the ICX-SKN product. 
Cell seeded fibrin gels have been investigated in-vitro by researchers investigating the 
wound healing remodelling process and developing tissue-engineered constructs. The 
processes that occur in-vitro to convert the fibrin matrix into a collagen matrix are 
reviewed in section 2.5. The current characterisation techniques used to measure the 
changes that occur during the remodelling process are reviewed in section 2.6. The use 
of biochemical and mechanical stimulation to increase collagen synthesis and 
mechanical properties of the matrices, are reviewed in section 2.7. In addition, the 
mechanotransduction process by which mechanical stimulation is transmitted from the 
extracellular matrix to the cells on a molecular level is described. Finally, the use of 
ultrasound as a form of mechanical stimulation and its suitability of scale-up is 
reviewed in section 2.8. 
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2.1. Composition, Structure and Function of the Skin 
The skin is one of the largest organs of the human body. It functions to protect the body 
from injury and dehydration, provide defence aga inst bacterial infection and regulate 
temperature (Barbucci 2002). It is composed of approx imately 70% water, 25% protein, 
2% lipids, and the remaining 3% is comprised of glycosaminoglycans (GAGs), 
proteoglycans (PGs), trace minerals and other chemical s (Barbucci 2002). The skin is 
composed of two principle layers (Figure I), the outer epidemlis which provides the 
protective, semi-permeable layer (Madison 2003) and the underlying dermis which 
provides the majority of the mechanical properti es of the skin (Lai-Cheong, McGrath 
2009). 
Stratum corneum 
Kerat inocytes Epidermis 
.. ,-
..: .. -~-
... ,., - ' 
• 
• 
• -;* .- .... . ~, 
'. , . -
-
Basal layer 
Fibroblast 
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Dermal matrix 
Figure I Cross-section of normal human skin . (Reprinted "\'ith permission from Organogenesis 
Inc.) 
The avascular epidermis comprises of up to four layers of keratinocytes cell s which 
continually di FFerentiate and move from the inner basa l layer to the outer stratum 
corneum layer where they are sloughed off every 2 - 3 weeks (Madison 2003). The 
dermis is 2-4mm thick and is predominately comprised of extracellular matri x (ECM) 
inter-di spersed between skin appendages, nerves, blood vessels and dermal fib roblast 
cells (See ley, Step hens et al. 2006, Tobin 2006). The ECM compri ses of fibri llar 
proteins such as collagen and e lastin, embedded in a viscous ground substance 
comprising of water, proteoglycans and glycosaminoglycans. Co ll agen forms the 
majori ty of the dermis accounting for approximately 70% of the dry weight (Table I). 
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The viscous ground substance and elastic collagen and elastin fibres give the dermis its 
viscoelastic properties which allow deformation and recovery of the skin (Ventre, 
Mollica et al. 2009, Silver, Seehra et al. 2002). The glycosaminoglycans (GAGs) and 
proteoglycans are attached to the co ll agen fibres and they function to bind the water in 
the ground substance to the collagen fibres. The GAGs and proteoglycans have also 
been shown to play an important role in extracellular assembly of collagen by binding 
collagen type [ fibres and controlling the inter-fibrillar spaces (Carrino, Sorrell et al. 
2000, Danielson, Baribault et al. 1997, Reed, Iozzo 2002, Kuwaba, Kobayashi et al. 
200 I, Longas, Fleischmajer 1985). 
The dermal fibroblasts ce lls are responsible for maintaining and remodelling the ECM 
in response to biochemical and mechanica l stimuli (Soyce 200 I). The fibroblasts 
remodel the ECM by a number of mechanisms such as secret ion of matrix 
metalloproteinase (MMP) enzymes which breakdown the ECM and secretion of new 
fibrill ar proteins (S tamenkovic 2003). The results of this remodelling are apparent in 
different areas of the body. For instance, the attac1unent of the skin to the body is loose 
over joint fl exures to allow for a range of movements but is relatively tighter and 
thicker on the soles of the feet to provide protection fTo m the frequent pressures to 
which they are subjected (Forslind 1995, Jarrett 1978, Seeley, Stephens et al. 2006). 
Component °fo 
Collagen fibres 66 - 69 
Non-fibre forming co llagens 2-4 
Elastin 2-4 
Hya luronic Acid (GAG) 0.03 - 0.09 
Table t Co mposition of the dry weight of the main components in the dermis (S il ve r, Siperke et al. 
2003) 
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2.1.1. Dermal Response to Mechanical Deformation 
Mechanical testing of the dennis has shown that different components of the ECM 
respond at increasing levels of strain (Forslind 1995, Silver, Siperko et al. 2003, Wailer, 
Maibach 2006, Pins, Christiansen et al. 1997, Silver, Christiansen et al. 2001). At low 
strains of 0%-30%, skin responds elastically due to the stretching of the elastin fibres. 
At 30%-60% strain skin demonstrates viscoelastic behaviour due to the gradual 
straightening of the collagen fibres and displacement of the viscous ground substance 
and water molecules bound to proteoglycans and GAGs. At high strains, 60%-70%, 
internal disruption and sliding between the collagen fibres and fibrils occurs. The 
ultimate tensile strength of skin, including the epidennallayer, has been reported to be 
21-34MPa (Bhat 2005, Edwards, Marks 1995) and in the elastic region the Young's 
modulus as OA-0.8MPa (Clark, Cheng et al. 1996, Manschot, Brakee 1987). 
2.1.2. Structure and Function of Collagen in the Dermis 
Many types of collagen have been identified in the dennis and provide a variety of 
functions. The collagen fibres are composed of collagen type I (80-90%), collagen type 
III (8-11%) and collagen type V (2-4%) and provide the majority of the elastic 
properties and tensile strength of the dennis (Tobin 2006, Silver, Siperko et al. 2003). 
Non-fibril fonning fibres such as collagen type XII and XIV are present on the surface 
of these fibres although their function is not fully understood (Lavker, Zheng et al. 
1987, Keene, Marinkovich et al. 1997). Other types of collagen such as type IV and VI 
and VII (1-5%) also fonn fibrillar networks that contribute towards the organisation and 
mechanical properties of the dennis (Keene, Marinkovich et al. 1997) and function to 
anchor the dennal ECM to the basement membrane between the dennis and epidennis 
(Silver, Siperko et al. 2003). 
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There has been much research into the mechanisms by which collagen is produced by 
the fibroblast cells in the dermis (Kadler, Holmes et al. 1996, Ghosh 2002) and is 
summarised below. In response to biochemical and mechanical stimuli, procollagen 
amino acid chains with the repeating structure of Gly-Xaa-Y aa are produced in the cell 
nucleus. Three procollagen molecules, approximately 300nm in length and 1.5nm in 
diameter, are processed into a triple helical structure in the endoplasmic reticulum by 
hydroxylation and hydrogen bonding of the chains. These procollagen assemblies are 
then packaged in secretory vesicles in the Golgi apparatus which move to the cell 
membrane and are secreted into the extracellular space. 
The procollagen molecules form larger collagen fibrils by bonding longitudinally 
through specific cleavage of their end N and C-terminal propeptides, and laterally 
through lysyl oxidase cross~linking. The fibrils (56-62nm in diameter) cross-link to one 
another form collagen fibres of between 0.3- 40llm giving the skin its tensile strength 
and elasticity (Ghosh 2002, Ushiki 2002, Bhogal, Stoica et al. 2005, Barton, Marks 
1984). 
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2.2. Primary Intention Wound Healing 
When the body suffers an insult or injury such as a breakage in the skin, a cascade of 
events occurs to heal the wounded area. For acute wounds which heal by primary 
intention that is, without human intervention, there are four stages to wound healing -
haemostasis, inflammation, proliferation and remodelling (Clark 1996, Li, Chen et al. 
2007, Broughton, Janis et al. 2006) and are summarised below. 
During haemostasis platelets from the blood release fibrinogen in the wound site which 
is then cleaved by thrombin to form a fibrin clot or provisional matrix within minutes of 
the injury. The provisional matrix controls the blood flow and provides a temporary 
protective barrier for the body. The platelets release cytokines and growth factors which 
stimulate migration and proliferation of cells that are required in subsequent stages of 
wound healing. The inflammation stage occurs after a few hours when inflammatory 
cells such as macro phages and monocytes migrate to the wound site and remove foreign 
particles and dead or injured cells. Macrophages and platelets secrete growth factors 
and cytokines that promote angiogenesis and stimulate migration and proliferation of 
surrounding fibroblasts into the provisional matrix. Re-epitheliaIisation of the wound by 
migrating keratinocytes also begins during this time. 
During the proliferation stage, the provisional matrix is broken down by digestive 
enzymes secreted by the macrophages and proliferating fibroblasts after 3-5 days. New 
blood vessels form an interconnecting network which provides oxygen and nutrients 
required by fibroblasts for the active synthesis of proteins such as collagen. After 4-5 
days, the fibroblasts synthesise and deposit a loose extracellular matrix including, 
collagen types I, III and V, glycosaminoglycans and proteoglycans. The collagen 
molecules polymerise into randomly organised fibrils over a period of about 2 weeks 
and this matrix is known as granulation tissue. The contractile fibroblast phenotype, the 
myofibroblast, acts to pull the wound margins together, causing the wound to shrink 
and reducing the surface area that the keratinocytes need to cover for complete re-
epitheIiaIisation. 
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Finally, remodelling of the granulation tissue occurs through the breakdown of collagen 
type III and further secretion of collagen type I by fibroblasts. The higher tensile 
strength of collagen type I compared to collagen type III and the reorganisation of ECM 
molecules by the fibroblasts result in the wound regaining approximately 20% of its 
tensile strength after 21 days (Oxlund 1986). Further remodelling in response to local 
stimuli, such as mechanical stimulation from moving joints, occurs over a period of 
years through the development of collagen fibrils and fibre bundles (Clark 1996, Li, 
Chen et al. 2007, Broughton, Janis et al. 2006). The change in composition of 
proteoglycans provides additional stability by binding to the collagen fibrils and filling 
the interstitial spaces (Chiquet-Ehrismann, Tucker 2004). The healed wound is reported 
to regain only 70-80% of the tensile strength of unwounded skin (Oxlund 1986) and 
often results in scarring caused by formation of dense collagen bundles. 
The wound healing process which remodels the fibrin clot to a functional collagen 
matrix forms the basis of the ICX-SKN manufacturing process discussed in section 
2.4.1. However, the processes that occur in-vivo differ from that in-vitro and are 
discussed in section 2.5. 
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2.3. Secondary Intention Wound Healing 
Secondary intention acute wounds, such as burns and those caused by accidents or 
surgical procedures, require human intervention for. healing in comparison to the 
primary intention wounds described previously. The current gold standard for healing 
these wounds is skin grafting where the patient's own skin is transplanted from a 
healthy donor site to the wound site (Horch 2006). These procedures have high success 
rates of more than 90% (Molnar, DeFranzo et al. 2004) and produce generally good 
cosmetic results. Skin grafts are autologous (from the patient) which reduces the risk of 
rejection, and retain structures such as blood capillaries which aid integration in the 
wound site by readily allowing vascularisation (Cheng 2006). The failure of skin grafts 
to take to a wound are generally caused by poor vascularisation of the skin graft which 
then results in a deficiency of nutrients and oxygen, and the movement of the graft in 
the wound site which can lead to haematomas at the graft-wound interface (Cheng 
2006). 
Despite the high success rate, skin grafting has a number of disadvantages. These 
include firstly, the need for sufficient, suitable donor sites which may be problematic in 
elderly or weak patients or patients with burns covering large areas of the body. 
Secondly, skin grafting creates a second wound at the donor site. This forms another 
source at risk of infection and is reported to be slow and painful when healing (Cheng 
2006, Damodaran, Syed et al. 2008). Thirdly, the clinicians are required to make a 
choice between using a full-thickness skin graft (dermis and epidermis) or split-
thickness skin graft (epidermis and thin layer of dermis). Full-thickness skin grafts 
(FTSG) prevent contraction of the wound and subsequent scarring but the donor site 
takes longer to heal compared to split-thickness skin grafts (STSG). In contrast, STSGs 
are superior when matching the pigmentation, texture and structure of the graft to the 
skin surrounding the wound but are more prone to scarring and contraction at the 
wound site (Cheng 2006). 
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Finally, the increasing incidence of skin carcinomas (Bath-Hextall, Leonardi-Bee et al. 
2007, Welch, Woloshin et al. 2005) especially those in highly visible regions of the 
body presents an additional dilemma for clinicians (Cheng 2006). The size and depth 
excised around the carcinoma needs to be sufficient to minimise the risk of recurrence 
but improved cosmetic results are achieved through smaller excisions and the 
associated social and psychological impact on the patient needs to be considered 
(Cheng 2006). 
2.3.1. Allografts 
When rapid closure of the wound is necessary to prevent morbidity but insufficient 
patient donor skin is available, donor, cadaver skin allografts from national tissue banks 
are conventionally used. The allograft provides time for the patient's skin to grow so 
that it is suitable for skin grafting and the structure of the allograft reduces contraction 
of the wound. The cost of a split thickness allograft is relatively cheap, at £ 1. 73/cm2 
(UK NHS price 2009, http://tissue.blood.co.uk). However, allografts are only a 
temporary wound cover as they are required to be surgically removed before rejection 
by the body for immunological reasons (Kearney 2007). 
The limitations of skin grafts and allografts have led to the research and development of 
skin substitutes. In 1987, at the National Science Foundation Meeting, a goal was set 
"to create a readily available tissue replacement with the biologic and pharmacologic 
properties of human skin" and to provide alternatives for clinicians (Bello, Phillips 
2000). Since then, numerous products have been developed for treatment of both 
chronic wounds such as diabetic foot ulcers and chronic leg ulcers, and acute wounds 
such as bums and surgical excisions. These products have been recently reviewed by 
Damodaran, Syed et al. 2008, Auger, Lacroix et al. 2009, Clark, Ghosh et al. 2007, 
MacNeil 2007. Skin substitutes can be split into three categories - epidermal only, 
dermal only and combined epidermal and dermal. Skin substitutes for treatment of 
acute wounds are reviewed below. 
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2.3.2. Epidermal Skin Substitutes 
Epidermal skin substitutes comprise of approximately 2-8 layers of autologous (from 
the patient) cells, such as keratinocytes .. These are usually housed on a synthetic 
membrane for ease of application to the wound. They are produced by expanding 
patient cells, taken from a small skin biopsy, in a laboratory and are then delivered back 
to the patient for application. This process was first demonstrated by Rheinwald and 
Green in the 1970s when it was shown that in 3 weeks, cells from a small skin biopsy of 
lcm2 could be expanded in-vitro to produce enough cells for an epidermal layer that 
could cover the whole body. Currently, epidermal skin substitute Epicel® (Genzyme 
Tissue Repair Cambridge, MA) is commercially available for the treatment of bums 
(Table 2). MySkinTM (CellTran, Sheffield, UK) also for the treatment of bums was 
commercially available in the UK. However, CellTran is currently under administration 
(http://www.celltran.com. 2009). 
Clinical studies reported that MySkin TM accelerated re-epithelialisation (Zhu, Wamer et 
al. 2005) and Epicel® aided rapid vascularisation of the dermis in bums patients 
compared to using a STSG (Balasubramani, Kumar et al. 2001, Carsin, Ainaud et al. 
2000). However, several disadvantages were also reported. These included the fragility 
of the Epicel® product (Lobmann, Pittasch et al. 2003), susceptibility to infection and 
contractures (Clark, Ghosh et al. 2007, Rue, Cioffi et al. 1993, Williamson, SneIling et 
al. 1995), and the high costs estimated at US$13 000 for coverage of 1 % total body 
surface area (TBSA) for Epicel® (Clark, Ghosh et al. 2007). 
In addition, the short shelf life of less than 48 hours, presented logistical challenges of 
co-ordinating the culture of the epidermal skin substitutes in the laboratory with 
delivery at the place of use when required by the clinicians (Ehrenreich, Ruszczak 
2006, Gobet, Raghunath et al. 1997, Supp, Boyce 2005). MySkinTM was reported to be 
robust to handle. However, the impact of a short shelf life on the commercial viability 
of such products was highlighted in a report that approximately 50% of MySkinTM 
manufactured was disposed of due to rescheduling of operation times or deterioration of 
the patient's condition before the scheduled operations (MacNeil2006). 
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2.3.3. Dermal Skin Substitutes 
Dennal skin substitutes are composed of a matrix which provides structural support 
within the wound, similar to a FTSG, and a template for adhesion and migration of 
patient cells from the surrounding tissue. In comparison to epidennal skin substitutes, 
dennal substitutes generally have a longer shelf life of more than 9 months which 
reduces the logistical challenges and provides potential for an off-the shelf product 
(Table 2). There are a wide range of commerchilly available dennal substitutes such as 
Allodenn (Life Cell Corporation NJ), TransCyte® (Smith and Nephew, UK) and 
Integra (Integra Life Sciences, NJ). The matrices of the dennal substitutes are typically 
collagen based but are manufactured using different approaches as summarised below. 
2.3.3.1. Alloderm 
Allodenn (Life Cell Corporation, NJ), was developed to incorporate the structural 
benefits of allografts but eliminate the need for surgical removal. Allodenn is produced 
by removing the epidermis and cells that could lead to graft rejection from donated 
human skin tissue from tissue banks. It is intended to be used in full-thickness bums 
with a split-thickness skin graft (http://www.lifecell.com.downloaded2009).Clinical 
studies reported that subjective assessment of cosmetic results favoured the Allodenn 
group in bums patients compared to STSGs (Lattari, Jones et al. 1997, Sheridan, 
Morgan et al. 2001, Wainwright, Madden et al. 1996). In addition, the vascular 
structures retained in Allodenn were reported to aid rapid revascularisation (Butler, 
Langstein et al. 2005, Diaz, Guy et al. 2006, Kim, Bruen et al. 2006, Menon, Rodriguez 
et al. 2003) and reduce the length of hospital stay and associated medical costs (Butler, 
Langstein et al. 2005, Buinewicz, Rosen 2004, Kaleya, Thomas 2005). Allodenn is one 
of the most commercially successful skin substitutes and has been used to treat over 1 
million patients since its launch in 1994 (http://www.lifecell.com. 2009). However, 
successful grafting of Allodenn was shown to be highly dependent on the dressing 
technique used by the clinician as it was more sensitive to shear stresses and prone to 
desiccation than STSGs (Keamey 2001). 
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2.3.3.2. Transcyte® 
TransCyte® (Smith and Nephew, UK) is temporary skin substitute produced in-vitro 
using newborn human fibroblast cells in a nylon mesh coated with porcine collagen. 
The cells enhance the matrix with structural and provisional matrix proteins, 
glycosaminoglycans and growth factors with the aim of producing a template that 
facilitates wound healing (http://wound.smith-nephew.comlzalProduct). At the end of 
the manufacturing process, the cells are destroyed. by freezing before grafting. 
TransCyte® is similar to allografts, as it has to be surgically removed to avoid 
immunological rejection and allergic reactions to the polymer membrane and nylon 
mesh coated with porcine collagen (http://wound.smith-nephew.com).Clinical studies 
reported that TransCyte® was easier to remove than the allografts and required a lower 
percentage of STSG when treating paediatric burns of greater than 7% TBSA (Purdue, 
Hunt et al. 1997, Kumar, Kimble et al. 2004, Lukish, Eichelberger et al. 2001). 
2.3.3.3. Integra 
Integra (Integra Life Sciences, NJ) was developed in the 1970s (Yannas, Burke 1980) 
and became the first marketed tissue-engineered skin with FDA approval in 1996. 
Integra consists of a porous, cross-linked, bovine collagen and chondroitin-6-sulphate 
dermal template and a .silicone .epidermal analogue layer intended for use on deep 
partial-thickness or full-thickness wounds (http://www.integra-ls.com). The pore size 
was designed to encourage adhesion, migration and proliferation of the patient's cells 
into the template when implanted in the wound bed (Dagalakis, Flink et al. 1980). Once 
inside the template the host cells synthesise a new collagen matrix and the dermal 
template degrades. The silicone epidermal layer is removed and replaced with a thin 
STSG after the new collagen matrix is vascularised (Balasubramani, Kumar et al. 2001, 
Jones, Currie et al. 2002). 
Clinical studies reported subjective improvements in cosmetic results and faster healing 
of the donor sites with less hypertrophic scarring when treated with Integra (Heimbach, 
Luterman et al. 1988, Heimbach, Warden et al. 2003, Moiemen, Vlachou et al. 2006). 
However, it was also shown that Integra had poorer take rates of 80-85% compared to 
93-95% for STSGs and was susceptible to infection. 
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2.3.4. Epidermal and Dermal Skin SUbstitutes 
Currently, Apligraf (Organogenesis, MA) is the only commercially available bi-Iayered 
skin substitute but is intended for the treatment of chronic wounds. The most promising 
bi-Iayered skin substitute currently in development for the treatment of bums is 
Permaderm (Lonza, Switzerland). Permaderm comprises of autologous keratinocytes 
and fibroblasts in a bovine collagen matrix (Boyce 2001). Initial studies have shown 
that Permaderm can be used to reduce the area of donor skin required when treating 
patients with full thickness burns of greater than 50% TBSA and has comparable 
cosmetic results to treatment with conventional skin grafts (Boyce, Kagan et al. 2002, 
Boyce, Kagan et al. 2006). However, there is no indication of clinical trials or 
commercial availability in the near future (Auger, Lacroix et al. 2009). In addition, the 
use of autologous cells presents logistical difficulties and delays in treatment of the 
patient, similar to those discussed for epidermal skin substitutes and the commercial 
viability needs to be proven. 
In conclusion, there remains an opportunity for development of a skin substitute for 
routine treatment of acute wounds. There are both scientific and commercial challenges 
that still need to be overcome for the routine use of skin substitutes in patients. The key 
challenges are development of a skin substitute that is easy to handle, has a suitable 
shelf life that minimises logistical and supply chain difficulties and demonstrates 
significant benefit over current gold standard (MacNeil 2007). The cost of production 
of skin substitutes also needs to allow for profitable reimbursement (MacNeil 2007). 
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2.4. Intercytex and ICX-SKN - A Manufactured Living Dermal Skin 
Equivalent 
Intercytex is an emerging healthcare company based in the UK and North America 
using a proprietary cell therapy to develop products to restore and regenerate skin 
(www.intercytex.com). Intercytex's ICX-SKN product aims to be a skin graft 
replacement for burns and acute wounds. ICX-SKN comprises of living allogeneic 
neonatal human dermal fibroblasts (HDF) in a human collagen matrix synthesised by 
the cells and successfully completed Phase I clinical trials in 2007 (Boyd, Flasza et al. 
2007). The manufacturing process, current understanding of the events that occur 
during manufacturing to produce ICX-SKN, and the proposed mechanism of action in-
vivo are described below. 
2.4.1. Manufacturing Process 
The manufacture ofICX-SKN is described in detail by (Flasza, Kemp et al. 2007) and 
summarised in Figure 2. The ICX-SKN construct is manufactured by embedding 
allogeneic neonatal human dermal fibroblasts (HDF) in a fibrin matrix and culturing the 
constructs using a specific media formulation for 49 days. During the manufacturing 
period the cells proliferate, breakdown the fibrin matrix and secrete a new collagen 
matrix in a similar sequence of events to those found during in-vivo wound healing 
(section 2.2). After 49 days, the ICX-SKN constructs are freeze dried for storage and 
sterilised by gamma-irradiation. Prior to packaging and shipping, the constructs are 
rehydrated and repopulated with HDF cells which secrete structural and provisional 
matrix proteins, glycosaminoglycans and growth factors before application in the 
wound. 
During manufacturing, it is hypothesised that the rate of fibrin degradation and collagen 
synthesis by the HDF cells is critical to the successful production of ICX-SKN 
(Personal communication with Dr.P.Kemp, CSO, lntercytex, 2007). A high fibrin 
degradation rate may result in no matrix to support the cells which would lead to the 
cells growing in monolayers and secreting collagen on the surface of the tissue culture 
plastic. A low fibrin degradation rates may result in long manufacturing times which 
will impact the cost of manufacture and commercial viability (Figure 3). A balance 
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between the fibrin degradation rate, collagen secretion rate and cost of manufacture is 
necessary for the commercial success ofICX-SKN. 
Human dermal fibroblasts cast in a fibrin matrix 
! 
Cellular matrix cultured by feeding with Total Media every 2 days 
! 
Fibrin matrix degraded and collagen matrix secreted by cells 
! 
ICX-SKN harvested and freeze dried after 49 days 
! 
ICX-SKN gamma irradiated and stored until required for use 
! 
ICX-SKN rehydrated and populated with human dermal 
fibroblasts 
! 
ICX-SKN packaged and distributed to required location 
Figure 2 Summary of the ICX-SKN manufacturing process 
2.4.2. Phase I Clinical Trial Results 
The Phase I Clinical trial results are described in detail by Boyd, Flasza et al. 2007 and 
are summarised below. ICX-SKN constructs were applied to full thickness excisions 
(5mm x l5mm), made in six healthy volunteers, for 28 days. No adverse responses in 
the volunteers were observed and there was minimal scarring after 28 days. 
Histopathology of the excised wound after 28 days showed that in 5 out of the 6 
patients a complete epidermis of keratinocytes with all components including the 
stratum corneum and spinous layer was formed as well as rete ridges at the epidermal 
and dermal interface. Migration and proliferation of host fibroblasts was observed in the 
graft and there was excellent integration between the graft and surrounding tissue. 
Furthermore, the formation of small blood vessels were observed providing evidence 
that the structure of the matrix allowed vascularisation. The presence of allogeneic HDF 
cells did not cause any adverse immune reactions towards ICX-SKN and there was only 
a small presence of non-specific inflammatory cells in the graft. 
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2.4.3. Proposed Healing Mechanism 
The processes that occur to integrate lCX-SK with the surrounding skin and 
encourage tissue regeneration in-vivo are not known. It is hypothesised that the 
allogeneic and patient HDF cells detected in the ICX-SK construct during the Phase I 
clinical tri als secreted growth facto rs, cytokines, col lagen and other extracellular matrix 
components to breakdown the ICX-SKN matrix and form a new co llagen matrix 
secreted from the patient' s cell s (Boyd, Flasza et al. 2007). In addition, the mechanical 
properties o f the matrix were hypothesised to provide structural support for the cells in 
the wound. 
The rate at which the ICX-SKN matrix is broken down and the new dermal matrix 
secreted is hypothesised to be criti cal for the success of ICX-SKN in-vivo (Persona l 
communication with Dr.P.Kemp, CSO, Intercytex, 2007). If the breakdown of the ICX-
SKN matrix is too rapid, the wound will reopen. If the breakdown of the ICX-SKN 
matrix is too slow, there is a ri sk that it will be encapsulated by the new dermal matrix 
rather than integrated with it which may impact cosmetic results (Figure 3). 
IN-VITRO IN-VIVO Native Skin 
MANUFACTURING IMPLANT WOUND HEALING 
Healed wound 
ICX-SKN Host collagen 
ICX-SKN Collagen 
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Figure 3 Proposed ICX-SKN manufacturin g process model and mechanism of action in-vivo 
(Personal communication with Dr.P.Kemp, CSO, Intcrcytcx) 
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Further understanding of the processes that occur during manufacturing are required to 
identify areas for process improvement for cost-effective manufacture and to provide a 
benchmark for the assessment of process changes. Identification of methods to improve 
the product is also required. The key areas for product improvement are to increase the 
collagen content to improve persistence of the construct in the wound and to increase 
the mechanical properties to improve the ease of handling of the construct. However, 
improvement of the ICX-SKN construct must also provide a matrix structure that 
facilitates vascularisation and cell adhesion, migration and proliferation in-vivo to allow 
for integration of the construct into the wound site. 
In addition, further development of repeatable and reproducible characterisation 
techniques to measure key processing parameters and final product properties is 
required. This will improve the understanding of the process variation and aid 
development of a product specification. This is important for commercialisation of 
ICX-SKN and tissue-engineered products as repeatable manufacture of product to pre-
determined specifications is required by regulation under Good Manufacturing Practice 
(GMP). 
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2.5. Cell Seeded Fibrin Matrices 
2.5.1. Introduction 
Cell-seeded fibrin matrices have been studied in-vitro as wound healing models and for 
the development of tissue-engineered constructs (Grinnell 2003). Collagen matrices 
synthesised from cells in fibrin matrices have been investigated for dermal, valve and 
arterial replacements (Neidert, Lee et al. 2002, Grouf, Throm et al. 2007, Ahlfors, 
Billiar 2007, Balestrini, BiIliar 2006) and for cardiovascular applications using smooth 
muscle cells (Grassl, Oegema et al. 2002, Ross, Tranquillo 2003). The processes that 
occur in cell seeded fibrin matrices and methods for improving collagen content and 
mechanical properties of the Constructs are described below. 
2.5.2. Cell Proliferation 
A wide range of cell densities, between 1 x I OS and 2x 1 06, have been used to seed fibrin 
matrices. Cell proliferation resulting in a more than 2-fold increase in the total cell 
number has been reported for human dermal fibroblast (HDF) and smooth muscle cells 
(Ahlfors, BiIliar 2007, Ross, Tranquillo 2003). A study of HDF cell proliferation in 
fibrin matrices over 9 days showed that the number of cells did not increase for the first 
3 days but subsequently doubled every 3 days until day 9 (Tuan, Song et al. 1996). The 
degree of cell proliferation has been shown to be dependent on the formulation of 
fibrinogen and thrombin used to produce the fibrin matrix (Dickneite, Metzner et al. 
2004). HDF cells were shown to proliferate poorly in formulations that consisted of a 
high fibrinogen concentration (34-50mglmL) and a low thrombin concentration 
(I U/mL) in comparison to formulations with a lower fibrinogen concentration 
(5mglmL-17 mg/mL) and low to medium thrombin concentration (I U/mL and 167 
UlmL) (Cox, Cole et al. 2004). 
The reasons for the differences in cell proliferation are not fully understood. However, 
it was suggested that spreading and rounding of the fibroblasts as they adhere and 
detach from the fibrin matrix during the normal 16-18 hour cell proliferation cycle was 
affected by the fibrin formulation (Cox, Cole et al. 2004). This is supported by studies 
of the structure of fibrin matrices which have shown that higher thrombin 
concentrations produce denser matrices with thinner fibrin fibrils (Wolberg 2007). In 
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addition, the mechanical properties of the fibrin matrix have been shown to increase 
with increasing fibrinogen concentrations (Benkherourou, Gumery et al. 2000, Mooney, 
Costales et al. 2008, Mooney, Costales et al. 2006) and may also provide mechanical 
signalling to the cells which affect cell proliferation. (Duong, Wu et al. 2009). 
The ability for the cells to proliferate and the number of cells in the fibrin matrices may 
be an important factor to consider when manufacturing tissue-engineered constructs 
from cell seeded fibrin matrices. This is because the cells are responsible for the 
remodelling of the fibrin matrix as they degrade the fibrin matrix and secrete collagen 
which forms the final product. The number of cells present in the matrix may therefore 
affect the efficiency ofthe manufacturing process. 
2.5.3. Matrix Compaction 
Cells seeded in matrices restrained around the edges (usually by the culture dish) 
compact the matrix causing a decrease in the thickness (Grinnell 2003, Neidert, Lee et 
al. 2002, Ahlfors, Billiar 2007, Ross, Tranquillo 2003). It has been shown that HDF 
cells seeded in a restrained fibrin matrix reorganise the fibrin fibrils which causes the 
compaction and generate tension in the matrix (Tuan, Song et al. 1996). Studies of HDF 
cells seeded in a collagen matrix have shown that the cells establish a level of 
"tensional homeostasis" within the matrix at which this level is maintained against 
opposing influences of external loading and unloading (Brown, Prajapati et al. 1998). It 
was suggested that this was achieved through rapid contraction and relaxation of the 
HDF cells through reorganisation of the cell cytoskeleton (Brown, Prajapati et al. 
1998). 
The thickness of cell seeded fibrin matrices has been shown to decrease over a period of 
4 to 28 days (Neidert, Lee et al. 2002, Grouf, Throm et al. 2007, Ahlfors, Billiar 2007, 
Grassl, Oegema et al. 2002, Ross, Tranquillo 2003, Sander, Johnson et al. 2008). The 
differences in the period of compaction may have been due to the differences in cell 
seeding density and fibrin formulation used in each of the studies. This may have 
affected the rate at which the fibrin fibrils were reorganised by the cells to achieve 
tensional homeostasis. The degree of compaction by the cells was typically more than 
70% resulting in decreases in the thickness of the matrices from approximately 2mm to 
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200J.lm. In addition, release of these constructs from the restraints resulted in retraction 
of the matrices showing that the matrices are under tension (Grinnell 2003, Feng, 
Yamato et al. 2003). Dermal skin substitutes such as ICX-SKN aim to provide 
structural support in the wound. Control of the compaction and retraction is necessary 
for control of the physical and structural properties of the final construct. 
2.5.4. Fibrin Degradation 
The rate of degradation of the fibrin matrix has not been widely reported. One study of 
SMCs seeded in a fibrin matrix showed that fibrin degradation occurred over 
approximately 18 days by measuring the levels of fluorescently labelled fibrinogen 
(Grassl, Oegema et al. 2002). This was supported by another study which showed by 
histological analysis that a fibrin matrix seeded with smooth muscle cells was 
predominantly composed of collagen after 3 weeks (Ross, Tranquillo 2003). In 
comparison, histological analysis of a HDF seeded fibrin matrix showed that fibrin was 
present in the matrix after 51 days (Neidert, Lee et al. 2002, Neidert, Tranquillo 2006). 
Studies have also monitored the gene expression of matrix metalloproteinase (MMP) 
enzymes as an indication of the degree of matrix remodelling that occurs in cell seeded 
fibrin matrices. In a 5 week study of an SMC seeded fibrin matrix, it was shown that 
expression of MMPI and MMP2, associated with degradation of collagen and fibrin 
(Kato, Yasukawa et al. 2000, Page-McCaw, Ewald et al. 2007, Green, Almholt et al. 
2008), peaked after 3 weeks (Ross, Tranquillo 2003). It is likely that the initial increase 
in the MMPs in the first 3 weeks was associated with degradation of fibrin. However, 
measurements of the levels of MMPs are only an indication of the degree of 
remodelling that is occurring and not the specific proteins that are being remodelled. 
Further understanding of the rate of fibrin degradation would be beneficial as it has 
been reported that the presence of fibrin stimulates collagen secretion from the cells 
(Grassl, Oegema et al. 2002). 
27 
2.5.5. Synthesis of Collagen and other ECM Proteins 
Collagen synthesis has been shown to begin 2 to 7 days after seeding the cells in fibrin 
matrices (Ross, Tranquillo 2003, Tuan, Song et al. 1996). Independent studies of HDF 
seeded fibrin matrices showed that 32% (Ahlfors, Billiar 2007) and 33% (Neidert, Lee 
et al. 2002) of the dry weight of the matrix was composed of collagen after 21 days. 
However, the absolute collagen content differed significantly between these studies 
which ~eported the total collagen content as 510Ilg and 50llg respectively. The 
differences were suggested to be due to the different media formulation and lower 
number of cells initially seeded in the latter study (Ahlfors, Billiar 2007). The latter 
study also showed that the collagen content increased by 130% when culturing 
constructs for a further 30 days (Neidert, Lee et al. 2002). 
In addition, a 5 week study of SMC seeded fibrin gels showed that the amount of 
collagen deposited in the matrix increased over the whole 5 week period although 
expression of the collagen type I and type III genes peaked after 3 weeks (Ross, 
Tranquillo 2003). The gene expression of collagen type I was also shown to be 8 to 10 
times greater that the expression of collagen type Ill. Finally other ECM components 
have also been shown to be synthesised in cell seeded fibrin matrices. Proteoglycans 
were shown to account for 2% of the dry weight of HDF seeded fibrin gels after 21 
days (Ahlfors, Billiar 2007) and elastin was detected in SMC seeded fibrin gels after 28 
days (Ross, Tranquillo 2003). 
2.5.6. Mechanical Properties 
A number of studies have shown that the increase in collagen content in the fibrin gels 
correlates with an increase in mechanical properties (Neidert, Lee et al. 2002, Ahlfors, 
Billiar 2007, Grassl, Oegema et al. 2002). Studies of SMC and HDF seeded fibrin 
matrices showed a 51 % increase in ultimate tensile strength (UTS) after 35 days (Ross, 
Tranquillo 2003) and a 150% increase in UTS after 51 days (Neidert, Lee et al. 2002) 
compared to the UTS after 21 days respectively. The increase in UTS was associated 
with Iysyl-oxidase cross-linking of the collagen fibrils (Neidert, Lee et al. 2002, Ross, 
Tranquillo 2003) and formation of collagen fibril bundles (Ahlfors, Billiar 2007). 
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The increase in UTS also correlated with the increase in collagen content. The UTS of 
the matrix with 51 OJ.lg of collagen discussed previously was 133KPa (Ahlfors, Billiar 
2007) compared to 2.4KPa for the matrix containing 50J.lg collagen (Neidert, Lee et al. 
2002). These findings were supported by studies of collagen gels which showed that the 
viscoelastic properties of the matrices increase with increasing collagen cross-linking 
and collagen concentration (Bron, Koenderink et al. 2008, Battista, Guamieri et al. 
2005, Raub, Suresh et al. 2007, Raeber, Lutolf et al. 2005). The in-vitro fibrin 
remodelling processes are summarised in Figure 4. 
Cell 
Figure 4 Main processes that occur over time in SMC and HDF seeded fibrin matrices 
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2.6. Characterisation Techniques 
A number of techniques have been used to measure the changes in physical biochemical 
and mechanical properties of cell seeded matrices. Light and electron microscopy 
techniques are widely used to qualitatively assess the changes in structure and 
biochemical composition. Quantitative tests to measure the collagen content and 
mechanical properties have also been established. However, cell seeded fibrin matrices 
are initially difficult to handle due to their gel-like consistency and repeatable 
measurement of their properties can be problematic. The repeatability and 
reproducibility of these techniques for use on cell seeded fibrin matrices with gel-like 
properties are reviewed below. 
2.6.1. Structural Characterisation 
Established light microscopy techniques such as histology and immunohistochemistry 
for observing the structure of tissues have been applied to tissue-engineered constructs. 
Histological stains such as Masson's Trichrome, Verhoeffs Van-Gieson's and Alcian 
Blue are used for detection of fibrillar proteins such as collagen, fibrin and elastin, and 
other ECM components such as proteoglycans and GAGs in connective tissue (Clark 
1973). These stains have also been applied to tissue-engineered constructs (Robinson, 
lohnson et al. 2008, Hoerstrup, Kadner et al. 2002, Mol, van Lieshout et al. 2005). 
Similarly, immunohistochemistry (!HC) has been used to identify specific fibrillar 
proteins and ECM components such as human collagen type I and the proteoglycans 
decorin and versican in tissue-engineered constructs (Cuttle, Nataatmadja et al. 2005, 
Fathke, Wilson et al. 2006, lunge, Klinge et al. 2004, Sullivan, Puolakkainen et al. 
2008, Hayes, Hughes et al. 2008, Heydarkhan-Hagvall, Esguerra et al. 2006). 
Electron microscopy is an established technique for analysing the structure of the 
extracellular matrix in tissues at higher magnifications. Tissue samples for electron 
microscopy are generally prepared by fixation followed by chemical dehydration to 
preserve the native structure and remove any liquid from the sample which would 
damage the electron microscopy equipment when imaging (Bozzola, Russell 1999). 
However, preparation of tissue-engineered samples for electron microscopy is 
problematic as the samples typically have high water contents of over 50%. 
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Conventional methods to prepare the samples often lead to disruption of the native 
structure and introduction of artefacts (AI-Amoudi, Norlen et al. 2004, Muscariello, 
Rosso et al. 2005). Recent advances in this field to facilitate the preparation and 
imaging of such samples have been reviewed by (Starborg, Lu et al. 2008) and are 
summarised below. 
Firstly, for scamiing electron microscopy (SEM) which provides images of sample 
surfaces, freezing of the samples to preserve the native structure has been investigated. 
Low temperature freezing of samples using slush liquid nitrogen at -196°C followed by 
freeze fracturing and then freeze-etching at _90°C to remove the water has been used for 
tissue-engineered constructs (K5se, Kenar et al. 2003, Wright, Conticello et al. 2003). 
However, this technique is prone to ice crystal formation when freezing and can 
damage the structure of the matrix. 
High pressure freezing has been developed to minimise the formation of ice crystals in 
samples and many authors have reported successful use of this technique for the 
imaging of cells and hydroge\s (AI-Amoudi, Norlen et al. 2004, McDonald, Morphew 
et al. 2007, Serp, Mueller et al. 2002). However, high pressure freezing equipment is 
expensive and small samples of less than 3mm3 are required which are often difficult to 
prepare and handle without damaging (McDonald, Morphew et al. 2007). The use of 
cryoprotectants such as dimethyl sulfoxide, in the samples before freezing has proved 
successful in larger biological samples to prevent ice crystal formation (Dahl, Chen et 
al. 2006). However, cryoprotectants can be toxic to cells so the concentration and 
duration of the cryoprotectants on the samples must be carefully monitored. 
Secondly, envirorunental scanning electron microscopy (ESEM) has been developed to 
image samples in the wet state without the need for any sample preparation 
(Muscariello, Rosso et al. 2005). Many successful studies of interactions between 
mammalian cells and biomaterials have been reported (Muscariello, Rosso et al. 2005, 
Motta, Migliaresi et al. 2004). However, there are also difficulties associated with using 
wet samples. The low vacuum used in the ESEM can cause the samples to change shape 
during imaging which can result in blurring. Also, the wet samples can produce 
different charge status across the surface which results in dark and light areas observed 
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in the images. The resulting images may provide misleading information of the surface 
topography (Muscariello, Rosso et al. 2005). 
Thirdly, observation of the cross-sections of samples has been demonstrated using 
transmission electron microscopy (TEM). The most effective technique for minimal 
artefacts formation and good structural preservation of samples has been reported to be 
through use of resin embedded samples. Resin is slowly infiltrated into the samples 
replacing the liquid with minimal damage to the constructs (Edelmann 2002). Detail of 
internal cellular organelles and interactions between cells and fibrillar molecules can be 
observed however, the preparation is labour intensive and TEM is restricted to a single 
slice in a three dimensional structure (Starborg, Lu et al. 2008). 
More recently, automated electron tomography techniques are being developed which 
take multiple thin, serial TEM sections which are then recreated into three dimensional 
images (Starborg, Lu et al. 2008). This method is advantageous as it can provide 
information about changes in structure through the whole sample. However, automated 
electron tomography is in its infancy and a single three dimensional compilation takes 
several days and much computing power. 
2.6.2. Fibrin Degradation and Collagen Synthesis 
Quantification of the rate of fibrin degradation in cell seeded fibrin gels is not widely 
reported. One study measured the fluorescence intensity from fluorescently labelled 
fibrinogen used to produce the fibrin matrix (Grassl, Oegema et al. 2002). Other studies 
have used Masson Trichrome staining for histological detection of fibrin (Neidert, Lee 
et al. 2002, Ross, Tranquillo 2003, Grassl, Oegema et al. 2003). 
Techniques to quantify the collagen content in tissue-engineered constructs are more 
widely reported. Assays that measure the content of hydroxyproline as an indication of 
total collagen content (Stegemann, Stalder 1967) and dye-based assays that bind to 
amino acid side chains present in collagen (Junqueira, Bignolas et al. 1979) are 
commonly used. Measurement of hydroxyproline has been used to determine the 
collagen content in several cell-seeded fibrin matrices (Neidert, Lee et al. 2002, Ross, 
Tranquillo 2003, Grassl, Oegema et al. 2003). Similarly, the Sircol™ assay which uses 
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Sirius red dye to bind to acid soluble collagen type I to IV and has been used by several 
authors (Mol, van Lieshout et al. 2005, Hansen, Schilnke et al. 2001, Ibusuki, Fujii et al. 
2003). 
However, studies conducted by Intercytex showed that both the hydroxyproline and 
Sircol™ assays produced positive readings when applied to control fibrin gels 
(Marshall 2005). In addition, for the hydroxyproline assay, collagen gels mixed with the 
fibrin gel resulted in higher absorbance readings compared to collagen only samples. In 
comparison, use of an enzyme-linked immunosorbent assay (ELISA) for collagen type I 
has been shown to not produce a positive reading from the control fibrin matrices. 
Increasing collagen concentrations were also shown in ICX-SKN samples over the 
manufacturing period using ELISA (Marsha1l2005). The use of ELlS A for detection of 
collagen in several tissue-engineered constructs has been reported (Chen, Altman et al. 
2003, Blunk, Sieminski et al. 2002, Hsu, Whu et al. 2004). However, detection of 
collagen type I synthesised by cells seeded in fibrin matrices has not been reported. 
Finally, other studies have used real-time PCR to quantify the gene expression of 
collagen, lysyl oxidase required for collagen cross-linking, MMPs which aid 
remodelling of the ECM and elastin (Ross, Tranquillo 2003, Thampatty, Li et al. 2007). 
Although gene expression provides valuable understanding of intercellular responses it 
does not necessarily correlate with secretion of the proteins or enzymes by the cells in 
the matrix. 
2.6.3. Mechanical Properties 
Mechanical testing of tissue-engineered constructs can provide supporting data for the 
qualitative structural observations and valuable understanding of the possible 
functionality of the constructs in-vivo (Billiar, Throm et al. 2005). Changes in 
mechanical properties can show important developmental processes such as deposition 
of structural proteins, remodelling of the proteins into a hierarchical arrangement such 
as collagen bundles, and physical and chemical bonding between the proteins (Sheu, 
Huang et al. 2001, Huang, McWilliams et al. 2003). Mechanical characterisation can 
therefore be potentially be used for process optimisation and quality control during 
manufacturing (Billiar, Throm et al. 2005). A number of techniques have been used to 
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detennine the mechanical properties of tissue-engineered constructs and are reviewed 
below. 
Tensile testing has been widely used to measure the ultimate tensile strength (UTS) and 
Young's Modulus (E) oftissue-engineered cartilage, tendon, heart valves and ligaments 
(Screen, Shelton et al. 2005, Screen, Lee et al. 2004, Moffat, Sun et al. 2008, Fratzl, 
Misof et al. 1998). The constructs are typically secured in uniaxial or biaxial testing 
machines using serrated grips or via sutures (Screen, Lee et al. 2004, Lu, Sacks et al. 
2005). However, repeatability of the results is problematic for tissue-engineered 
construct with gel-like properties as they are difficult to handle and load into the 
machines without damage. 
It has been reported that such constructs are prone to failure at the grips due to stress 
concentrations. Also, the established "dog-bone" shape used to improve repeatability 
and accuracy of the test is difficult to cut in soft materials without introducing defects 
and premature failure of the samples propagating from these defects can occur (Billiar, 
Throm et al. 2005). In addition, it has been suggested that the strength and extensibility 
of uniaxially tested soft tissue samples is overestimated due to unrestrained 
reorientation of the structural fibres in the direction of stretch (Feng, Yamato et al. 
2003). 
Inflation techniques to detennine mechanical properties of planar tissue-engineered 
constructs have been used to address the issues with tensile testing described above. 
The construct is typically secured between two plates. The lower plate has a circular 
opening through which the constructs is inflated with a fluid or compressed air (Billiar, 
Throm et al. 2005). The UTS and extensibility of a HDF seeded fibrin gels was reported 
to be approximately 28KPa after 25 days in culture (Billiar, Throm et al. 2005) using 
this method. The advantages of this method include the minimal handling and cutting of 
the samples required prior to testing and reduction of stress concentrations around the 
grips (Billiar, Throm et al. 2005). The disadvantages of this type of test are firstly, the 
need for the samples to isotropic and produce a perfect spherical cap. Secondly, the 
porous nature of the constructs may allow for perfusion of the inflation fluid through 
the sample which can interfere with optical measurement systems (Billiar, Throm et al. 
2005). 
34 
Finally, rheology and dynamic mechanical analysis (DMA) have been used to measure 
the viscoelastic properties of soft tissue-engineered constructs for applications such as 
bladder reconstruction (Freytes, Martin et al. 2008), intervertebral disc regeneration 
(Bron, Koenderink et al. 2008) and wound healing (Holt, Tripathi et al. 2008). The 
serrated parallel plate set-up is typically used for rheological testing. The construct is 
placed between a stationary base plate and top plate which oscillates at a specified 
frequency or strain. The elastic properties of the constructs are represented by the shear 
storage modulus (G') and the viscous properties by the shear loss modulus (G"). Studies 
have shown that G' and G" are related to the microstructure and composition of the 
constructs. G' and G" have been shown to increase with decreasing pore sizes 
(Borzacchiello, Mayol et al. 2007), increasing degrees of chemical cross-linking (Sheu, 
Huang et al. 2001, Sosnik, Sefton 2005, Vanderhooft, A1coutlabi et al. 2008) and 
increasing concentrations of solid microbeads (Zhao, Ma et al. 2008). 
Rheological testing of pig skin showed that at low frequencies the gradual increase of 
G' and G" was observed. This was attributed to the elastic straightening and relaxation 
of the collagen and elastin fibres (G') and viscous movement of the ground substance 
between the fibres (G"). At higher frequencies a pronounced increase in G' and G" was 
observed and attributed to the inability of the viscous components of the dermis to adapt 
to the rate of load application causing compaction of the fibres (Holt, Tripathi et al. 
2008). Furthermore, the strain rate dependency of the shear modulus in pig skin has also . 
been reported when testing using uniaxial compression testing and was attributed to the 
viscous losses within the ground substance between the collagen fibres and viscoelastic 
losses within the collagen fibrils (Shergold, Fleck et al. 2006). 
These results are supported by dynamic mechanical analysis (DMA) of collagen gels 
which showed increasing G' and G" with increasing cross-linking by glutaraldehyde 
additions (Sheu, Huang et al. 2001). Shearing DMA uses similar principles to rheology 
but linear rather than oscillatory shear is used. However, DMA can usually only tests 
small samples, approximately 1 Omm2, and many studies have reported difficulties with 
slippage between the DMA plates (Sheu, Huang et al. 2001). Studies of fibrin gels have 
shown that increasing the fibrinogen concentration causes increases in G' due to 
structural changes in the fibrin matrices (Eyrich, Brandl et al. 2007). 
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2.7. Factors that Affect the Fibrin Remodelling Process 
A number of factors that affect the degree of compaction, cell proliferation and collagen 
synthesis in cell seeded fibrin gels have been reported. The effect of the fibrin matrix 
formulation on cell proliferation and the potential benefits of increasing the number of 
cells in fibrin based tissue-engineered constructs has been described previously in 
section 2.5 .2. Other studies have shown that the number of cells in the construct can 
also be increased by supplementing the culture media with TGF - ~ 1 (Ross, TranquilIo 
2003), increasing the frequency of the media change from once per week to three times 
per week (Neidert, Lee et al. 2002) and by application of external mechanical 
stimulation (Prajapati, Eastwood et al. 2000b, Eastwood, Mudera et al. 1998). The 
initial cell seeding density has also been shown to increase the rate of collagen synthesis 
from SMCs seeded in fibrin matrices but did not affect the total amount of collagen in 
the matrix after 5 weeks in culture CRoss, TranquilIo 2003). An increase in the rate of 
collagen synthesis would be beneficial when manufacturing fibrin based tissue-
engineered constructs as it may lead to a decrease in manufacturing time and associated 
costs. 
In addition, a current challenge for tissue-engineered constructs is to improve the 
properties of the final matrix to achieve biological functionality and the mechanical 
properties for application in vivo. A number of approaches have (Neidert, Lee et al. 
2002) been investigated to improve the properties of tissue-engineered constructs and 
have been focused on increasing the collagen synthesis in the constructs. Biochemical 
stimulation through the addition of growth factors to the media has been shown to be a 
practical method of increasing collagen synthesis. Application of external mechanical 
stimulation has been shown to further improve the properties of the constructs and both 
of these areas are reviewed below. 
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2.7.1. Biochemical Stimulation 
The growth factor TGF-pl has been widely reported to increase ECM and collagen 
deposition in-vivo during wound healing and in-vitro when used to supplement culture 
media used for cellular fibrin gels. A 0.66 fold to 4-fold increase in collagen synthesis 
from cells in fibrin gels have been reported (Table 3) as well as an increase in Iysyl 
oxidase synthesis which is required for cross linking of collagen fibrils (Colwell, 
Faudoa et al. 2007, Sales, Engelmayr Jr et al. 2006, Grande 1997, Hong, Uzel et al. 
1999, Rodriguez, Martinez-Gonzalez et al. 2008). In addition, the use of combinations 
of TGF -P I, plasmin and insulin have been shown to further increase collagen synthesis 
(Neidert, Lee et al. 2002, Grassl, Oegema et al. 2002). The addition of insulin alone was 
shown to cause a similar 4-fold increase in collagen synthesis to the addition ofTGF-pl 
alone. However the addition of plasmin in the absence of TGF-p I and insulin did not 
cause and increase in collagen synthesis or UTS. This suggested that combinations of 
growth factors can have a synergistic effect on collagen synthesis. 
However, TGF-pl is a relatively expensive growth factor and has a half life ofless than 
30 minutes in-vivo (Neidert, Lee et al. 2002). The use ofTGF-pl on a commercial scale 
may cause manufacturing complications and impact cost effectiveness. Other authors 
have investigated the use of alternative growth factors such as epidermal growth factor 
(EGF) to address these issues (Grouf, Throm et al. 2007). In a comparative study of 
EGF and TGF-pI, EGF was shown to increase collagen synthesis by 15% more than 
TGF-pl and increase the UTS 10 fold (Grouf, Throm et al. 2007). Finally, the addition 
of ascorbic acid to the media has also been shown to affect collagen synthesis by human 
dermal fibroblasts in a fibrin matrix in a dose-dependent manner. Additions of 10!lg/ml 
of ascorbic acid were· shown to increase collagen synthesis but addition of 50!lg/ml 
decreased collagen synthesis compared to the control not supplemented with ascorbic 
acid. 
TGF-p I was also shown to suppress cell proliferation but contrasting results of 
increased cell proliferation have also been reported (Grouf, Throm et al. 2007, Ross, 
Tranquillo 2003). In the latter study, the media used was supplemented with both TGF-
PI and insulin which may explain the different results observed in these studies. 
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5ng/ml TGF.~1 1 x4 14.1 
5ng/ml TGF·~1 1 x7 16.1 2~g/ml Insulin 
5ng/ml TGF.~1 (Neidert, Lee et al. 2002) 
O.OIU/ml Plasmin 1 x9 18.4 
I Insulin 
2~g/ml Insulin 1 x4 13·5 
1 O~g/ml Ascorbic Acid 1 x2 
(Gillery, Bellon et al. 1989) 
50~g/ml Ascorbic Acid I 
Table 3 The effect of media supplements on collagen synthesis, UTS and cell number in cell-seeded 
fibrin scaffolds. Numbers represent fold increase compared to control 
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2.7.2. Mechanical Stimulation 
2.7.2.1. Cellular Responses 
Application of mechanical stimulation has been widely reported to improve the 
properties of tissue-engineered constructs for a range of applications. Application of 
tensile, compressive and shear forces to tissue-engineered constructs for vascular, 
ligament, tendon and intervertebral discs regeneration (Isenberg, Williams et al. 2006, 
Henshaw, Attia et al. 2006, Screen, Shelton et al. 2005, MacKenna, Summerour et al. 
2000, Neidlinger-Wilke, Wurtz et al. 2005) has been shown to increase collagen 
synthesis and the mechanical properties of the constructs (Table 4). A particular study 
of interest applied 16% equibiaxial strain at 0.2Hz to a HDF seeded fibrin gel for 8 days 
and showed that collagen synthesis increased by 15% and mechanical properties by 
10% (Balestrini, Billiar 2006). A follow up study by the same research group 
investigated the effects of the magnitude of strain (0-16%) on the matrices and showed 
that the degree of compaction of the matrix and UTS increased with increasing strain 
(Balestrini, Billiar 2009). 
Other studies have also shown that mechanical stimulation promotes secretion of 
TGF~-I from the cells (Ng, Hinz et al. 2005, Kessler, Dethlefsen et al. 2001, Webb, 
Hitchcock et al. 2006) and may contribute towards the increase in collagen synthesis in 
the matrices·. Mechanical stimulation has also been shown to cause alignment of the 
fibres in the matrices in the direction of the applied force (Henshaw, Attia et al. 2006, 
Ng, Hinz et al. 2005, Ng, Swartz 2003, Girton, Barocas et al. 2002) and promote the 
secretion of MMPs which aid the remodelling of the extracellular matrix (Le, Rattner et 
al. 2002, Prajapati, Chavally-Mis et al. 2000a, Berry, Shelton et al. 2003). 
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2.7.2.2. The Effect of Mechanical Stimulation Parameters on Cellular Responses 
The cell responses have been shown to be dependent on a number of parameters that 
control the mechanical stimulation regime. These include the type, magnitude, 
frequency and duration of the mechanical stimulation as well as the total study period 
over which the stimulation was applied and is discussed below. 
2.7.2.3. Type of Stimulation 
The importance of selection of the type of mechanical stimulus used to elicit cellular 
responses has been demonstrated in a study of bone marrow derived mesenchymal stem 
cells (BMSCs) and smooth muscle cells (SMCs) in a PGAlPLLA scaffold (Engelmayr, 
Rabkin et al. 2005). The application of cyclic flexure for 3 weeks resulted in the 42% 
and 63% increase in collagen synthesis for the BMSC and SMC construct respectively, 
compared to the control. However, application of cyclic flexure and shear flow resulted 
in no increase in collagen synthesis by the SMCs but a 75% increase when using 
BMSCs (Engelmayr, Rabkin et al. 2005). 
2.7.2.4. Magnitude 
The magnitude of the mechanical force is also important as it needs to be sufficient to 
cause a cellular response (Eastwood, Porter et al. 1996, Syedain, Weinberg et al. 2008), 
but not to high to cause undesired responses such as cell apoptosis (Keamey, 
Prendergast et al. 2008), undesired cell phenotype changes (Ng, Hinz et al. 2005, 
Syedain, Weinberg et al. 2008, Arora, Narani et al. 1999, Tomasek, Gabbiani et al. 
2002, Grinnell 2000), rapid degradation of the matrix (Seliktar, Nerem et al. 2003, 
Seliktar, Nerem et al. 2001) and tearing of the matrix (Syedain, Weinberg et al. 2008). 
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The use of incremental strain, where the magnitude of the strain was increased over 
study duration has been shown to increase in collagen synthesis and mechanical 
properties compared to using a constant strain over the study duration (Syedain, 
Weinberg et al. 2008, Isenberg, Tranquillo 2003). The use of incremental strain from 
5% to 15% resulted in a 36% increase in mechanical properties and 84% increase 
collagen content compared to using constant strain. This was supported by a study of 
HDF· seeded fibrin matrices subjected to equibiaxial strain which also showed that 
collagen deposition correlated with increasing strains from 2%-16% (Balestrini, Billiar 
2009). 
2.7.2.5. Frequency 
It has been shown that the application of cyclic mechanical stimulation is beneficial for 
collagen synthesis compared to application of continuous mechanical stimulation 
(Balestrini, Billiar 2009). The frequency and duration of the cycle control the time that 
the cells are stimulated and are at rest. Studies have shown that longer relaxation times 
in between stimulation of SMC and HDF seeded fibrin gels increased mechanical 
properties and collagen content (Balestrini, Billiar 2009, Isenberg, Tranquillo 2003). 
2.7.2.6. Total Duration of Application 
Finally, the majority of studies investigating the effects of mechanical stimulation on 
tissue-engineered constructs only compare the properties of tissue-engineered 
constructs at the start and end points of the study. Fewer studies have monitored the 
collagen content and mechanical properties at several time points during the culture 
period. These studies demonstrated that prolonged mechanical stimulation could also 
have a detrimental effect on the construct properties. For example, a 20-week study of 
SMCs in a PGA matrix, showed an increase in mechanical properties of the construct 
up to 10 weeks but a decrease in subsequent weeks (Kim, Nikolovski et al. 1999). 
Comparison of the mechanical properties at the start and end points only would have 
shown that mechanical stimulation caused an increase in mechanical properties but 
would not have shown the peak in mechanical properties that occurred after 10 weeks. 
Separate studies of SMCs and HDFs in a collagen matrices showed similar results 
where an increase in mechanical properties was observed after 4 days followed by 
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deterioration over the following 4 days, although they remained higher than the 
properties of static controls (Seliktar, Nerem et al. 2003). 
2.7.3. Mechanotransduction 
On a molecular level, many studies have identified the mechanisms by which cells 
detect and respond to mechanical stimulation (Figure 5) and this process of 
mechanotransduction has been recently review by Chiquet, Ge\man et al. 2009, Wang, 
Tytell et al. 2009 and Ingber 2006. Mechanical stimulation activates mechanoreceptors 
such as integrins, G proteins, receptor tyrosine kinases and stretch activation channels 
on the cell membrane. These cause changes in the structure of the cytoskeleton and 
activate signalling pathways which lead to the activation of transcription factors, gene 
transcription and subsequent cellular responses such as protein synthesis, cell division 
and apoptosis (Iqbal, Zaidi 2005, Coppolino, Dedhar 2000, Ingber 2003a, Ingber 2003b, 
Eckes, Zigrino et al. 2000). 
In particular, integrins alpl and a2pI have been shown to be responsible for the 
binding of fibroblasts to collagen in the extracellular matrix, in response to tension and 
the transmission of mechanical stimuli between cells and ECM (Ng, Hinz et al. 2005, 
Langholz, Roeckel et al. 1997, Heino 2000). Integrin al P I has been shown to regulate 
collagen synthesis and be necessary for cell and matrix alignment in matrices subj ected 
to mechanical stimulation (Ng, Hinz et al. 2005, Langholz, Roeckel et al. 1997, Heino 
2000). Integrin a2p I has been shown to be responsible for fibroblast spreading and 
adhesion to collagen fibres, matrix contraction, cell migration, regulation of MMP-I, 
and the up-regulation of collagen synthesis and fibril formation, when fibroblasts are 
subjected to mechanical stimulation (Ng, Hinz et al. 2005, Eckes, Zigrino et al. 2000, 
Eckes, Zweers et al. 2006). Other studies have shown that application of tensile force to 
fibroblasts up-regulates secretion ofTGF-pI which is required for the activation of the 
Smad signalling pathways and subsequently leads to the transcription of procollagen 
aI(I) gene expression (Lindahl, Chambers et al. 2002, Verrecchia, MauvieI2002). 
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Mechanical stimulus 
Activation of transmembrane 
mechanoreceptors 
Activation of signalling pathways 
Activation of transcription factors 
j 
Gene transcription 
Cellular Response 
Cyclic stretching ofHDFs 
+ 
Integrin al~l 
TGF-~ binding 
~ 
Smad 2, 3, 4 
~ 
P300/CBP co-activators 
~ 
COLlA2 
~ 
Collagen Type 1 synthesis 
Figure 5 Left: Simplified overview of the mechanotransduction process. Right: Potential signalling 
pathway involved in collagen type 1 synthesis 
I 
I 
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Rat Smooth Type 1 collagen sponge 7% Cyclic strain, 1 Hz for 20 wks -67% 600% 1 1700% 1. (Kim, Nikolovski et al. 1999) muscle cell 
Myofibroblast Non-woven PGA Laminar flow for 2 wks 52% - - (Jockenhoevel, Zund et al. 2002) 
Myofibroblast Non-woven PGNP4HB 9% Cyclic uniaxial strain, for 3 wks 71±23% 
- -
(Mol, Bouten et al. 2003) 
Tendon Fibroblasts Human tendon fascicles 5% CYClic uniaxial strain, 1 Hz for 24 hrs 25.1% 
- -
(Screen, Shetton et al. 2005) 
Chrondocytes 2% agarose hydrogel 10% Dynamic compression 1 Hz for 21 days 37% 300%1 (Mauck, Soltz et al. 2000) -
SMC PGAlPLLA CycliC flexure, 1 Hz for 3 wk.s 63% 
-
78%T (Engelmayr, Rabkin et al. 2005) 
Cyclic f1exure 1 Hz 42% 
-
187%1 
BMSC PGAlPLLA Flow induced shear stress, 1 dyne/cm' 16% 
-
159%1 
(Engelmayr, Sales et al. 2006) 
Flexure and flow, for 3 wks 75% 
- 166%1 
SMC PGAlPLLA Flexure and flow, for 3 wk.s 0% 
-
78%1 
SMC Collagen gel Cyclic distension, 5 wk.s 0% 80% 80% (Isenberg, Tranquillo 2003) 
SMC Collagen gel Cyclic distension, 8 days - 240% 108% (Seliktar, Black et af. 2000) 
Human nucleus Type 1 rollagen gel Hydrostatic pressure,1 Hz, 0.25MPa for 24hrs -30% 
- - (Neidlinger-Wilke, Wurtz et al. 2005) pulpous 
HDF Fibrin gel 0-16% Equibiaxial strain @0.2Hzfor8days 15% 10%1 0% (Balestrini, Billiar 2006) 
HDF Collagen gel 10% Uniaxial Strain@1Hz for 24 hrs 11% (2mN) 17%. 25%1 (Berry, Shelton et al. 2003) Pre-Ioading 2mN and 10mN 0% (10mN) 28%! 30%1 
Table 4 The effect of mechanical stimulation on collagen type I content and mechanical properties of cell-seeded matrices compared to static controls 
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2.8. The Effect of Ultrasound on Biological Responses 
2.S.1. Diagnostic, Therapeutic and Disruptive Ultrasound 
Ultrasound is defined as acoustic or mechanical waves of frequencies above 20 kHz 
(Kinsler, Frey et al. 2000). Ultrasound is produced by a piezoelectric transducer which 
transforms electrical energy into mechanical energy and delivers acoustic waves 
through the transducer (Kinsler, Frey et al. 2000). The ultrasound frequency, intensity, 
duty cycle and duration have been shown to affect the propagation of acoustic waves 
through tissues and the subsequent cellular responses. The acoustic conditions 
determine whether the ultrasound application has a therapeutic, disruptive or diagnostic 
use through thermal andlor biological effects (Ziskin 1987, Baker, Robertson et al. 
2001). 
Typically, diagnostic ultrasound uses microsecond pulses at frequencies in the kilohertz 
range and therapeutic ultrasound millisecond to second pulses at frequencies of 1 to 
20MHz. Disruptive ultrasound typically uses frequencies is in the upper region of the 
therapeutic range. The most common use of diagnostic ultrasound is for imaging 
developing foetuses and it has more recently been applied to cardiac and ophthalmic 
diagnosis (Bamett, Ter Haar et al. 2000). Disruptive ultrasound uses high intensity 
ultrasound to cause targeted cavitation in tissues. It is routinely used to as a non-
invasive technique to break up kidney stones and more recently to target and treat 
tumours (Miller 2007, ter Haar 2007). Ultrasound in the therapeutic range has become 
increasingly used to elicit positive responses in a number of biological applications and 
is reviewed in the following sections. 
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2.8.2. Ultrasound and Wound Healing In-Vivo 
In-vivo, therapeutic ultrasound has been used in physiotherapy to accelerate healing of 
soft tissue injuries, accelerate the bone healing through the promotion of new bone 
formation, enhance drug uptake through the skin and more recently to transfer genes 
into diseased tissue (ter Haar 2007, Chang, Sun et al. 2002). Several studies have shown 
that ultrasound aids wound healing of rat tendon through an increase in collagen 
deposition, UTS and stiffness (DA Cunha, Parizotto et al. 2001, Ng, Ng et al. 2004, Ng, 
Wong 2008, Yeung, Guo et al. 2006). 
Application of ultrasound to rat skin wounds has also been reported to have beneficial 
effects during the first 14 days of wound healing (Mendonya, Ferreira et al. 2006). In 
this study pulsed ultrasound was applied at a frequency of I.SMHz, duty cycle of 20% 
and intensity of 0.3W/cm2 for 10 minutes on alternate days for 14 days. After 3 days 
less fibrin and more young collagen was observed in histology sections of the 
ultrasound stimulated group compared to the non-stimulated group. After 7 days, more 
regularly distributed collagen was observed in the ultrasound group and a small but 
statistically significant increase of 0.37% in collagen types I and III was reported 
compared to the control groups. By day 14, more developed collagen, the development 
of dermal papillae and partially repaired sebaceous glands and pilary follicles were 
observed in the ultrasound group. Accelerated re-epithelisation was also reported in the 
ultrasound group and the formation ofa thicker epidermis after 14 days. 
This study is supported by a study which applied ultrasound to wounded pigs and 
observed increased collagen deposition in the wound compared to the non-stimulated 
control pigs (Baker, Robertson et al. 2001, Byl, McKenzie et al. 1992). However, a 
study of the healing rates of cockerel tendon showed that ultrasound did not accelerate 
wound healing (Ramirez, Schwane et al. 1997, Turner, Powell et al. 1989). The 
difference in response of healing rates to the ultrasound may have been due to the 
driving frequency of ultrasound used. In the study of cockerel tendon healing, a 3MHz 
frequency was used compared to 1-I.SMHz frequency used in the other studies of skin 
and rat tendon healing (Table 7). 
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2.8.3. The Effect of Ultrasound on Cellular Responses In-Vitro 
In-vitro application of ultrasound to cell mono layers and tissue-engineered constructs 
has been shown to affect cellular responses such as, cell proliferation and synthesis of 
collagen, proteoglycans, GAGs and growth factors. The application of ultrasound has 
been shown to increase cell proliferation in monolayers of chrondocytes, fibroblasts and 
human mesenchymal stem cells (Doan, Reher et al. 1999, Webster, Pond et al. 1978, 
Zhou, Schmelz et al. 2004) and in cellular tissue-engineered constructs (Hsu, Kuo et al. 
2006, Takeuchi, Ryo et al. 2008, Noriega, Mamedov et al. 2007). However, other 
studies have reported no increase in cell proliferation of osteoblast, chrondocyte and 
hMSC cells (Takeuchi, Ryo et al. 2008, Ebisawa, Hata et al. 2004, Harle, Salih et al. 
2001, Nishikori, Ochi et al. 2002, Parvizi, Parpura et al. 2002). 
There are also contrasting reports on the effects of ultrasound on collagen, proteoglycan 
and GAG synthesis (Table 5). Monolayers of chrondocytes, fibroblasts osteoblasts and 
human mesenchymal stem cells (hMSCs) have been reported to increase collagen, 
proteoglycan and GAG synthesis when stimulated by ultrasound (Ebisawa, Hata et al. 
2004, Tsai, Pang et al. 2006, Yang, Lin et al. 2005). In addition, ultrasound was shown 
to increase collagen synthesis from cultures of fibroblasts which had been treated with 
collagenase to simulate injury (Ramirez, Schwane et al. 1997, Doan, Reher et al. 1999). 
In these studies, it was shown that collagen synthesis was increased by up to 40% after 
collagenase treatment and application of ultrasound compared to the controls. However, 
it was also shown that ultrasound decreased collagen synthesis from fibroblast 
mono layers not treated with collagenase and ultrasound (Ramirez, Schwane et al. 1997, 
Doan, Reher et al. 1999). 
Similarly, there are contrasting reports of the effect of ultrasound on collagen, GAG and 
proteoglycan secretion from cells in tissue-engineered constructs (Table 6). Increased 
collagen and ECM synthesis has been reported from chrondocytes seeded in a range of 
matrices for cartilage regeneration and nucleus pulpous and annulus fibrous cells 
seeded in alginate beads for intervertebral disc regeneration (Hsu, Kuo et al. 2006, 
Noriega, Mamedov et al. 2007, Cui, Park et al. 2006, Iwashina, Mochida et al. 2006, 
Miyamoto, An et al. 2005). However, decreases in mechanical properties and collagen 
synthesis have also been reported in a chrondocyte seeded fibrin matrix (Duda, Kliche 
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et al. 2004). Comparison of the differences in the response of the cells seeded in 
matrices is problematic due to the wide range of acoustic conditions used to stimulate 
the constructs and experimental arrangements as discussed in section 2.8.5. 
Intercytex have investigated the effect of ultrasound on collagen synthesis and 
mechanical properties of ICX-SKN constructs (Johnson, Marshall et al. 2006). 
Ultrasound was applied to the ICX-SKN constructs through a transducer secured to the 
base of the culture dish. A I MHz frequency and ultrasound pulse of 10 seconds on and 
180 second off was applied for 21 days. However, the results were inconclusive as an 
increase in mechanical properties and collagen content was only observed in one of six 
constructs tested (Personal communication Dr.PJohnson, Research Director Intercytex, 
2007). The experimental set-up and 21 day stimulation duration is likely to have caused 
heating in the constructs due to the build up of standing waves (section 2.8.5). This may 
have affected the cellular responses and variation in the results: 
Few studies have investigated the affect of different acoustic conditions on cellular 
responses. The frequency and intensity of the ultrasound has been shown to affect cell 
viability and collagen synthesis. One study showed that collagen synthesis from 
chrondocytes seeded in a chitosan scaffold was increased with increasing the frequency 
from 1.5MHz to 5MHz over a range of intensities and duty cycles (Noriega, Mamedov 
et al. 2007). Other studies have shown that a lower ultrasound intensity of 0.002W/cm2 
promotes collagen synthesis from chrondocyte mono layers at 1.5Hz frequency and 20% 
duty cycle compared to a higher intensity of 0.03W/cm2 (Zhang, Huckle et al. 2003). In 
addition, it has been reported that intensities above OAW/cm2 at IMHz frequency and 
20% duty cycle can cause fibroblast lysis and detachment from the surrounding matrix 
(Doan, Reher et al. 1999). 
The role of TGF -~ in the up-regulation of collagen synthesis has been discussed 
previously (section 2.7.1). Ultrasound stimulation has been shown to increase TGF- ~ 
from monolayers of fibroblast and osteoblast cells (Tsai, Pang et al. 2006, Harle, Mayia 
et al. 2005) which has also been reported for other forms of mechanical stimulation of 
tissue-engineered constructs (Ng, Hinz et al. 2005, Kessler, Dethlefsen et al. 2001, 
Webb, Hitchcock et al. 2006). In addition, supplements of TGF -~ to culture media have 
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also been shown to up-regulate proteoglycan synthesis from hMSCs stimulated by 
ultrasound (Ebisawa, Hata et al. 2004). 
2.8.4. Mechanisms that Cause Cellular Responses 
The propagation of ultrasound waves through tissue-engineered constructs cause 
cellular responses through thermal and non-thermal effects (Baker, Robertson et al. 
2001). The exact mechanisms by which ultrasound elicits cellular responses are not 
currently fully understood. However, it is believed that mechanical stimulation of the 
cells and thermal effect are caused by particle oscillation, cavitation and acoustic 
streaming as it propagates through the construct (Williams 1983) and are discussed 
below. 
When ultrasound waves propagate through a material several phenomena may occur to 
cause particle movement (Challis, Povey et al. 2005). Firstly, propagating waves will 
pass through solid and liquid components of a material to cause particle movement. The 
speed of the wave propagation is dependent on the compressibiIity and elastic modulus 
of the components in the tissue. For instance, the wave propagation velocity through 
collagen has been shown to be greater than that through water (Duck 1990). Secondly, 
the propagating wave causes local compression and expansion of liquid and solid 
particles as the wave energy is stored elastically and subsequently released as kinetic 
energy. The release of kinetic energy can cause particle movement and heating of the 
material as the energy is deposited in the surrounding material. 
Cavitation is defined as the formation and life of bubbles in liquids (Suslick, Nyborg 
1990). Bubbles resting near a boundary oscillate when ultrasound is applied, causing 
fluid flow and shear stress at the boundary (Miller 2007, ChalIis, Povey et al. 2005). 
Bubbles formed away from boundaries travel towards the boundary before collapsing. 
Three possible effects of collapsing bubbles have been reported (Mitragotri, Kost 
2004). Firstly, the bubble can collapse near the boundary causing pressure waves on the 
surface of the boundary. Secondly the collapse of the bubble at the boundary can cause 
pressure waves which resonate through the boundary. 
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Finally, the bubble can cause disruption of the boundary. The formation, movement and 
collapse of the bubbles may impart shear and compressive forces on cell membranes 
and the extracellular matrix. The magnitude of shear force that is required to cause a 
cellular response has not been reported. However, studies have shown that cellular 
responses to local shear stresses on cells in suspension is dependent on the cell density 
(Miller 2007) and that a shear stress of 100-160Pa is required for detachment of 
adherent cells in culture (Ohl, Wolfrum 2003). 
Acoustic streaming can be categorised as bulk streaming and micro-streaming. Bulk 
streaming is caused by propagation of the ultrasound through a liquid and movement of 
the fluid in a single direction. Micro-streaming causes eddies to flow adjacent to an 
oscillating source and is associated with cavitation (Baker, Robertson et al. 2001, 
Starritt, Duck et al. 1991). Micro-streaming is more mechanically powerful than bulk 
streaming ((Mitragotri, Kost 2004, Ogura, Paliwal et al. 2008, Kushner IV, Kim et al. 
2007) and has been shown to alter cell membrane permeability as a result of the 
streaming disturbing concentration gradients at the cell membrane interface (Starritt, 
Duck et al. 1989, Starritt, Hoad et al. 2000, Pohl, Antonenko et al. 1993). 
Other studies have shown that ultrasound stimulation increases cell permeability by 
demonstrating the increased uptake of fluorescent dyes into the cells (Yang, Shirakata 
et al. 2005, Husseini, Diaz de la Rosa, et al. 2005), increased uptake of insulin and 
calcium ions into fibroblasts (Parvizi, Parpura et al. 2002, Mitragotri, Kost 2004) and 
the recent use of ultrasound for enhanced drug uptake reviewed by (ter Haar 2007). 
However, cell apoptosis, damage to intercellular organelles such as Iysosomes and 
mitochondria (Baker, Robertson et al. 200 I), and cytoplasm leakage have also been 
associated with cavitation and acoustic streaming (Hallow, Mahajan et al. 2006, Lai, 
Wu et al. 2006). 
Finally, the molecular mechanisms by which ultrasound stimulation is converted into 
biochemical signals have been shown to be via integrin transmembrane 
mechanotransducers and formation of focal adhesion in cells stimulated by ultrasound 
(Zhou, Schmelz et al. 2004, Yang, Lin et al. 2005, Tang, Lu et al. 2007). Specific 
molecules in signalling pathways associated with collagen synthesis and cell 
proliferation have also been shown to be up-regulated by ultrasound (Zhou, Schmelz et 
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al. 2004). For example, ultrasound stimulation (1.5 MHz, 200).ls pulse modulated at 1 
kHz) of human dermal fibroblast monolayers, resulted in increased cell proliferation via 
the integrin 131 receptor and the Rho/Rock/SrclERK signalling pathway. These reports 
are comparable to reports of tissue-engineered constructs mechanically stimulated by 
tensile, compressive and shear forces (Billiar, Throm et al. 2005, Paez, Jose et al. 2000). 
2.8.5. Experimental Apparatus for In-Vitro Ultrasound Stimulation 
A number of different experimental set-ups have been used to apply ultrasound to 
tissue-engineered constructs and cell mono layers. The simplest set-up attaches an 
ultrasound transducer to the base of a culture dish via a coupling gel or in the media 
above the cells (Zhou, Schmelz et al. 2004, Nishikori, Ochi et al. 2002, Tsai, Pang et al. 
2006). However, ultrasound stimulation of the cells in this set-up is in the near field of 
the ultrasound beam where there are large variations in acoustic pressure (Humphrey, 
Duck 1998). This can cause inhomogeneous stimulation of the cells. In addition, the 
cells are prone to heating as standing waves are likely to develop in the cultures. 
Other apparatus have been used to stimulate cells and tissue engineered constructs in 
the far field of the ultrasound beam where the acoustic pressure is the most 
homogeneous. Typically, the culture dish is placed in a water bath so that the base of 
the dish is in contact with the water. The water bath is adapted so that an ultrasound 
transducer can be attached to the base and the ultrasound propagates through the water 
bath to the cells (Hsu, Kuo et al. 2006, Siu, Jackson et al. 2007, Warden, Favaloro et al. 
2001). However, this experimental arrangement is still prone to the build-up of standing 
waves and heating of the cells. Addition of a liquid path for the ultrasound to propagate 
through after it has passed through the cells would minimise the build up of standing 
waves. This experimental arrangement has been used for cells cultured in flasks and an 
ultrasound absorbing material was also used to reduce the reflection of the ultrasound 
back into the constructs (Harle, Salih et al. 2001). 
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.' ., (MHz) I··· .•. · ." '. Mal.n 1 .~~" c' Yl"'. . . . . ... '" .' 'c' ...... . ..... 
. c'·' ·/.L;· '.' . .•... . . ..... ..l 
Chrondocyte 1.0 0.33-1.0 20 &50 10minlday 6 days Cell no. t @0.67W/cm', 20% (Hsu, Kuo et al. 2006) 
Chrondocyte 1.5 0.002-0.03 20 20mln/day 7 days Cell no. t@day 3 only (Zhang, Huckle et al. Collagen 11 t @0.002W/cm' 2003) 
Osteoblast 3 0.13-0.18 100 10minlday 1 day TGF~t with intensity (Harle, Mayia et al. 2005) Cell no. +-+ 
Osteoblast 1.0 0.06- 0.2 
-
10minlday - Collagen I t @O.IW/cm' Integrin expression t (Yang, Un et al. 2005) 
, Cell no t (Zhou, Schmelz et al. Fibroblast 1.5 0.03 20-100 6-11mins 1 day Formation of focal adhesions 2004) 
Fibroblast 1.0 0.1-0.4 20 5mins 9 days Cell no t 50% (Doan, Reher et al. 1999) Collagen! 
Collagen +-+ (Ramirez, Schwane et al. Fibroblast 1.0 0.4 20 and 100 3min/day 
-
Collagen t when cells treated 
with 1997)97. 
hMSC 1.0 0.015-0.12 20 20min/day 
Cell no .. _ (Ebisawa, Hata et at 
- r 'c and ., 2004) 
with TGF~ in mea'a ;;'niy 
Tendon cells 1.0 0.1-1.0 20 5min 1 day Collagen I and III t (Tsai, Pang et al. 2006) TGF~ t with intensity 
leukaemia 1.0 0.1-2.0 100 10min 
-
Cell apoptosist with intensity (Feril, Kondon 2004) Cells 
Table 5 The acoustic conditions used to elicit cellular responses from cell monolayers. j= Increase, l=decrease, - = no significant difference 
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Chrondocytes in 
polyester scaffold 
Chrondocytes in 
collagen sponge 
Chrondocytes in 
chitosan scaffold 
Chrondocytes in 
Atelocollagen gel 
Chrondocytes in 
fibrin glue 
Fibroblasts in 
collagen gel 
Nucleus pulpous 
& annulus fibrous 
in alginate beads 
Nucleus pulpous 
& annulus fibrous 
in alginate beads 
hMSC in PGA 
mesh 
1.0 
I.S 
I.S & S 
I.S 
I.S 
2.0 
1.0 
0.8 
0.03-0.1 
0.03 
I.S 
S 
8.S 
0.03 
0.03 
8 
0.03 
0.2 
20 
20 
161see on 
51 sec on 
24 sec on 
20 
20 
10minlday 7wks 
20minlday 
Twice a day 10 days 
20minslday 3wks 
20minlday 
BOseoons 
20minlday 20 days 
20minlday 12 days 
10minslday 4wks 
Cell no.t 
GAGt 
Collagen t 
UTS t 
Collagen I t 
Collagen 11_ 
Cell no. t 
Cell no. t 
Collagen t @ 5MHz 
Collagen_ @ I.SMHz 
Proteoglycan 52%j 
Cell no_ 
Stiffness_ 
Collagen II! 
E! 
Cell penneability t 
Proteoglycan 24% t 
Collagen 11 16%t 
Proteoglycan t 
CeUno_ 
Compressive strength j 
GAG more distributed 
(Hsu, Kuo et al. 2006) 
(Takeuchi, Ryo et al. 2008) 
(Noriega, Mamedov et al. 
2007) 
(Nishikori, Dehi et al. 2002) 
(Duda, Kliche et al. 2004) 
(Vang, Shirakata et al. 
200S) 
(Miyamoto, An et al. 200S) 
(lwashina, Mochida et al. 
2006) 
(Cui, Park et al. ·2006) 
Table 6 The acoustic conditions used to elicit cellular responses from tissue-engineered constructs. t= Increase, !=decrease, _ = no significant difference 
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.. : '. : 
RalAchilles 
tendon 
Cockerel tendon 
Skin (ral) 
Skin (pig) 
Skin permeability 
1.0 
1.0 
3.0 
1.5 
1.0 
0.2-004 
1.0 & 2.0 
0.5 
0.5 
0.2 
0.03 
0.1-0.3 
1-3MHz 
-.~.,""" i,e' Duty Cycle .::1': ..... ,.0. ellv ..ery .. : 
. (%) . : .... il .. ' :·.f~~'me .,: 
100 
20 
20-100 
20 
4mins for 
6dayslwl< 
Smins 
5mins 
10mins 
alternate days 
' .. study: .' 
, Du,tati~~\::; 
25 days 
14days 
14days 
UTS@IW/cm'tI5% 
UTS@2W/cm't40% 
UTSt 
Et 
Collaaen t 
Collagen bundle 
organisation T 
(Ng. Ng el al. 2004) 
(yeung, Guo el al. 2006) 
(DA Cunha, Parizotto el al. 2001) 
Collagen _ (Turner, Powell el al. 1989) 
Acceleraled healing (Mendonl"', Ferreira el al. 2006) 
Collagent (Byl, McKenzie el al. 1992) 
Insulin uplake t@IMHz (Milragolri, Kos(2004) 
Table 7 The acoustic conditions used in-vivo to accelerate wound healing. t= increase, !=decrease, - = no significant difference 
2.9. Conclusion 
The processes that occur in cell seeded fibrin constructs to produce a collagen matrix 
for tissue-engineering applications have been widely reported. Human dermal fibroblast 
(HDF) cells seeded in a fibrin matrix have been used to develop tissue-engineered 
constructs for dermal regeneration applications and to investigate the wound healing 
remodelling process in-vitro. The major processes that occur in HDF seeded fibrin 
matrices are cell proliferation, matrix compaction, fibrin degradation and collagen 
synthesis. These processes were also observed in fibrin matrices seeded with smooth 
muscle cells (SMC) for cardiovascular applications. 
The Intercytex dermal substitute, ICX-SKN, is currently produced by seeding HDF 
cells in a fibrin matrix and culturing the constructs for 49 days. Increases in the 
mechanical properties and collagen content of a HDF seeded fibrin matrix over this 
duration have been reported by one study which compared the properties after 21 days 
and 51 days in culture (Neidert, Lee et al. 2002). However, more frequent 
measurements would provide a better understanding of the rate of change and trends in 
the property evolution during this period. A 5-week study of SMCs in a fibrin matrix 
monitored the changes in mechanical properties, fibrin degradation, collagen synthesis 
and cell proliferation at weekly time points (Ross, TranquiIJo 2003). A similar method 
could be adopted to provide a better understanding of the interactions between the 
changes in biochemical, physical and mechanical properties of ICX-SKN over the 49 
day manufacturing process. 
It is well established that the compaction of restrained cell seeded matrices results in a 
decrease in the thickness of the constructs (Grinnell 2003). However, few studies have 
analysed the homogeneity of the matrix structure through the thickness of the construct 
after the compaction. The efficacy of ICX-SKN is hypothesised to be dependent on the 
degradation rate of the collagen as discussed in section 2.4.3. Therefore, further 
investigation into the homogeneity of the matrix would be of value to provide further 
understanding of the degradation rate in different areas of the construct. In addition, 
reports of the thickness of the tissue-engineered constructs have been based on single 
point measurements (Tuan, Song et al. 1996). Analysis of the thickness of the whole 
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constructs would be beneficial for ICX-SKN as it also aims to provide structural 
support when applied to a wound. 
A number of techniques to qualifY and quantifY the changes in the physical, 
biochemical and mechanical properties of tissue-engineered constructs have been 
reported. The quantity of collagen deposited in cell seeded fibrin gels and the 
mechanical properties of the final matrices are suggested to be the key parameters for 
improving the efficacy of tissue-engineered constructs in-vivo. Hydroxyproline based 
assays are most commonly used to measure the quantity of collagen deposited in cell 
seeded fibrin gels. However, studies by Intercytex have shown that the hydroxyproline 
assay produces positive reading when applied to control fibrin matrices and may 
provide misleading data (Marshall 2005). Further development of the hydroxyproline 
assay to eliminate the fibrin content before testing or use of alternative assays such as 
ELISA is required for measurement of collagen in ICX-SKN. 
Repeatable measurement of the mechanical properties of cell seeded fibrin matrices has 
also been shown to be problematic due to their gel-like properties (Billiar, Throm et al. 
2005). Inflation techniques that apply biaxial strain and rheology applying shear strain 
have been shown to the most repeatable techniques for determining the UTS and 
viscoelastic properties of gel-like planar tissue-engineered constructs. In addition, it has 
been shown that careful preparation of lis sue-engineered constructs for observation by 
electron microscopy is required to minimise damage to the structure of the matrix. High 
pressure freezing and resin embedded sections for analysis of the surface and cross-
sections of the constructs have been shown to be suitable techniques but are expensive 
and time consuming. 
Many of the characterisation techniques described in the literature were destructive and 
therefore require a large number of samples to- be produced when monitoring the 
changes in properties of tissue-engineered constructs over time. Manual production of 
large batches of constructs are susceptible to variation and contamination due to lapses 
in aseptic technique due to operator fatigue. The development of non-destructive tests 
to analyse the biochemical and physical properties of tissue-engineered construct would 
allow for a reduction in operator related batch variation and more cost effective 
research. 
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A current challenge for tissue-engineered constructs is to achieve biochemical 
functionality and mechanical properties suitable for application in-vivo. Many studies 
have reported the use of biochemical and mechanical stimulation to increase the 
collagen content and improve the mechanical properties of tissue-engineered constructs. 
The use of culture media supplemented with EGF and TGF-~1 in combination with 
plasmin and insulin has been shown to increase collagen synthesis and mechanical 
properties in for HDF seeded fibrin matrices by up to 4-fold. In addition, increasing the 
frequency that the media and growth factors were replenished from once a week to 3 
times a week showed a further increase in collagen synthesis and mechanical properties. 
Intercytex have developed a media formulation, Total Media, for the culture of ICX-
SKN which contains EGF and TGF-~I, plasmin and insulin. The frequency of the 
media change in the current process is 3 times per week and therefore, further 
investigation into increasing collagen synthesis and mechanical properties of ICX-SKN 
will be focused on using mechanical stimulation. 
Application of mechanical stimulation to cell seeded matrices has been shown to 
increase collagen synthesis and mechanical properties of a range of tissue-engineered 
constructs. The type of stimulation (tensile, compressive or shear), magnitude, 
frequency and total duration of stimulation has been shown to affect the degree of 
collagen synthesis from the cells. For HDF seeded fibrin gels, it has been shown that 
collagen synthesis and mechanical properties increase with increasing cyclic equibiaxial 
strain form 0% to 16% (Balestrini, Billiar 2009). In addition, it was shown that 
application of intermittent strain (6 hours on, 18 hours off) increased collagen synthesis 
compared to continuous strain (24hours on) over an eight day study duration 
(Balestrini, Billiar 2009). 
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However, many of the apparatus used to apply the mechanical stimulation required 
physical coupling to the constructs. This would be problematic for the ICX-SKN 
constructs as they initially have gel-like properties which are prone to tearing. 
Ultrasound has been identified as a practical method of applying mechanical 
stimulation to gel-like constructs without the need for physical coupling. The use of 
ultrasound in the therapeutic range has also been shown to increase collagen synthesis 
and mechanical properties in a number of cell seeded scaffolds for tissue-engineering 
applications. 
Most commonly, ultrasound stimulation has been used to promote collagen synthesis 
from chrondocyte seeded matrices for cartilage regeneration (Hsu, Kuo et al. 2006, 
Takeuchi, Ryo et al. 2008) and nucleus pulpous seeded matrices for intervertebral disc 
regeneration (Iwashina, Mochida et al. 2006). In-vivo, ultrasound has also been shown 
to increase the rate of wound healing in bone and soft tissue (Yeung, Guo et al. 2006, 
Mendonya, Ferreira et al. 2006, Perry, Parry et al. 2009,Kaufman, Luo et al. 2008). 
Intercytex have previously investigated the use of ultrasound on collagen synthesis in 
ICX-SKN. However, the experimental arrangement used was prone to inhomogeneous 
stimulation of the constructs and undesired heating effect which may have caused the 
inconclusive results. Other studies investigating the effect of ultrasound on HDF seeded 
fibrin gels has not been reported in the literature. 
Ultrasound has also been shown to decrease collagen synthesis and mechanical 
properties when applied to cell seeded constructs. However, the reasons for the 
differences in cell response are difficult to establish due to the large range of 
experimental arrangements and acoustic parameters used in independent studies. A few 
studies have shown that the magnitude of the ultrasound intensity and frequency can 
affect collagen synthesis. However, investigation into the affect of the combinations of 
intensity, frequency and duration of stimulation has not been reported. 
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Chapter 3 Characterisation of SKN Construct Properties 
3.0. Introduction 
ICX-SKN constructs are currently manufactured by casting human dennal fibroblasts 
(HDF) in a fibrin matrix and feeding the constructs with a specific media fonnulation 
for 49 days (section 2.4.1). The construct is then freeze dried for storage and sterilised 
by gamma-irradiation. Prior to application in a wound site in-vivo, the constructs are 
repopulated with HDF cells (Flasza, Kemp et al. 2007). The characterisation studies in 
this thesis are focused on the first 49 days of the manufacturing process where it has 
been shown that the fibroblasts breakdown the fibrin matrix and secrete collagen to 
fonn the final ICX-SKN product (Boyd, Flasza et al. 2007). 
The following characterisation study aims to improve the qualitative model of the 
processes that occur during manufacturing as described in section 2.4.3 and by Boyd, et 
al 2007. The constructs used in the following studies were produced using the same 
process as described for the manufacture of ICX-SKN (Flasza, Kemp et al. 2007) but 
substituted the human fibrinogen, with bovine fibrinogen to allow for cost-effective 
research. These constructs are referred to as SKN constructs in this thesis. The 
methodologies developed for SKN constructs have been shown to be transferable to 
ICX-SKN constructs (personal communication with PJohnson, Director of Research, 
Intercytex, 2007). Other research groups have previously reported changes in 
biochemical and mechanical properties of similar cellular fibrin gels over time (Ahlfors, 
Billiar 2007, Neidert, Lee et al. 2002). However, no study has characterised the 
physical, structural, biochemical and mechanical properties over a 49 day study period. 
The materials and methods used to produce the SKN constructs is described in sections 
3.1 to 3.2. The materials and methods to characterise the physical, structural, 
biochemical and mechanical properties of the SKN constructs during manufacturing are 
described in sections 3.3 to 3.5. The results of the characterisation studies are described 
in sections 3.6 to 3.9. The improved four phase SKN construct manufacturing process 
model is described in section 3.10. Further areas of research to improve the cost-
effectiveness of the process and build upon the process model developed in this study 
are summarised in section 3.11 and expanded in Chapter 7. 
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3.1. Materials and Methods 
The materials and methods used for the production of SKN constructs and 
characterisation of the physical, structural and mechanical properties and biochemical 
composition of SKN constructs during manufacturing are described in the following 
sections. A separate batch of SKN constructs was cast for each characterisation 
technique described unless otherwise stated. The time points during manufacturing at 
which the constructs were characterised for each technique is summarised in Table 8. 
Section 3.2.1 describes the semi-automated production of master and working human 
dermal fibroblast cells banks using the CompacT SelectT (The Automation Partnership, 
UK) and the method for casting SKN constructs. 
Section 3.3 describes the materials and methods used to model the physical changes in 
the SKN constructs using precision surface profiling and observe changes in the 
structure and composition of the matrix by light and electron microscopy. SKN 
constructs were prepared for histology, immunohistochemistry (IHC) and confocallaser 
fluorescent scanning microscopy (CLFM) at the Advanced Microscopy Unit (AMU), 
Nottingham University, UK. Standard preparation techniques used for tissue samples 
were optimised by Dr.S.Anderson, M.Smith and D.Christie, for imaging of the SKN 
constructs. Cross-sections of the SKN constructs were analysed for changes in the 
composition of fibrin, collagen, proteoglycans and elastin using histology and the type 
of collagen using· IHC. CLFM was used to analyse the orientation and spatial 
distribution of the cells and collagen structure viewed from the top and bottom surfaces 
of the SKN constructs. 
Scanning electron microscopy (SEM) was used to investigate the morphology of the 
SKN construct matrix and interactions with the cells at higher magnifications. Since the 
constructs were comprised of over 50% water, conventional sample preparation 
techniques were modified to minimise the shrinkage of the construct and damage to the 
native structure. Development of the sample preparation methodology for the SKN 
constructs and imaging by SEM was carried out by Dr.A.Brain, Chief Technical Officer 
at the Centre of Ultrastructural Imaging (CUI), King's College London. Transmission 
electron microscopy (TEM) was used to investigate the internal structure of the 
fibroblast cells to give an insight into cell activity in the SKN constructs. Preparation of 
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resin embedded TEM sections and imaging was also carried out at the AMU, 
Nottingham University, UK. 
Section 3.4 describes quantitative assays to measure the changes in the biochemical 
composition of the SKN constructs during manufacturing. The number of human 
dermal fibroblast cells in the construct was determined using trypan blue and the 
percentage of live, apoptotic and dead cells determined by flow cytometry. The time 
taken to digest the SKN constructs in collagenase B was used as an indication of the 
degree of cross-linking in the constructs. The SKN constructs were dehydrated to 
evaluate the change in the percentage of water and insoluble extracellular matrix during 
manufacturing. The quantity of collagen type I was analysed using an enzyme -linked 
immunosorbent assay (ELISA). Finally, the use of Raman spectroscopy was 
investigated as a non-contact, non-destructive technique to identify the structure and 
biochemical composition of the SKN constructs in collaboration with Dr.I.Notingher, 
Nottingham University School of Physics, UK. 
Section 3.5 describes the rheological analysis of the viscoelastic properties of SKN 
constructs during manufacturing to provide quantitative data to support the qualitative 
physical and structural observations and changes in biochemical composition. The 
rheological protocol was developed with assistance from Dr.L.Hamilton, Nottingham 
University School of Pharmacy and Mr.S.Goodyear, Anton Paar, UK. 
Statistical differences between the averages of results of each time point during the 
manufacturing period was analysed using a 2 sample T -tests in Minitab® 14 Statistical 
Software. A statistically significant difference was represented by a p-value of less than 
0.05. 
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Surface Profiling 
Histology 
IHC 
CLFM 
SEM 
FEGSEM 
TEM 
Digestion 
Flow Cytometry 
Dehydration 
ELlSA 
Raman Spectroscopy 
Rheology 
Fibrin Structure 
Collagen Structure 
Collagen Type I 
Collagen Type III 
Cell Orientation 
Collagen Type I Structure 
Matrix Structure 
Cell Distribution 
Matrix Structure 
Cell Distribution 
Cell Ultrastucture 
Activity 
Collagen/Fibrin cross-
linking 
and 
Live, apoptotic, dead cells 
Wet weight 
Dry weight of ECM 
Collagen Type I 
Collagen/Fibrin 
Composition 
Shear storage modulus 
Shear loss modulus 
3 
3 
,; .......• 4 
5 
6 
7 
8 
8 
; .• 9,10,AC2 
11 
. ',., .... '.' 
, ............. ,.,;." 9,AC3 
10,AC4,CD 
Table 8 Summary of the techniques used to characterise the SKN constructs and the time points at which measurements were taken during manufacturing 
(shaded). Far right column: The batch of constructs used for each characterisation technique where AC=acellular constructs. CD=cadaver dermis 
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3.2. Production of SKN Constructs 
3.2.1. Cell Culture 
A master cell bank for use in SKN constructs was created by culturing passage 0 (PO) 
neonatal human dermal fibroblast (HDF) cells (TCS Cell works, UK) to P3 using the 
CompacT SelecT robotic automated cell culture system manufactured by TAP (The 
Automation Partnership, UK). The CompacT SelecT comprises of a robotic arm, which 
manipulates tissue culture flasks, and an integrated incubator and cell counting system 
(CEDEX, Innovartis, Germany). Automated programs for the seeding, culturing, 
harvesting and counting of the HDF cells were developed from the standard operating 
procedures for manual culture of HDF cells (see Appendix I for automated programs 
and manual protocols). 
Briefly, DMEM-IO culture media comprising of Dulbecco's Modified Eagle's Medium 
(BEI2604, Lonza, UK), supplemented with gamma irradiated fetal bovine serum (10%, 
SAFC Biosciences, UK) and L-Glutamine (5%, Sigma-Aldrich, UK) was prepared and 
loaded on the CompacT SelecT. PO HDF cells were manually recovered from 
cryostorage according to Experimental Operating Procedure, EOP008 (Appendix I). 
The HDF cells were resuspended in DMEM-IO media and the cell suspension (30mL) 
was seeded in a bar-coded T175 tissue culture flask (BD Biosciences, UK) at a density 
of 5000 cells/cm2. The flask was imported into the CompacT SelecT and stored in the 
humidified incubator at 37°C and 5% C02. The CompacT SelecT was progranuned to 
retrieve the flask from the incubator after 3 days, dispose of the spent media, dispense 
fresh DMEM-lO media (30mL) and replace the flask back in the incubator for further 
cell proliferation. 
After 7 days, the cells were near confluence under these growth conditions. The 
CompacT SelecT was programmed to dispose of the spent media, dispense 0.25% 
trypsinlEDTA (6mL, Sigma-Aldrich, UK) into the flask and replace the flask in the 
incubator for 6 minutes to allow enzymatic detachment of cells from the growing 
surface. The flask was then retrieved from the incubator and DMEM-IO media (IOmL) 
was added to inactivate the trypsin. The flask now containing the PI cells was exported· 
from the CompacT SelecT and the cells pelleted by centrifugation at 500g for 5 
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minutes. The supematant was aspirated and the cell pellet manually resuspended in 
DMEM-I0 media (30mL). The cell suspension was placed in a new bar-coded flask 
which was then imported into the CompacT SelecT. The cell concentration was 
determined using the integrated CEDEX automated cell counter and the required 
volume of DMEM-I0 media was added to obtain a final cell suspension of 8.7Sxl0s 
cells/mL. The number of flasks that could be seeded from this cell suspension at a 
density of SOOOcells/cm2 was calculated. DMEM-I0 media (29mL) and ImL of the cell 
suspension from the imported flask was dispensed into the calculated number of new 
flasks in the CompacT SelecT before placing in the incubator. The DMEM-I0 media in 
these flasks was changed after 3 days and the cells trypsinised after 7 days as described 
previously. The resulting P2 cells were pooled in a single flask before exporting and 
centrifuging as described previously. 
This was repeated until P3 when the cells were resuspended in DMEM-lO 
supplemented with DMSO (10% Sigma-Aldrich, UK) at a density of 1.5xl07 cells/mL. 
ImL of the cell suspension was place in a cryovial and the cryovials placed in a "Mr 
Frosty" cell freezing container stored at 4DC (Nalgene Labware, NY, USA) with 2S0mL 
of isopropanol (Sigma-Aldrich,UK) as per the manufacturer's instructions. The "Mr. 
Frosty" was placed in a _80DC freezer for 24 hours after which the cryovials were 
transferred to liquid nitrogen to store the master cell bank. One vial of P3 HDF cells 
was taken from the master cell bank after 24 hours, recovered from cryopreservation 
and cultured to P7 using the CompacT SelecT procedures described above. The P7 cells 
were cryopreserved as described above to create a working cell bank. This was repeated 
for subsequent vials of P3 HDF cells to replenish the working cell bank when 
necessary. The P7 cells were recovered from cryopreservation immediately prior to use 
in the SKN constructs and resuspended at a density of3xl06cells/mL in DMEM-lO. 
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3.2.2. Casting of SKN Constructs 
SKN constructs were produced by adding 2.6mL of 5mglmL bovine fibrinogen (Sigma-
Aldrich, UK) in phosphate buffered saline (PBS minus Mg2+ and Ca2+, Lonza, 
Switzerland), 0.63mL of the HDF cell suspension and 0.63mL of 25IU/mL thrombin 
(Baxter Healthcare, UK) in PBS, to a 15mL Falcon tube. Immediately after addition of 
the thrombin solution, 3.4mL of the mixture was drawn into a 5mL micropipette and 
cast into a rectangular 28mm x 38mm well in a culture dish (Nunc, NY, USA). The 
constructs were allowed to gel for 10 minutes at room temperature before DMEM-IO 
media (4mL) was placed on the top of the constructs to break the surface tension. This 
, 
media was aspirated and 2mL of fresh DMEM-IO media was placed on each construct. 
The casting day was denoted D-2. After 48 hours Total Media (TM) was used to feed 
the SKN constructs every Monday, Wednesday and Friday for the total manufacturing 
period of 49 days The first feeding of the constructs with Total Media (TM), two days 
post-casting, was denoted day 0 (DO). Total Media was produced immediately prior to 
use by adding the supplements specified in Table 10 to Matrix Producing Media 
(MPM) specified in Table 9, which was prepared in advance. This process is equivalent 
to the ICX-SKN manufacturing process except for the substitution of bovine fibrinogen 
for human fibrinogen. 
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I ' , ~~~I~~)M;diUm lonza - N/A 646 
Hams F12 Lonza - N/A 216 
Fetal Bovine Serum SAFC N/A 100 Biosciences -
L-Glutamine Lonza ddH20 200mM 10 
Hydrocortisone 5i9ma 5mg/mL ethanol 200~g/mL 2 
and ddH20 
,+ 0-
"': 5i9ma ddH20 50mM + 50mM 2 
Trilodo-I-thyronine + 5igma + lMHCI 2.5mg/mL + 2 Transferrin Millipore 10~M/mL 
Selenious acid Molekula ddH20 3.39~g/mL 2 
Ascorbate Molekula ddH20 25~g/mL 2 
L-Proline Molekula ddH20 100~g/mL 2 
Glycine Molekula ddH20 50~g/mL 2 
Polyethyleneglycol 5i9ma pas 10%(wlv) 5 wrw 3,400-3,700 
Amphotericin B Invitrogen ddH20 250~g/mL 1 
Gentamycin Molekula ddH20 50mg/mL 1 
Table 9 Composition of Matrix Producing Media (MPM) 
rhTGF-~ R&D Systems 10~g/mL 5~1 
rhEGF R&D Systems 1 mg/mL Bovine Serum 10~g/mL 6.25~1 Albumin in pas -
Plasmin Calbiochem pas lU/mL 10~1 
Insulin Serologieals pas 2,5~g/mL 2~1 
Table 10 Supplements added to MPM to produce Total Media 
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3.3. Physical and Structural Properties 
3.3.1. Precision Surface Profiling 
The surface profile of SKN constructs was mapped using a Talysurf300 Precision 3D 
Surface Pro filer with 3mm white light CLA gauge (Taylor-Hobson Precision, UK). The 
SKN constructs in the culture dishes were removed from the 37°C and 5% C02 
incubator, the media was aspirated and the constructs were placed in the surface profiler 
(Figure 6 top). 100 data points on the surface of the SKN construct were taken at 
2.6mm and 3mm intervals, over a 26 x 36mm area, in the x and y axis respectively to 
produce a 3D meshed image. A 4mm slip-gauge was used as a z-axis reference point 
and to ensure that the maximum height of the SKN construct was within the 3mm 
working range of the machine gauge (Figure 6, bottom). It was not possible to obtain 
data from the outer 2mm perimeter of the SKN constructs due to the deflection of the 
white light by the edge of the culture dish, away from the receiver. 
The volume of the SKN construct was calculated by multiplying the average area in the 
y-axis (calculated by the TalySurfGold software) by 26 (the width of the construct) and 
adding the rectangular volume ofthe construct below the slip gauge. The thickness, t, of 
the constructs was calculated by adding the distance between the top of the construct at 
the centre and the top of the slip gauge, to the distance between the base of the culture 
dish and the top of the slip gauge (Figure 6, bottom). After measurement, 2mL of fresh 
media was placed on the constructs and the culture dish replaced in the incubator. Three 
SKN constructs were cast as a batch and the surface profile, volume and thickness of 
these constructs was measured on days D-2, DO, D2, D5, D7 and then every 7 days until 
D49. This was repeated for a separate batch of SKN constructs (n=3) and acellular 
constructs (n=3). 
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Calculated area 
z 
c :added 
White light CLA 
Gauge 
SKN Construct 
Slip gauge (SG) 
Figure 6 Top: Experimental Set-up of S KN Co nstruct in th e Prec ision 3D Surface Profiler. Bottom: 
Schematic of cross-section where t=thickness and SG = slip gau ge 
3.3.2. Histology 
On ~O, 0 2 1 and 049 a section (approximately 3mm x 10mm) was cut from the centre 
of the SKN construct using a scalpel and fi xed in 10% neutral buffered forma li n 
(Sigma-Aldrich, UK) for 24 hours. The section was processed through a series of 
increasing ethanol concentrations (70%, 80%, 96% and 100%), xylene and molten wax 
over 17 hours using a Leica TP 1020 automatic tissue processor (Appendix [] fo r full 
ti ssue processor timings). The samples were then embedded in wax uSlllg a Leica 
EG 11 50c ti ssue embedding station and 8flm cross-sections were cut using a Leica 
RM21 35 rotary microtome. The samples were stained with Masson's Trichrome (MT) 
for detection of fibrin and collagen and viewed under a li ght microscope. This was 
repeated using Alcian Blue (AB) stain fo r detection of proteoglycans and Elastic Van 
Gieson's (EVG) stain for detecti on of elastin (Appendix 11 for full staining protocols). 
Samples of human li ver, skin and intestine were used as controls for the respecti ve 
stains. 
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3.3.3. Immunohistochemistry 
The wax embedded samples prepared for histological analys is were also used for 
immunohistochemical analys is as fo llows. Afler cutting the 8flm sections on the rotary 
microtome, the IHC sections were placed in xylene for 30 minutes to remove the wax, 
then in decreas ing grades of ethanol for 10 seconds ( 100% three times, 90%, 70% and 
50%) fo llowed by distilled water fo r 10 seconds to rehydrate the sample. The sections 
were placed in I : 1 00 Antigen Unmasking Solution (Vector, CA, US) in ultra-pure water 
and heated in a 950W microwave three times for 7 minutes at 60% power setting. The 
sections were cooled at room temperature for 20 minutes and then washed in PBS. The 
sections were washed twice in Buffer at room temperate for 5 minutes and then placed 
in Buffer supplemented with normal goat serum (2%, NGS) for 10 minutes. The Buffer 
comprised of PBS supplemented with bovine serum albumin ( I %, Invitrogen, UK) and 
Tween 20 (0.2%, Sigma-Aldrich, UK). 
Primary antibodies for co llagen type I (ab292 Abcam, UK) and type III (ab63 I 0, 
Abcam, UK) were used for immunohistochemical determination of these two co llagens 
in the SKN construct. Secondary antibodies conjugated to FITC (# 111-095-003 
l ackson-Immuno, US) and TRlTC (#115-025-003 l ackson-Immuno, US) were used to 
detect anti-collagen type I and anti-collagen type III anti bodies respecti vely. Working 
solutions of the primary and secondary antibodies were prepared in Buffer at 1 :200 
dilut ions. Co ll agen type I primary antibody (250flL) was placed on each section for 20 
hours at 4°C and then washed twice in buffer for 5 minutes . FITC secondary antibody 
(250 fl L) was placed on each sample for 3 hours at room temperature, in the dark and 
then washed twice in buffer for 5 minutes. This was repeated for the collagen III 
primary and TRITC secondary antibodies. The sections were mounted on a glass slide 
with OABCO fluorescent mounting medium and analysed using a Leica Le itz OMRB 
fl uorescent microscope. This was repeated fo r a 049 SKN construct without the 
addition of the primary collagen type I and III antibodies, to determine the leve l of 
background fluorescence of the FITC and TRITC antibodies. 
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3.3.4. Con focal Laser Fluorescent Microscopy (CLFM) 
On 0-2, 0 6 and 049, sections (approx imately 5mm x 5mm) were cut from the corner 
of a SKN construct and placed in a 24-well tissue culture plate. The samples were fixed 
in 5mL of 4% para formaldehyde in 0.1 M sodium cacodylate for 30 minutes. The 
samples were washed in PBS for 30 minutes fo llowed by two 5 minute washes in 
Buffer (described in section 3.3.3) and a 10 minute wash in Buffer supplemented with 
2%NGS. 
Primary antibody for collagen type I (ab292 Abcam, UK) and secondary antibody 
conjugated to FITC (# 111-095-003 lackson-Immuno, US) were used to detect co llagen 
type I in the SKN constructs. Alexa Flour® 647 phalloidin (A22287, Invitrogen, UK) 
was used to detect the cell actin fil aments and OAPI (0 I 306, Invitrogen, UK) to detect 
the cell nuclei . Working solutions of each anti body were prepared according to the 
manufacturer' s guidelines for CLFM prior to use. Briefl y, I : I 00 dilutions of collagen 
type I and FITC antibodies were prepared with Buffer. The Alexa Flour® 647 
phalloidin was dissolved in methanol to yield a stock solution of 200unitlmL from 
which a I :50 working solution was prepared with PBS. A 5mglmL working solution of 
OAPI was prepared with PBS. 
Collagen type I antibody (200flL) was placed on the sample fo r 20 hours at 4°C in the 
dark and the samples were then washed twice in Buffer for 5 minutes. Th is was 
repeated for FITC and conjugated phalloidin. OAPI (200~L) was then placed on the 
sample for 30 minutes at room temperature, in the dark to stain the cell nuclei. The 
samples were washed twice in Buffer for 5 minutes and mounted in a g lass bonomed 6 
well-plate fo r imaging on a Leica SP2 confocallaser fluorescent microscopy with Leica 
OM I RE2 inverted fluorescent microscope. Images were taken using sequential 
acqui si tion at intervals of I ~m from the top surface of the SKN construct to a depth of 
40~m and repeated from the bottom surface by turning the samples over. A x20 
magnification glycerol immersion lens was used unless otherwise stated. This was 
repeated on a 0 49 SKN construct without the add ition of the primary co ll agen type I 
antibody, to determine the level of background fluorescence of the FITe antibody. 
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3.3.5. Scanning Electron Microscopy 
On DO, 0 3, 014, and then every 7 days until 049 sections (approximately Smm x 
10mm) were cut from the centre of SKN constructs and fi xed in 3% glutaraldehyde in 
0. 1 M sodium cacodylate buffer (SmL) for 2 hours. The samples were washed twice in 
0. 1 M sodium cacodylate buffer (SmL) for 20 minutes and then placed in 2.3 M sucrose 
(S mL) for 24 hours at 4°C. Smaller sections (approximately Smm x 2mm) were cut 
from the samples which were then rapidly frozen in slush liquid nitrogen. The samples 
were transferred onto an aluminium plate in the liquid nitTogen where they were 
fTactured with a hammer and razor blade. The fractured pieces were washed twice in 
di stilled water for 15 minutes and then placed in increasing concentrations of acetone 
(30%, SO%, 70%, 90% and 100%) three times at each concentration for IS minutes . The 
samples were placed in microporous critical point drying sample holders (Agar 
Scientifi c, UK) fill ed with 100% acetone and dried in a Polaron E3000 critical point 
dryer with 3 flushes of liquid carbon diox ide over a 90-minute soaking period. The 
dried samples were mounted on sWbs with adhes ive carbon pads and splutter coated 
with gold for 2 minutes in a Polaron ESI 00 sputter coater. The samples were imaged 
using a Leica StereoScan360 SEM on 03, 014, 0 2 1, 0 28 and D3S. Higher reso lution 
images were taken using an FEI Quanta 200F Field Emission Scanning Electron 
Microscope (FEGSEM) operated at SkV in high vacuum mode on DO, 014 and 0 49 
using SKN constructs from a di fferent batch. 
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3.3.6. Transmission Electron Microscopy 
On 0 5, 0 2 1, 033 and 049 secti ons (approximately 5mm x 10mm) were cut fro m the 
centre of the SKN constructs and fi xed in 3% glutaraldehyde in 0.1 M sodium 
cacodylate Buffer (5mL) for 24 hours. The samples were washed, post-fi xed in 1% 
osmium tetrox ide in 0. 1 M sodium cacodylate buffer (5mL) and then ri nsed 5 ti mes in 
di stilled water fo r 1 minute. The samples were dehydrated using increas ing 
concentrati ons of ethano l (30%, 50%, 70%, 90% and 100%) and graduall y infiltrated 
with resin over 24 hours us ing a 3: I acetone:resin mixture, fo llowed by I : I 
acetone:resin mixture. The samples were then incubated in three changes of pure resi n, 
embedded in BEEM® capsules and polymerised at 60°C for 48hrs. Semi-thin res in 
cross-sections (0.5 f.lm) were cut using a glass knife on a Reichert-lung ultra-cut 
ultramicrotome and placed on glass microscope slides for staining with 2% toluidine 
blue. The sections were exam ined using a Leica OM4000B light microscope to ensure 
that sections contained the sample. The block face was trimmed to a trapezoidal shape 
and ultra-thin (90nm) sections were cut using a di atome diamond knife and collected on 
hexagonal 100 mesh copper grids (Agar Scientific, UK). The sections were contrasted 
using methanolic uranyl acetate and lead citrate and viewed in an FEI Tecnai BioTwin 
TEM operated at 100kV. 
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3.4. Biochemical Composition 
3.4.1. Collagenase Digestion and Flow Cytomctry 
On 0 -2, 07 and week ly intervals until 0 49, three SKN constructs were placed in 
separate bijou tubes containing 0.28U1mL co llagenase B (Roche, Switzerland) in PBS 
(2mL). The bij oll tubes were placed in a water bath at 37°C until the HDF cell s were 
released from the constructs and the constructs were full y digested with no so lid matrix 
visible. The digested solution (I mL) was placed in the CEOEX automated cell counting 
machine and the total cell number recorded . The remaining solution was used for fl ow 
cytometry analys is as described below. 
Flow cytometry using Vybrant® Apoptos is Assay Kit #2 (Molecul ar Probes, UK) was 
used to dete rmine the percentage o f live, apoptot ic and dead cell s in the SKN 
constructs. The apoptoti c assay kit used Annexin V, which has a high affinity for 
phosphatidyl serine present on the outer surface of the cell membrane during apoptosis, 
and propidium iodide (PI) which binds to nucleic acids in dead cells (Koopman, 
Reutelingsperger et al. 1994). The cell digest and working solutions were prepared for 
flo w cytometry according to the manufacturer' s instructions. Briefl y, the cell digest was 
centrifuged at 500g for 5 minutes, washed in co ld PBS (4°C) and suspended in I X 
Almexin V- binding buffer at 2x I 06 cell s/mL. 100flL aliquots of the cell suspension 
were placed in fi ve micro-centri fuge tubes. 
A positive control was prepared by adding 70% ethanol (l OOIlL) into one of the 
aliquots fo r 3 minutes to induce apoptosis. This aliquot was centrifuged, washed in PBS 
and suspended in I X Annexin V-binding buffer. Conjugated Alexa Fluor 488 Annexin 
V (5 IlL) and I mglmL propidium iodide (I ilL) working solution was added to three of 
the aliquots. The remain ing aliquot was used as a negati ve control without the addit ion 
of PI and Alexa Fluor to determine the autofl ourecence fro m the cell s and binding 
buffer. All of the fi ve aliquots were incubated for 15 minutes at room temperature and 
then I X Annexin-binding bu ffe r (400 IlL) was added to each aliquot. The aliquots were 
stored at 4°C until flow cytometry analysis at fl uorescence emissions of 530nm and 
575nl11 . 
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3.4.2. Chemical Dehydration 
On 0-2, ~O, 07 and weekly intervals until 049, three constructs were carefull y 
removed from the culture dish using tweezers and a spatula. Excess surface water was 
removed by sl iding the top and bottom surfaces of the construct over the edge of the 
dish. Each construct was placed in a weighing boat and weighed using a Oenver 
Instrument APX-I 00 balance. The samples were chemically dehydrated by placing in 
formal in (20mL, Sigma-Aldrich, UK) for 45 minutes fo llowed by increasing 
concentrations of ethanol (20mL of 10%, 20%, 70%, 100%) fo r 45 minutes, two 
changes of 99% abso lute ethanol (20mL) for 45 minutes, hexamethyldistalazane 
(20mL, Sigma-Aldrich, UK) for 45 minutes and finally fTesh hexamethyldistalazane 
(20mL) until the liquid had completely evaporated. The dried constructs were weighed 
on a Oenver Instrument APX-I 00 balance. This was repeated for a separate batch of 
SKN constructs (n=5) and a batch of acellular fibrin constructs (n=3). 
74 
3.4.3. Collagen Type I Enzyme-Linked Immunosorbant Assay (ELISA) 
On 0-2, 0 7 and weekly time-points until 049, three SKN constructs were digested in 
Smg/mL of pepsin in O.S M acetic acid (2mL, Sigma-Aldrich, UK). The constructs were 
agitated on a shaker for 2 days at 4°C and then stored at -80°C until processing. All of 
the samples were processed as a batch for ELISA analys is. 
The samples were thawed at room temperature and I mL of each sample was freeze 
dried for 24 hours. Human Type I Collagen ELI SA kit (Chondrex Inc, DC, USA) was 
used according to the manufacturer's instructions. Brie fl y, capture antibody solution 
(l OO flL) was added to each well of the 96 well-plate and incubated at 4°C overnight. 
The freeze d ried samples were resuspended in ELI SA buffer (300flL) and standards 
were prepared by adding the stock solution to the dilution buffe r as deta iled in Table 11 . 
The ELI SA plate was washed six times with I X wash buffer and each standard and 
sample (l OO).lL) was added to the plate in dupli cates . The plate was incubated at room 
temperature for 2 hours and then washed in I X wash buffer. Detection antibody 
( IOO fl L) was added to each well and incubated at room temperature for 2 hours. The 
plate was washed three times with IX wash buffe r and Streptavidin Peroxidase ( I OOflL) 
was added to each well. The plate was incubated at room temperature for I hour and 
then washed three times in I X wash buffer. OPD-Urea H202 ( IOOflL) was added to 
each well and the reaction was stopped after IS minutes with stop solution (S O).lL). The 
plate was read using a Molecular Devices SpectraMax 190 plate reader, at 490nm. 
Standards Stock Dilution 
(~g1mL) Solution (~L) Buffer (~L) 
10 (A) 50 450 
5 (6) 250 (A) 250 
2.5 (C) 250 (6) 250 
1.25 (D) 250 (C) 250 
0.625 (E) 250 (D) 250 
0.313 (F) 250 (E) 250 
0.156 (G) 250 (F) 250 
O(H) 0 250 
Table II Volume of stock solution and dilution buffer for preparation of collagen type I standards 
for ELlSA 
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3.4.4. Raman Spectroscopy 
A Micro-Raman Spectrometer, custom bui lt fo r analysis of biological material s by 
Or.I.Notingher, Nottingham Univers ity, UK (Jell , otingher et al. 2008) , was used to 
investigate the changes in biochemical composition of the SKN constructs during 
manufacturing (Figure 7). The 00, 07 and 049 KN constructs dried by chemical 
dehydration as described in section 3.4.2 were analysed as fo llows. A dried sample was 
placed on a magnesium fluoride cover slip and then on the inverted microscope stage. A 
785nm diode laser was energized, sent through the microscope and foc used into the 
sample via a x50 microscope objective lens. Scattered light from the construct was 
passed back through the microscope objecti ve and a notch filter. The Raman scattered 
li ght was focused into the entrance of the spectrometer for detection using a charge-
coupled detector (CCD) camera and conversion into Raman Spectra and. The Raman 
spectra were acquired using an acquisition time of I Os. This was repeated for each dried 
sample, a hydrated acellular fibrin ge l, a 0 63 hydrated SKN construct and OMEM-I O 
media as a control. 
Figure 7 Micro- Ram an experimental set-up. Reproduced with permission from Or.I.Notingher, 
Nott ingham University, UK 
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3.5. Mechanical Properties 
3.5.1. Rheology 
Humidifying chamber 
Top Plate ----
SKN Construct ___ _ 
Base plate ----
Figure 8 Experimental set-up of rheom eter usi ng parallel plates. Left: Rheometer. Right: SKN 
construct between para llel plates 
On ~O, 07 and at week ly interva ls until 049, the viscoelastic properties of three SKN 
constructs were measured. An Anton Parr Physica MCR30 I Rheometer wi th parallel 
plate attachments was used to measure the shear storage modulus (G') and shear loss 
modulus (G" ) of the SK constructs (Figure 8). A 25mm diameter serrated top plate 
and 100mm serrated base plate were attached to the rheometer. A motor adjustment was 
run to calibrate the rheometer on each testing day. The temperature of the base plate 
was set to 37°C and a humidi fy ing chamber was used to minimise evaporation during 
testing. A SKN construct was carefully removed from the 8-well plate using tweezers 
and a spatula and excess surface water was removed by sliding the top and bottom 
surfaces of the construct over the edge of the dish. 
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The construct was placed on the base plate of the rheometer ensuring that there were no 
bubbles under the construct to reduce the variation in measurements. The top plate was 
lowered onto the construct until 0.1 N of normal force was applied. This a llowed for 
repeatable, homogeneous loading of each construct and accounted for any variations in 
thickness. A frequency sweep was carried out at 1.2% strain between 0.00 I and 16Hz to 
observe the construct response to strain rate. This was fo llowed by a strain sweep 
carried out between 0.0 I % - 100% at II-Iz to observe the response of the SKN 
constructs to increasing shear deformation. In add ition, a strain sweep was carried out 
on acellular gels on DO (n=3) to determine the contribution of the cell s to the 
viscoelasti c properties, and on cadaver dermis (n=5), donated by NHSBT, Liverpool , 
UK, to provide a reference point for the SKN constructs. 
78 
3.6. Res ults and Discussion 
The quantitative results are summarised in Table 13 and quali tative results in Table 14. 
3.7. Physica l and Structural Properties 
3.7. 1. Surface Profiling 
The 3D-meshed images of the surface profil e of the SKN constructs showed that the 
constructs had a convex surface after casting which changed to a concave surface 
during manufacturing. These results correlated with decreases in the construct vo lume 
and thickness (Figure 9). On 0 -2, the constructs had a convex surface with a centre 
point thickness of 2.97mm and volume of 281 2mm l (Figure 10). The volume of the 
I mm wide perimeter of the SKN constructs, which could not be measured by thi s 
method, was estimated to account for approx imately 358mml of the volume of the SKN 
constructs on 0-2 assuming that the thickness was 2.8mm (the average thickness of the 
outer edge measured) in thi s area. 3.4mL of the SKN construct casting mixture was 
used to produce each construct which suggested that the volume of the construct 
reduced by approx imately 229mml between the time of casting and the time of the 
measurement, 4 hours after casting. 
By ~O, there appeared to be a decrease in the radius of curvature of the convex surface 
and the constructs were 70% of the ori ginal thickness and 96% of the original volume. 
The SKN constructs had a concave surface profi le by 0 2 and the radius of curvature 
appeared to increase until 014. Between 014 and 049 the surface profil e did not 
change, and the thickness and volume of the constructs were 47% and 53% of the 
original constructs respecti vely. The thickness of the constructs was greater at the edge 
compared to the central regions after 0 2 (Figure I I ) . Visual inspection of the interface 
between the constructs and the culture di sh showed that the edges of the SKN 
constTucts were anchored to the sides of the culture di sh throughout the manufacturing 
process. 
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In compari son, the surface profi le, thi ckness and vo lume of the acellular control 
constructs remained constant until D35. This showed that the changes in surface pro fil e 
of the SKN constructs were caused by the HDF ce ll s and was supported the findings of 
other studies which reported that HDF cell s remodelled loosely arranged fibrin fi brils 
into closely packed organised fi bres and in turn caused construct compaction (Tuan, 
Song et al. 1996). The decrease in thi ckness and reduction in the radius of curvature of 
the convex surface of cellular constructs over time has been reported prev iously 
(Neidert, Lee et al. 2002, Tuan, Song et al. 1996, Tuan, Song et a l. 1996). However, in 
these studies the observations of the change in surface profil e were qualitative and 
measurement of the thickness of these constructs was limited to a single point measured 
by focussing a microscope on the top and the base of the constructs. The novel 
application of surface pro filing demonstrated in this study provided a method to 
quanti fy the changes of the whole surface profi le of the SKN constructs over time and 
more accurate measurements of the volume and thickness of the constructs. 
Precision surface profiling provides a useful too l for non-contact, non-destructi ve 
monitoring of the changes in surface profi le of ti ssue-engineered cons tructs. This may 
prove useful for future des ign of restraints and culture dishes which has been shown to 
control the shape of the constructs (Robinson, 10hnson et al. 2008, Sander, 10hnson et 
al. 2008, Isenberg, Williams et al. 2006). In addition, surface profiling may be used to 
quanti fy the size and shape of tissue-engineered constructs and determine whether a 
product is within speci fi cation. 
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Day Volume Thickness 
0-2 2812 2.97 
00 2690 2.07 
02 1935 1.75 
07 1560 1.66 
014 1494 1.57 
021 1495 1.57 
028 1495 1.57 
035 1497 1.57 
042 1494 1.57 
049 1496 1.57 
Figure 9 Exa mple of th e surface profil e of a SKN co nstructs during manufacturin g and the ave rage 
vo lum e and th ickn ess of the co nstructs (11=8) 
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Figure 10 T he ave rage vo lume of two batches of SKN constructs (n~8) and acellu la r co nst ructs 
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Figure t I Surface profil e im age showing the va riation in thickness over the whole s urface of a 049 
SKN co nstruct. Sca le ba r represents d istance from the top of th e slip gauge at I023.4"m to the 
surface of the construct 
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3.7.2. Histology 
Masson's Trichrome stained the fibrin fibres purple/red, collagen fi bres blue and cell 
nuclei dark bluelblack (Figure 12 and Appendix 1I for control). The results showed that 
the composition of the SKN construct matrix changed during the manufacturing period 
from a fi brin matrix to a predominantly co llagen matrix. On DO the matrix was 
comprised of fibr in and the cell nuclei were evenly distributed throughout the thickness 
of the construct. On 0 2 1, the majority of the matrix was composed of co llagen but 
some areas of fibrin were also evident. The cell density appeared to be greater 
compared to DO and a layer of cell s had fo rmed at the construct-media interface . 
On 049 there was a dense co llagen matrix with more intense collagen staining around 
the cell nuclei. Higher magnification images of the 049 construct showed that there 
were thin co llagen fibril s spanning between the cell s. These resul ts supported the 
fi ndings of other studies that showed a change in matrix composition fro m fib ri n to 
coll agen in ti ssue-engineered cellular fibrin scaffo lds fo r cardiovascular applications 
over time (Neidert, Lee et al. 2002, Mol, van Lieshout et al. 2005). In addition, these 
results confirmed the qualitati ve model . proposed fo r the ICX-SKN manufacturing 
process descri bed in section 2.4.3 and showed that fibrin was sti ll present in the SKN 
constructs on 0 2 1. 
In contrast, there was no evidence of proteoglycans or elastin in the SKN constructs 
(Figure 13 and Appendix 11 for control sample) at any time in the manufacturing 
process. These results were unexpected as other authors have reported the presence of 
both proteoglycans and elastin in fi broblast seeded fi brin matrices (Ahl fo rs, Billiar 
2007). It was possible that a low concentration of proteoglycans and elastin was present 
in the SKN constructs but was not detectable using thi s histology methodology. Further 
studies are requ ired to confi rm these findings and alternative assays such as BlyscanTM 
fo r quantitat ive analysis of sul fated proteoglycans and glycosaminoglycans could be 
used (Ahl fo rs, Billiar 2007). 
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Figure 12 Masson ' s Trichrome sta ined cross-scctions of SKN construct. 00: Cells (blue/black) 
evenly distributcd in fibrin matrix (purple/red). 021: Co llagen (bl ue) and fibrin in matrix and 
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Figure 13 Cross-sections of 021 SKN co nstruct. Lcft: Cytoplasmic rcgions (rcd) but no evidence of 
proteoglycans (bluc). Right: Collagen fibres (dark red) but no evidence of clas tin (black) 
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3.7.3. Immunohistochemistry 
The IHC sections stained collagen type I green, co llagen type III red and the ce ll nuclei 
blue. The negative controls showed low levels of background fluorescence fo r FITC 
and TRlTC secondary antibodies (Appendix 11) The results showed that both co ll agen 
type I and coll agen type III were present in the SKN construct during the earl y stages of 
manufacturing but only collagen type I was present in the final SKN construct on 049. 
On 00 co ll agen type I and co ll agen type III were not present in the constructs (Figure 
14 top row) which confirmed the Masson 's Trichrome staining that only fibrin was 
present in the matri x as reported previously. On 021, both co llagen type I and III were 
present in the SKN constructs (Figure 14 middle row). The coll agen fibrils were 
concentrated around the ce ll membrane but there was little ev idence of inter-cellular 
collagen deposition. In contrast, by 049 onl y coll agen type I was detectable and many 
thin collagen fibril s were observed between the cells. 
The processes that occur during manufacturing of the SKN constructs are similar to that 
of wound healing in-vivo where HOF cells breakdown the fibrin matrix and secrete 
collagen types I and III (section 2.2). A study of acute wound healing in humans 
(Robins, Milne et al. 2003) supported the imrnunohistolochemical observations reported 
in thi s study. In-vivo, equal quantities of co ll agen type I and III were present in the 
wound after 2 I days but the percentage of collagen type 1II decreased over time with 
significant decreases observed at time point afler 12 weeks (Robins, Milne et al. 2003). 
The ratio of collagen type III to collagen type I in SKN constructs showed a similar 
trend to this in-vivo study but the degradation of collagen type III was more rapid as 
almost no co ll agen type III was observed after 7 weeks. 
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Collagen Type I Collagen Type III 
Figure 14 I HC cross-sections of SKN constrllcts. DO: No collagen type I (green) o r 11\ (red). 0 21: 
Collagen type I and III present around cell membranes. 049: Collagen type I prese nt around cell 
membranes with thin fibril s spa nning between cells. No co lla gen 11\ detecta ble. Ce ll nuclei (blue) 
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3.7.4. Confocal Microscopy 
The CLFM images stained the cell nuclei blue, cell actin fil aments red and collagen 
type I fi bres green. The negative control showed low levels of background fluorescence 
from the secondary anti body (Appendix 11). Images of the individua l layers of the SKN 
constructs viewed from the top of the construct (Figure 15) and the bottom of the 
construct (F igure 16) showed that the morphology of the ce lls was bipolar and Y 
shaped. In addition, the density of cell s was greater towards the top at the construct-
media interface compared to areas nearer the construct- tissue culture plastic interface. 
The cell s did not show any preferred orientation apart from those on the top surface at 
the edge of the constructs. The cells in thi s area were orientated towards the centre 
(Figure 15). 
Between 0 -2 and 0 49, stacked images of the central region of the top 40flm of the 
SKN constructs showed an increase in cell density and collagen type I (Figure 17). The 
0-2 SKN construct showed that there was no collagen in the matri x and that there was 
no cross-reactivity between the fibrin matrix and co ll agen type I anti body. There was an 
increase in cell density between 0-2 and 0 6, and there was intense sta ining of collagen 
around the cell membranes on 0 6. A fu rther increase in the number of cell s and 
collagen was observed in the 0 49 construct with ev idence of inter-cellular collagen 
deposition. These results supported the hi stological and immunohistochemical findings 
which also showed an increase in the number of cell s and quanti ty of collagen during 
manu facturing. 
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Figure 15 Representative I"m C LFM layers of a 049 SKN construct through th e depth of the SKN 
co nstruct , view from the top surface. HOF cells preferentia lly o rientated on top surfa ce (z=O"m) at 
edge but no preferentia l orientation below 14"m. Ma gnification x20 
Figure 16 Representative I"m C LFM layers ofa 0 49 SKN cOllstru ct through th e depth of the SKN 
construct, view from the bottom surface. (z=OJlm ). Fewer ce lls co mpared to top of co nstruct and no 
ce ll orientation. Magnifica tion x20 
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(Ca ption on next page) 
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Figure 17 Slacked CLFM image of Ihe lop 40,,01 of SKN consl rucls. Top Lefl Q ua rler: Cell nuclei. 
Top Righl Qua rler: Co llagen type I. BOllom Lefl Q ua rter: Cell Actin filaments. BOllom Righl 
Quarler : Complied im age. 0-2 (prev ious page): Bipola r cells but no co llagen type I in malri x. 0 6: 
More cells Ihan 0-2 and sla inin g of collagen Iype I a round the cell membranes. 049 (previous 
page) : High ce ll density, intense stai ning of co llagen type I around th e ce ll membranes and inter-
cellula r co llagen deposilion 
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3.7.5. Scanning Electron Microscopy (SEM) 
Analys is of the morphology of the SKN constructs at higher magnifications using SEM 
showed that the fibroblasts cell s were embedded in a highl y cross-linked, porous 
matri x. The density of the matrix and degree of cross-linking appeared to decrease 
between D3 and D1 4. However, the matrix density appeared to increase between D I4 
and D35 (F igure 18). 
Higher reso lution, low magnification images of the DO, D14 and D49 SKN constructs 
using FEGSEM showed that the th ickness of the constructs decreased between DO and 
DI 4 but was similar between DI4 and D49 (Figure 19 left co lumn). This supported the 
surface profiling results reported in section 3.7. 1. However, the thickness of the 
construct on DO was measured as 2.07mm using surface profiling but only 1.3 8mm 
when measured fro m the FEGSEM image. Similarly, on DI4 the thickness of the 
construct was 1.57mm using surface profi ling compared to 1.18mm measured by the 
SEM images . This suggested that the sample preparation of SKN constructs for SEM 
resulted in approximately 30% shrinkage on DO and approximately 25% shrinkage in 
the constructs a fter D14. 
In addition, these images showed that the cell s were evenl y distributed through the 
matrix on DO but on DI4 and D49, the cell density appeared to be greater at the top of 
the constructs (Figure 19 le ft co lumn). Images of the surface of the constructs at the 
construct-media interface showed that there were no cells on the surface of the 
construct on DO but a layer of cell s on the surface on D 14 (Figure 19 right column) and 
D49 (data not shown). In contrast, onl y a few cells were observed on the bottom surface 
of the constructs at the construct-tissue culture plasti c interface at these time points 
(Figure 19 ri ght co lumn). These observations supported the CLFM findings which a lso 
showed a greater cell density towards the top of the constr uct. 
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Further analysis of the cross-section of the 049 construct at 2500x magnification 
showed that the matrix pores were elliptical towards the top of the construct compared 
to approx imately circular pores towards the bottom of the construct (Figure 20, left 
column). This may have been caused by the compaction of the construct reported in 
section 3.7.1. In add ition, a cell layer with fibril s between the ce lls was observed at the 
construct-surface interface and supported the hi stological resul ts . In contrast, onl y a few 
cell s protruding through the matri x at the construct-ti ssue culture plasti c interface 
(F igure 20, ri ght column). 
Analys is of the SKN constructs at 10 OOOx magnification showed that the DO fi brin 
matri x shown by hi stological analysis was comprised of thin fibres that formed 
aggregates on DO (Figure 2 1 top). In contrast, the 0 49 collagen matrix appeared to be 
denser and have a highly interconnected netwo rk of individual co ll agen fi brils. Thicker 
fibres, which appeared to be collagen fibril bundles around the cell membrane, were 
also observed (Figure 2 1 bottom). The diameters of these matrix structures ranged 
between 62.5nm and 125nm, which are typical of co llagen fibril s and fibril bundles 
(Kadler, Holmes et al. 1996). The 014 matri x appeared to have a combination of 
co ll agen fi bril and aggregates of fibrin fibres (Figure 2 1 middle) which supported the 
Masson's Trichrome stained sections which showed that both collagen and fibrin were 
present on D2 1. 
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Figure 18 SEM cross-section of SKN constru cts during manufact uring. 0 3: T hick fi bres a nd la rge 
pores. 014 10 0 35 more structured matrix with in creas ing matrix density. OF = human dermal 
fi broblas t 
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Figure 19 Left column: SEM cross-sections of SKN constructs during manufa cturing. DOa Evenly 
distributed ce lls in co nstruct. DI 4a and D49: Higher cell density a t top of construct. Right co lumn: 
Surface view of SKN constructs. DOb: Top surfa ce with no cells. D14b: Layer of derm al fibroblasts 
(OF) on top surface. D14c: Few cells on bottom surface of SKN co nstruct 
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Figure 20 D49 SKN construct at 2500, magnification. A: Cross-section of top of SKN construct 
wit h elliptica l pores and cell layer at construct-media interface (arrow). B: Cross-section of bottom 
surface of SKN construct with circular pores. C: Top surface view of dermal fibroblast (DF) with 
collagen (C) between the cells. D: Bottom surface view of cell protruding through the collagen 
matrix 
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Figure 21 10000. magnification SEM Cross-sections of SKN constructs. 00: Fibrin fibril 
aggregates (1'). 014: Fibrin and co lla gen mat rix. 049: Structured collagen matr ix (C) with collagen 
fibril bundles (CB). OF~dermal fibroblast. *fibrobl aSl fallen out on frac ture 
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3.7.6. Transmission Electron Microscopy (TEM) 
The ultrastructure of the fib roblast cell s and the matrix in the SKN constructs changed 
during manufacturing. The individual cell s shown in Figure 22 were representati ve of 
the majority of the population of fibrob last cell s in the SKN constructs at each time 
point. On D5 the fib roblasts had a very convo luted cell membrane and nucleus (Figure 
22, D5a). There were many secretory ves icles, mitochondria, endoplasmic reticulum 
and Golgi apparatus (Figure 22, D5b). There also appeared to be an abundance of 
procollagen in the top right end of the cell (Figure 22, DSc). These features suggested 
that the cell was actively secreting collagen as it is known that procollagen molecule 
chains are assembled in the endoplasmic reticulum and packaged into vesicles in the 
Golgi apparatus which then move to the plasma membrane where the contents is 
discharged (Ghosh 2002, Fawcett 1994). In addition, the long mitochondria function to 
provide usable chemical energy for processes such as protein synthesis (Sadava 1993). 
On D2 1 the cell membrane was less convoluted and there was a high density of 
co llagen fibril s surrounding the cell membrane. The matrix also appeared more 
structured and collagen fi bril s orientated parallel to the cell s were observed. By D33 
numerous Iysosomes were present in many of the cell s and the matrix surrounding the 
cell s was denser than the matrix on D21. Lysosomes contain digesti ve enzymes and one 
of their functions is to breakdown injured or ageing cell organelles (Fawcett 1994) 
which suggested that some of the cell s were beginning to undergo apoptosis by 0 33. 
On D49 the cells were beginning to detach from the surrounding matrix and also 
contained many Iysosomes and some lipids (Figure 22, D49a). Detachment from the 
matrix caused by cell shrinkage is also associated with cell apoptosis (Bortner, 
Cidlowski 1998, Barry, Behnke et al. 1990, Bride, Viennet et al. 2004). A dense matri x 
surrounded the cell s and higher magni fication images showed that the matrix fi bres had 
the typical collagen banding pattern (Figure 22, D49b). 
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Figure 22 TEM cross sections ofSKN constructs. Osa: Active cell with convoluted nucleus (N) and plasma membrane. Osb: Many endoplasmic reticulum (ER) and 
secretory vesicles (SV). DSc: Procollagen (PC) and mitochondria (M). 021 Colla gen fibrils a rou nd cell membrane. 033a and b: Increasing presence of Iysosomes 
(L) and collagen between the cells. 049a: Cell shrinkage away from matrix (S). 049b: Collagen banding on fibril 
99 
3.8. Biochemical Composition 
3.8. 1. Collagenase Digestion and Flow Cytometry 
The number of live, apoptotic and dead HDF ce ll s ID the SKN constructs during 
manufacturing is shown in Figure 23. The average total number of cell s (n=3) in the 
construct 3 hours after casting was 1.35x I 06 (cr= 4.73x 1 04) with 4% (cr= 0.33) apoptotic 
cells and 8 % (cr= 4.4) dead ce lls. On D7 the average total number of cell s had 
significantly increased to 6.72x 1 06 (cr= 6. 53x 1 05, p= 0.005) cell s. Between D7 and D42, 
the average total number of cells fluctuated between 6.72x 1 06 and 7.93x I 06. However, 
the number of li ve ce ll s remained relati vely constant at an average of 5.41x l 06 (cr= 
2.90xI05). The percentage ofapoptotic ce ll s was 13.5% (cr= 2.5) and dead ce ll s was 9% 
(cr= 2) between D7 and D35 but increased to 17% (cr= I) apoptotic and 18.5% (cr= 
0.5%) dead cells after D35 . On D49 the average tota l number of cell s significantly 
decreased to 6.08x 106 cells (cr= 4.88xI06, p= 0.0 16) and the average number of li ve 
cell s decreased by 26% compared to D42. These findings supported the increase in the 
number of cells observed in the light and electron microscopy sections during 
manufacturing and the apparent increase in the percentage of apoptotic cell s after D33 
observed by TEM (sections 3.7.2 to 3.7.6). 
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manufact uri ng (n=3). Error ba rs represent onc sta nda rd erro r of the tota l num ber of ce ll s. * 
p=O.OOS. ** p=O.O I6 
100 
3.8.2. Digestion Time 
The average digestion time (n=3) was relatively constant between 0-2 and 0 28 but 
significantly increase by 48% (p=O.002) between 0 28 and 0 42 (Figure 24). This 
suggested that the degree of cross- linking in the SKN constructs increased between 0 28 
and 042 of the manufac turing period. A 12% decrease in the average digestion time 
occurred between 042 and 0 49 but there was no statistical di fference between the 
results at these time points. The plateau in the digestion time between 0 42 and 049 
suggested that co llagen synthes is had ceased or that the matri x was being remodelled. 
However, further measurement of the digestion time after 049 are required to confirm 
thi s. 
The method used for determining the digestion time was reliant on operator judgement 
as to when the SKN construct had full y digested. However, judgment of thi s point was 
problemati c as some small areas of the constructs did not full y breakdown in some of 
the constructs. Measurement of the digestion rate by recoding the change in weight of 
the constructs over time may improve the accuracy of this measurement and provide an 
increased understanding of the development of the cross-links in the constructs during 
manufacturing. Further work is required to develop a more repeatable method for 
determining the quantity of cross-linking in the constructs. 
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Figure 24 Avera ge time taken 10 digest SKN constructs in co llagenase so lution durin g 
manufacturing (11=3). Error bars represent onc sta nd ard error. * p=O.002 
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3.8.3. Dehydration 
A 50% decrease in the wet weight of the SKN constructs was measured between 0-2 
and 07 (p=0), fo llowed by a relatively stable wet weight between D7 and D49 for two 
separate batches of SKN constructs (Figure 25). However, the wet weight of the 
acellu lar constructs did not significantly differ during the manufacturing period which 
showed that the cell s were responsible for the decrease in wet weight. [n addi tion, the 
change in the wet weight of the SKN constructs correlated with the compaction of the 
matrix reported in section 3.7. [ which suggested that water was squeezed out from the 
constructs due to the compact ion by the HDF cells. 
The dry weight of the SKN constructs decreased by 30% between D-2 and D-\ and then 
remained relati vely constant between D-\ and D28 (Figure 26). This suggested that the 
degradation of the fibrin matrix began soon after casting of the SKN constructs and that 
collagen depos ition in the matrix occurred after 0-1 to balance the decrease in dry 
weight due to the fibrin degradation. The dry weight significantly increased by 16% 
(p=0.002) on 0 35 and 28% (p=0.000) on D49 compared to D-[ which suggested that 
the changes in the extracellular matrix were dominated by collagen deposition rather 
than fibrin degradation after D28. Analysis of the results using the Two Sample T-Test 
showed that the increase in dry weight between 0-1 and 049 was between 3.0mg and 
5.5mg using 95% confidence intervals. [n compari son, the ace llular dry weight 
decreased between DO and 0 2 1 and then increase between D21 and 049. However, the 
reasons fo r the changes in the acellular dry weight are not known. 
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Figure 26 Average dry weight of two batches ofSKN constructs ( n~6) and onc batch of acellular 
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3.8.4. Collagen Type I Enzyme-Linked Immunosorbant Assay (ELlSA) 
The collagen type I ELlSA aimed to provide quantitative data on the concentration of 
collagen type I in the SKN constructs. However, the method used in thi s study proved 
to be unsuitable for SKN constructs and development of a quantitative co ll agen assay is 
still required. The results showed that the collagen concentration in the SKN constructs 
increased between 0 -2 and 0 2 1, decreased between 0 21 and 042 and then increased 
between 0 42 and 049 (Figure 28). However, the data between 0 -2 and 042 was not 
reliable as the absorbance signal from the samples was very low and the assoc iated 
co llagen concentration had to be extrapolated beyond the first data point the standard 
curve, 0. 149,Ig/mL, (Figure 27). In addition, calculation of the total quantity of co llagen 
type I in the D49 construct using the ELlSA results showed that the average weight of 
collagen type I was 0.724f.l g. This was significantly below the dry weight of 16.4mg 
measured on 049 (section 3.8.3) and it was expected that co llagen type I would account 
for the majority of the total dry we ight of the construct as suggested by the 0 49 
hi stological sections. 
The low absorbance signal from the SKN constructs using th is methodology may be 
due to a number of factors which include poor extraction of the collagen from the SKN 
construct or poor binding of the antibodies to the epitotes of the ex tracted collagen. 
Further investi gation is required to improve the ex traction of collagen from the SKN 
constructs or use of an alternative assay such as Chloramine T which has been 
demonstrated by other authors fo r detection of collagen (Ahlfors, Billiar 2007, Ibusuki , 
Fuj ii et al. 2003, Balestrini , Billiar 2006, Boccafoschi , Habermehl et al. 2005). 
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3.8.5. Raman Spcctroscopy 
Analys is of dehydrated SKN constructs and SKN constructs in their native state showed 
that there was potential to identi fy the biochemical changes that occurred in the 
constructs during manufacturing using Raman spectroscopy. The Raman spectra for the 
dried SKN constructs showed common peaks at DO, D7 and D49 indicating thei r 
similarity in biochemical composition (Figure 29). In particular, common peaks at 
1248cm·! , 145 Icm·! and 1670cm·! were similar to those found in Raman spectra for 
collagen type I and human dermis (Caspers, Lucassen et a!. 1998, Fendel, Schrader 
1998, Azrad, Zahor et a!. 2006, Nijssen, Schut et a!. 2002). In addit ion, peaks at 856cnf 
! and 938 cm·! were identified and represented the vibrating of C-C bonds in the 
collagen backbone and the amino acid pro li ne ring respectively and are found in high 
concentration in co llagen (Caspers, Lucassen et a!. 1998). The wavelengths of the 
prominent peaks in the Raman spectra and the associated molecular components are 
summari sed in Table 12. 
The DO Raman spectra showed additional peaks at 520cm-!, 665cm-! and 784cm-! not 
observed in the other constructs. This suggested that the peaks were associated with 
fibrin as previous analysis of the SKN constructs using light microscopy showed that 
the matrix was only composed of fibrin on DO. The peaks that were associated with 
collagen in the DO Raman spectra were unexpected as co llagen was not detectable by 
light microscopy at this time point. These peaks may have been detected from co llagen 
that had not yet formed into fibril s and were not visible by light microscopy. Other 
studies have shown that co llagen is biochemically detectable in fi broblast seeded fibri n 
gels after 2 days in culture (DO of th is study) but onl y detectable by TEM after 9 days in 
culture (Tuan, Song et a!. 1996). 
In addition, the peaks associated wi th fi brin in the DO spectra were not present in the 
D7 spectra although the hi stology images showed that fibrin was present in the 
constructs fo r at least 21 days after casti ng. This may be due to rapid degradation of the 
fibrin matrix by the cell s between DO and D7 reducing the fibrin signal in the Raman 
spectra. Other studies have shown that the rate of fi brin degradation by myofi broblasts 
is the greatest in the first 5 days post-casting after which the degradation rate decreased 
(Grass l, Oegema et a!. 2002). 
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Initial experiments to analyse the composition of the SKN constructs in their native sate 
showed that the Raman spectra of an acellular fibrin construct and a 063 SKN construct 
was dominated by the composition of the OMEM- I 0 media (Figure 30). However, 
peaks at 520cnf l , 665cm- 1 and 784cm-1 were identified in the Raman spectra of the 
acellular fibrin construct and correlated with the peaks identified in the 00 dried 
sample. In addition, a peak at 856cm·1 which is associated with the proline ring found in 
collagen was identified in the 063 SKN construct. 
The results suggested that there was potential for use of Raman spectroscopy as a non-
contact, non-destructive tool to determine the composition of SKN constructs in their 
native state . However, improvements in the Raman system are required to improve the 
acquisi tion of the signal and resolution of the peaks in the spectra especia lly from the 
hydrated constructs . For the ICX-SKN constructs, Raman spectroscopy could also be 
used as a non-destructive technique to identify the biochemical composi ti on of ICX-
SKN constructs after the freeze-drying stage of the manufacturing process. 
Wavelength (cm,l ) Component Reference 
622 and 1006 Phenylalanine (Frushour, Koenig 1975) 
856 v(C·C) proline ring (Caspers. Lucassen et al . 1998, 
Fendel, Schrader 1998, Azrad, Zahor 
938 v(C·C) of protein backbone et al. 2006. Nijssen, Schut et al . 2002) 
1248 Amide III group (Fendel, Sthrader 1998, Azrad. Zahor 
et al. 2006) 
1451 O(CH3, CH2) (Azrad, Zahor et a1. 2006, Frushour, Koenia 1975) 
1670 Amide I group (Azrad, Zahor et a1. 2006, Frushour, Koenig 1975) 
Table 12 Components represented by the prominent peaks in the Raman spectra of dehydrated 
constructs and also identified in human dermis 
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3.9. Mechanical Properties 
3.9. J. Rheology 
The shear storage modulus (0 ') represented the elastic properties of the SK construct 
and the shear loss modulus (0") represented the viscous properties. The frequency 
sweep results showed that the viscoelasti c behaviour of the SKN constructs was 
independent of frequency below 3H z at constant strain of 1%. 0' was greater than 0 " 
for frequencies below 3Hz for each time point measured during the manufacturing 
process (Figure 3 1). This showed that the SKN constructs behaved more like an elastic 
solid and the deformations of the construct were essentially elastic and recoverable 
(Rao 2007). Deformation of the constructs above 3 Hz resulted in a decrease in 0 ' and 
an increase in 0 " . Above 10Hz, 0 " was greater than 0 ', which showed that the 
behaviour of the SKN constructs was more liquid-like and the energy used to deform 
the construct was viscous ly di ssipated (Rao 2007). 
200 
,eo 
, .. • 
• 
.. , 
>2, 
Freq...eney (HII 
- DO 0 ' Average 
-OOO" "'Yflrlge 
07G' Avel1lge 
070" Average 
__ D1 4 G' Average 
- 01. 0" Avet1Ige 
.. 021 G' Average 
021 G" Averlge 
_ A _ 028 G' Averag, 
0280' Average 
.. 035 G' Average 
0350" Average 
042 G' Averag!! 
0<120" Average 
().49 0' Avernll' 
[).4110" Avel1lge 
Figure 3 1 Viscoelastic properties of the SKN co nstru cts ove r the manufact uring period in response 
to frequency and 1% strain (0=3). Standard error for each data point ranged between 1.2Pa a nd 
6.3Pa. Error ba rs not shown for clarity 
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In the SKN constructs the elastic properties are related to the straightening and 
relaxation of the matrix fibres such as fibrin and co llagen. The viscous properties are 
related to the flow of the fluid in the constructs which may be affected by numerous 
factors such as the viscosity of the fluid , concentration of proteoglycans which bind 
water to collagen fib rils (Silver, Seehra et al. 2002) and the structure of the matrix. The 
cross-over ofG' and G" at high fTequencies may have been due to the decreasing abil ity 
of the fibres to straighten and relax as the rate of loading increased and therefore, 
caused an increase in the di ssipation of the deformation energy by the viscous 
components. 
The strain sweep was carri ed out at I Hz so that analys is of the response of the SKN 
constructs to strain was independent of frequency and to minimi se the testing time. The 
strain sweep showed that there was a linear viscoelastic region (L VR) where the SKN 
constructs were independent of strain (Figure 32). The constructs behaved more like an 
elastic so lid in this region as G ' was greater than G". After the LVR, G' decreased and 
G" increased resulting in G" being greater than G' for the DO and D7 constructs. Visual 
extrapolation of the curves for the Dl4 to D49 constructs indicated that G" would be 
greater than G' at strains above 100%. A greater G" than G' indicated that the SKN 
constructs had more liquid-like behaviour in thi s region of strain (Rao 2007). The 
transition from predominantly elastic properties to predominantly liquid properti es due 
to shear deformation may have been due to di sruption of the cross-links or a decrease in 
entanglements in the SK matri x. 
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Figure 32 Viscoclastic properties of the SKN constructs over the manufacturing period in response 
to strain at I Hz frequency (0=3). Standard error for each data point ranged between 1.7Pa and 
6.5Pa. Error bars not shown for clarity 
Comparison of the viscoelastic properti es of the acellular and DO SKN constructs 
showed that G ' and G" were 128% and 78% greater for the DO construct, respective ly 
(Figure 33). This suggested that the fib rob last cell s contributed towards the viscoelastic 
properties of the construct. In addition, G' began to decrease after approx imately 3% 
strain for the DO SKN construct compared to approx imately 90% strain for the acellular 
constructs. This was unexpected as the fibrin matri ces used fo r both constructs were 
cast from the same working so lution of fib rinogen and thrombin. However, a possible 
explanation for thi s result is that the decrease in elasti c properties of the DO SKN 
construct was caused by detachment of the HOF cell s from the matrix (Figure 33). 
The HO F cell s in the construct also appeared to affect the structure of the fibrin matri x. 
Extrapolation of the G' and G" curves above I 00% strain for the acellular SKN 
constructs and the cellular DO constructs showed that the cross-over point of G' and G" 
occurred at a greater strain for the acellular constructs (Figure 33). The transition of the 
properti es of the DO SKN construct from predominantly elastic so lid to predominantly 
viscous liquid at a lower strai n compared to the acellular construct suggested that the 
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fibrin matrix in the DO construct had less cross- links or less entanglements assuming 
that the majority of the cells were detached from the matrix at thi s strain . 
[n comparison to the DO construct, the cross-over point of the 07 to 049 SKN 
constructs occurred at greater strain and the viscoelastic properties in the L VR were 
greater. In thi s study, it has been shown that the number of cell s, co llagen deposition 
and cross-linking increased between DO and 07 (section 3.7). These increases may have 
caused the increase in G' and G" in the LVR and the increased strain at which G' and 
G" crossed over (Figure 33). This would support the findings of other studies which 
showed that G' and G" increased with increasing collagen content and cross-linking 
(Sheu, Huang et al. 2001 , Sosnik, Sefton 2005 , Vanderhooft, AIcoutlabi et al. 2008). 
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Figure 33 Proposed relationships between the S KN matrix composition and viscoelast ic properties. 
Acellu lar construct (red lines). DO construct (blue lines). G' and G" representative of D7-D49 
construct (black lines). Data extrapolated above 100% strai n 
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The viscoelastic properties of the SKN construct also corre lated with the changes in the 
biochemical composition and structure of the matrix describe in previous sections. The 
cell proliferation and matrix compaction between 0-2 and 07 corre lated with a 70% 
increase in G' . After 07, it has been shown that construct compaction ceased and the 
number of viable cells in the construct remained constant (sections 3.7. 1 and 3.8.1). 
Therefore, the elastic properties of the SKN constructs during thi s part of the 
manufacturing process were of primary interest as they represented the changes in the 
quantity and degree of cross-linking in the matrix. The changes in G' in the linear 
viscoelasti c region during manufacturing is shown in Figure 34. Between 07 and 0 28, 
G' remained relatively constant at 84±3Pa. G' then increased to 96.5 Pa (not significant) 
on 0 35 and 11 2Pa (p=0.006) on 042 compared to 0 7 before reaching a plateau 
between 0 42 and 049. These results correlated with the measurements of dry weight 
and digestion time (sections 3.8.2 and 3.8.3) and qualitative observations of increasing 
matrix density and collagen in the SKN constructs (section 3.7.2 to 3.7.6). 
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Figure 34 Shear storage modulus (G') of the SKN constructs in the linea r viscoclastic region over 
the manufacturing period (n=3). Error bars represent onc standard error . • p=O.006 
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Finally, compari son of the SKN constructs with cadaver dermis showed that the 
viscoelasti c properties were approx imately ten times greater for the dermis which had a 
G' of I OOO Pa and G" of 200Pa in the linear viscoelastic region. This was supported by 
the SEM images of the dermis which showed a denser co ll agen matrix with large fibre 
bundles (Figure 36). The linear viscoelastic region for the dermis was also greater, 
between 0% and 8%, aft er which G' decreased. The viscous properties represented by 
G" also began to decrease after 30% strain and G' did not cross G' in contrast to the 
SKN constructs. The magnitude of the viscoelastic properti es of the SKN construct 
relative to the native dermis that are required to improve the efficacy of the constructs 
in-vivo are not known. However, the preliminary data of the effi cacy of ICX-S KN in 
the Phase I clinical trials suggested that the constructs did not have to be of similar 
magnitude in terms of viscoelasti c properties fo r successful integration into a wound 
si te as suggested by other authors (Hilborn, Bjursten 2007). 
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Figure 35 Viscoelastic properties of cadaver dermis (n= l) in response to increasing strain at 1Hz 
frequency 
Figure 36 SEM cross-sect ion of hum an dermis (donated by NHSBT, Liverpool) Left: Collagen 
fibrils forming collagen bundles (.2500 mag)_ Right: Cross-section of fibre bundle made up of 
many fibril bundles (x I 0000 mag) 
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n 0-2 DO 07 014 021 028 035 042 049 
Surface profile Convex Convex Concave Concave Concave Concave Concave Concave Concave 
Thickness (mm) 8 2.97 2.07 1.66 1.57 1.57 1.57 1.57 1.57 1.57 
% decrease * 30 44 47 47 47 47 47 47 
Volume (mm' ) 8 2690 1560 1494 1494 1495 1495 1497 1494 1496 
% decrease * 42 44 44 44 44 44 44 44 
Viable cell number 3 1.35E+06 - 6.72E+06 5.82E+06 6.41 E+06 6.23E+06 5.82E+06 5.99E+06 4.79E+06 
% increase * - 397 331 374 361 331 343 254 
% Apoptotic cells 3 3.95% - 11.43% 15.70% 12.61 % 13.30% 16.67% 17.53% 16.22% 
% Dead cells 3 8.38% - 7.23% 10.67% 8.21 % 8.48% 7.94% 19.08% 18.04% 
Digestion time (min) 3 90 - 98 109 110 120 147 229 200 
% increase * - 9 21 22 33 63 154 122 
Wet weight (g) 6 2.83 2.35 1.39 1.36 1.34 1.31 1.37 1.30 1.39 
% decrease * 17 51 52 53 54 51 54 51 
Dry weight (mg) 6 18.43 13.50 12.93 13.69 14.11 14.23 14.92 16.24 16.43 
% increase * 27 30 26 23 23 19 12 11 
G' (Pa) 3 - 48.80 8307 81 .07 87.50 83.25 96.45 111 .50 99.50 
% increase - • 70 66 79 71 98 128 104 
G" (Pa) 3 - 5.68 12.87 12.57 14.50 12.15 13.65 14.67 14.47 
% increase - * 127 121 155 114 140 158 155 
Table 13 Summary of characterisation results during manufacturing. Percentage change calculated relative to D-2 or DO as indicated by' 
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0-2 DD 07 014 021 035 049 
Active cells with Active cells with Cell shrinkage and 
many organelles, collagen fibrils Increased presence increased presence TEM of Iysosomes in of Iysosomes. secretory vesicles parallel to cell 
cells. Denser matrix Collagen banding 
and procollagen membrane 
on fibrils 
Clumps of fibres + More structured More defined Increased matrix Increased matrix matrix, individual SEM evenly distributed matrix+ higher cell density density fibrils , collagen fibril 
cells density at surface bundles 
Fibrin + evenly Fibrin and collagen Collagen matrix + Histology MT matrix + ce ll layer at distributed cells 
surface cell layer at surface 
Histology No proteoglycans No proteoglycans No proteoglycans Alcian Blue 
Histo logy EVG No elastin No elastin No elastin 
50:50 collagen I : III Collagen I on ly with IHC No collagen 1 or III 
matrix fibri ls spanning between ce lls 
Collagen t matrix+ 
CLFM No collagen I orientated cells on Increased collagen I 
surface at edge 
Table 14 Summary of structural analys is of SKN constructs during manufacturing 
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3.10. Characterisation Conclusion 
Characteri sation of the SKN constructs has provided an improved understand ing of the 
changes in physical , biochemical and mechanical properties that occur during the 49-
day manufacturing process. This study also confirmed that the human dermal fibroblast 
cells were the processing units responsible for the majority of these changes. The I-10F 
cells functioned to compact the SKN construct, degrade the fibrin matrix and synthesise 
co llagen. It is suggested that biochemical and mechanical signall ing from the changing 
composition and mechanical properties of the SKN construct stimulated the cells 
responses. Four phases of cellu lar activity were identified in the SKN manufacturing 
process and are di scussed below and illustrated in Figure 37. 
In addition, the shear storage modulus (G') and shear loss modulus (G"), measures of 
the elasti c and viscous properties respectively, were shown to be related to the changes 
in the biochemical composition and physical properties of the SKN construct. In 
particular, the elastic properties were related to the quant ity and degree of cross-linking 
in the SKN construct matrix, and the adhesion of the cell s to the matrix whereas the 
viscous properties were related to the abi li ty of the fluid to flow within the constructs in 
response to shear deformation. The relationship between the change in phys ical, 
biochemical and mechanical properties and the shear storage modulus is also illustrated 
in Figure 37. 
3.10.1. Phase 1: D-2 to D7 Cell Proliferation and Matrix Compaction 
Between 0-2 and 07, the manufacturing process was dominated by cell proliferation 
and compacti on of the matrix by the cell s suggested to be through the reorganisation of 
the fibrin fibres (Tuan, Song et al. 1996). The number of viable cell s in the SKN 
construct increased by 397% and the volume fraction of cell s in the construct increased 
from I % to approx imately 14% (Figure 38 and Appendix III fo r assumptions used for 
calculation o f cell vo lume fraction). The construct was compacted to 47% of the 
original thickness and 53% of the ori ginal vo lume. This correlated with a 70% increase 
in the shear storage modulus and 127% increase in the shear loss modu lus. The stimulus 
for cell proliferation may have been from biochemical and mechanical signalling from 
the fibrin matrix as other studies have shown that the fibrinogen and thrombin 
formulation used to produce the fibrin matrix affects the degree of cell pro liferation 
I 18 
(Cox, Cole et al. 2004, Ouong, Wu et a l. 2009). In addition, Total Media, which 
contained TGF-p I and insulin, may have also stimulated cell proli fe ration as observed 
in other studies of cell seeded fibrin matrices (Ross, Tranquillo 2003). 
Mapping of the surface pro fil e of the SKN constructs showed that cellular construct 
compaction caused the initial convex surface to become concave in profil e and that 
compaction ceased by 014. The decrease in wet weight of the construct over the same 
period suggested that water was squeezed out from the constructs due to the compact ion 
and resu lted in a decrease in vo lume fraction of water from approx imately 98% on 0 -2 
to 88% after 07 (Figure 38). [n add ition, confoca l microscopy images showed that the 
cell s around the edge of the top surface of the construct were preferentiall y aligned 
towards the centre of the construct. Other studies have shown that tension is generated 
in cellular matrices in response to matrix compact ion (Grinnell 2003, Georges, Janmey 
2005) and that cell s orientate In a preferential direction in response to directional 
mechanical stress (De, Zemel et al. 2007, Mudera, Pleass et al. 2000, Eastwood, 
Mudera et al. 1998). The aligned cell s observed in this study suggested that tension 
generated by compaction was greater on the surface of the construct between the edge 
of the SKN constructs and the culture dish. Mechanical signall ing from the tension 
generated in the matrix may have been responsible fo r the cease in matri x compaction 
by the HOF cell s after 014. 
Histological analysis USIng Masson's Trichrome staining showed that the matrix 
comprised of fib rin on DO with cells evenly distributed thought the matrix. However, 
the 27% decrease in dry we ight between 0-2 and DO suggested that degradation of the 
fibrin matrix by the cell s occurred rapidly after casting the constructs. Collagen type I 
deposition by the cell s was detected by 0 6 in the CLFM images . However, analysis of 
the biochemical compos ition using Raman spectroscopy suggested that collagen was 
present as early as DO. This supported the fi ndings of other studies which showed that 
collagen is biochemically detectable in fibroblast seeded fibrin gels after 2 days in 
culture (DO of this study) but only detectable by TEM after 9 days in cul ture (Tuan, 
Song et al. 1996). [n addi tion, high ly active cell s containing many cellular organel les 
and secretory vesicles, characteristic of cell protein synthesis, were observed by TEM 
on 0 5. 
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3.10.2. Phase 2: D7 to D28 Fibrin Degradation and Collagen Synthesis 
Between 0 7 and 028, the total number of viable ce lls was relatively constant 
(5 .41 x I 06, G=5 .8x I 05) and matrix compaction had ceased. No significant differences in 
dry weight (13.9± 1 mg), digest ion time (11 O± 1 Ominutes) and shear storage modulus 
(72.5±6.5Pa) during thi s period suggested that the manufacturing process was 
dominated by fibrin degradation and collagen synthes is. The Masson's Trichrome 
stained histological sections showed that on 021 , the majority of the matrix was 
composed of collagen but some areas of fibrin matrix were still present. The ll-IC 
sections showed that both collagen type I and type III were present on 02 I which is 
consistent with the composition of acute wound healing sites in humans after 3 weeks 
(Robins, Milne et al. 2003). Other studies have shown that fibrin stimulates collagen 
secretion from HOF cells (Grassl, Oegema et al. 2002, Grassl, Oegema et al. 2003) and 
this may have provided part of the stimulus for co llagen synthesis by the HOF cell s 
during thi s period. 
In addition , after 07 the cell density appeared to be greater towards the top of the 
construct and a layer of cell s had formed on the construct-media interface. This cell 
layer was not present on the DO construct which suggested that the cell s migrated to the 
surface of the construct. The reason for the migration is not known but may be due to 
the greater availability of nutrients from the media on the surface . It is a lso possible that 
there was also a higher concentration of nutrients towards the top of the construct 
resulting in cell migration or greater cell proli feration observed in this area by CL FM 
and SEM. However, the difference in cell density may have also been caused by 
compaction of the constructs. 
Further investigation into the cause of the inhomogeneous cell density in the SKN 
constructs may lead to process and product improvement and is discussed in section 
3. 1 1. 
3.10.3. Phase 3: D28 to D35 Collagen Synthesis 
Between 0 28 and 0 35, there were significant II1creases 111 dry weight by 16%, 
(p=0.002), digestion time by 48% (p=0.002) and shear storage modulus by 33% 
(p=0.006). This was supported by the SEM cross-sections which showed an increasing 
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matrix density and the fo rmation of collagen fi bril bundles during this peri od. These 
results suggested that fibrin degradation had ceased between 0 2 1 and 0 28 and the 
manufac turing process was dominated by collagen deposition during thi s peri od. This 
was supported by other studies which used fluorescent labelling of fi brinogen to show 
that the degradation of a fibrin matri x by myofi broblasts occurred over a peri od of 
approximately 20 days (Grass l, Oegema et al. 2002, Ye, Zlind et al. 2000) . 
3.10.4. Phase 4: 042 to 049 Remodelling 
Between 042 and 049, no significant difference in dry weight, digestion time and shear 
storage modulus was observed but the number of viable cells decreased by 
approximately 26%. Histological and immunohistochemical analysis showed that the 
matrix was composed of co llagen type I but there was no evidence of any collagen type 
lll , proteoglycan or elastin deposition reported by other studies of cellular fibrin 
matrices (Ahlfors, Billiar 2007). These events are similar to those that occur during the 
remodelling stage of wound healing in-vivo when co llagen type III is broken down and 
cell apoptos is increases (section 2.2) . However, in-vivo, further remodelling occurs 
through lysis of old collagen and secretion of new collagen over several years until the 
wound has regai ned approximately 80% of the strength of the nati ve tissue (Li, Chen et 
al. 2007). It has been suggested that biomechanical signalling across the wound and 
movement from joints provides the stimulus responsible fo r these events (Li, Ch en et al. 
2007, Clark 1996). However, such mechanica l stimuli are not present in-vitro and 
between 042 and 049 the biochemical compos ition and mechanical properties of the 
SKN construct may have become suitable for the function of sustaining the cell s in the 
culture dish. Further secretion of collagen to increase the mechanical properties of the 
SKN construct is li kely to require an external mechanical stimulus and is investigated 
through use of ultrasound stimulation in Chapters 4 and 5. 
In summary, the 4-Phase model of the SKN manufacturing process has provided an 
increased understanding of the changes and interactions between the biochemical, 
physical and mechanical properties of the SKN constructs and the time scales over 
which the changes in properties occur. It is the fi rst study to the author's knowledge that 
has monitored the changes and interaction of these properti es of a cellular fi brin matrix 
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over a 49 day study period. Thi s study showed that after 2 1 days (the typical study 
period reported by other authors), the fibrin matrix continues to degrade and further 
co llagen is synthesised by the cells until 042 when co llagen synthesi s reaches a plateau. 
The time scales over which these events occur are likely to be dependent on a number 
of factors. These include the structure and biochemical composition of the initial fibrin 
matrix , the total number of viable cells supported by the matrix during manufacturing 
and the composition and availabi lity of the media to the cells in the matrices. a greater 
understanding of the interaction and affects of these factors on collagen synthesis and 
the mechanical properties of the constructs will allow for further process and product 
improvement of the ti ssue-engineered constructs. 
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3.11. Further Work 
Characterisation of the SKN constructs confirmed that the HDF cell s were responsible 
for the changes in physical, biochemical and mechanical properties during the 49-day 
manufacturing process. Further research to investigate the effect of increasing the total 
number of cell s in the SKN constructs through optimisation of the fibrin matrix 
formulation and suppl y of culture media is described in Chapter 7. It is hypothesised 
that increas ing the number of cell s in the construct will increase the rate of fibrin 
degradation and co llagen synthes is and in turn improve the cost-effectiveness of the 
manufacturing process through a reduction in manufacturing time. 
This study also provided an increased understanding showing the key phases of the 
manufacturing process and produced a semi-quantitative process model. Further 
improvements to this model can be achieved through development of assays to quantify 
collagen concentration, digestion rate and fibrin degradation rate in the SKN constructs 
and are discussed in Chapter 7. These areas of further work are important in the 
commerciali sation of tissue-engineered products as firstly, cost-effecti ve manufacture is 
required for profitable reimbursement of products. Secondly, quantifi cation of key 
processing parameters allows measurement of the magnitude of improvement from 
process changes fo r cost-benefit analysis, measurement of the product properti es for 
development of product specification and an improved understanding of the 
mechani sms o f action of iterations of the product in-vivo. 
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Chapter 4 Ultrasound Stimulation of SKN Constructs 
4.0. Introduction 
This chapter investigates the use of ultrasound stimulation in the therapeutic range to 
improve the biochemical and mechanical properties of the SKN construct. In vitro, 
therapeutic ultrasound stimulation of tissue-engineered constructs for applications such 
as cartilage repair (Ebisawa, Hata et al. 2004) and intervertebral disc regeneration 
(O'Halloran, Pandit 2007) have been shown to increase collagen synthesis from cells 
and improve mechanical properties of the constructs. In-vivo, therapeutic ultrasound 
also been used to accelerate wound healing in bone (ter Haar 2007, Chang, Sun et al. 
2002) and skin (Mendonya, Ferreira et al. 2006). However, the effect of ultrasound 
stimulation on ti ssue-engineered skin constructs or human dermal fibroblast cel ls 
seeded in a fibrin matrix has not been reported in the public domain. 
The use of ul trasound as a form of mechanical stimulation has several key advantages 
compared to other forms of mechanical stimulation. These include firstly, the ability to 
couple the ultrasound transducer to the cellular constructs through liquid paths, such as 
the culture media. This is beneficial as other stimulation devices require phys ical 
coupling to the constructs which is problematic for SKN constructs as their gel-like 
properties make them susceptible to tearing at the physica l point of application. 
Secondly, the wide avai lability of different sizes and shapes of ultrasound transducers 
and the ability to focus the ultrasound beam can provide homogeneous stimulation over 
the whole SKN construct. The ability to control the ultrasound output and potential for 
non-contact appl ication provides a means of mechanical stimulation which is suitable 
for scale-up. 
However, the optimum ultrasonic parameters required to elicit a positive biological 
response is not clear as it has also been reported that ultrasound does not accelerate 
wound healing in-vivo or promote co llagen synthesis in-vitro (Duda, Kliche et al. 2004, 
Turner, Powell et al. 1989). There are numerous combinations of ultrasound parameters 
such as intensity, duty cycle and duration of stimulation that can be used for 
stimulation. It is likely that the ultrasound parameters required to promote desired 
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cellular responses are dependent on the type of ti ssue or cellular construct that IS 
stimulated. 
This chapter demonstrates the use of a screeI1lng design of experiments (DOE) 
methodology to investigate the effect of di fferent combinations of ultrasound intensi ty, 
duty cycle and stimulation time on the co llagen synthes is and the mechanical properties 
of SKN constructs. The use of ultrasound stimulation in the SKN manufacturing 
process to improve the properti es of the SKN construct, based on the DOE results is 
di scussed in Chapter 5. 
4.1. Experimental Set-Up 
Ultrasound stimulation in the therapeutic range was provided through a Sonoplus490 
phys iotherapy ultrasound unit (EnrafNonius, Netherlands) which allowed control of the 
ultrasound intensity (I), duty cycle (DC), and stimulation duration (t). The ultrasound 
unit was calibrated at each duty cycle, over the full range of the transducer output 
power, using a radiation force balance (Farmery, Whitti ngham 1978) to determine the 
actual acousti c intensity at the transducer face (Appendix IV for calibration curve). 
A custom-bui lt ultrasound stimulation device was designed in co llaboration wi th 
Dr.M.Mather, remedi Nottingham Uni versity and Mr.S.Hall , Biomedical Science 
Workshop, Nottingham University to couple the SKN constructs and ultrasound 
transducer for repeatable and reproducible stimulation of the constructs (Figure 39). 
The device comprised of a Teflon water co lumn, stainless steel cradle with central cut-
out and water tank lined with an ultrasound absorbing materi al (Aptflex F28, Precision 
Acoustics, UK). A clamp was designed to securely fi x the transducer to the top of the 
water co lumn. The ultrasound was coupled to the SKN constructs through a 0.6flm 
Teflon acoustic window at the base of the water column which was in turn coupled 
media above the constructs. The acousti c window was set at a di stance of 100mm from 
the transducer face so that the SKN constructs were stimulated in the far fi e ld of the 
ultrasound beam where the pressure was the most homogeneous but leas t divergent (see 
Appendix IV fo r calculations). 
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The location pins on the water tank ensured that the culture di sh, cradle and water 
co lumn were centrall y aligned to enable repeatable and reproducible ultrasound 
stimulation. The central cut-out in the cradle allowed the culture di sh to contact the 
water in the water tank. This allowed propagation of the ultrasound away from the 
constructs and minimised the affects from undesired heating in the constructs. The 
ultrasound absorbing lining prevented the formati on of standing waves between the 
water tank and SKN constructs which may have caused uncontrolled ultrasound 
stimulation. 
Transducer 
1r=;i~' E~~~~====~----- Clamp 
Water Column 
Acoustic Window~=~i~~~~~~~~~~~~~~~~f ~' f~_~. SKN Construct in Culture Dish 
Cradle 
t--- Location Pin 
Central cui-out 
Hole for 
Location Pin 
Cradle 
-8 
I 
I 
DD ---
Water 
Absorbing Lining 
Water Tank 
~ 
I 
I 
I 0 I 
Culture Dish 
SKN Constructs 
I 
---
Figure 39 Top: Schematic of custom-built ultraso und stimulation device for SKN construcls 
Bottom : Plall view of crad le wilh cul-oul (dashed lilies) housing SKN conslrucls (grey) in celllral 
wells of culture dish 
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4.2. The Effect of Ultrasound on SKN Construct Properties 
4.2.1. Screening Design of Experiment 
Mintitab® 14 Statisti cal Software was used to generate a des ign of experiments (DOE) 
with 3 fac tors (ultrasound intensity, duty cycle and stimulation duration), 2 levels 
(max imum and minimum settings for each factor available on the ultrasound unit), one 
centre po int (midpoint setting for each factor) and three replicates (n=3 SKN 
constructs). The minimum and max imum settings for the Sonoplus490 ultrasound unit 
were 0.5 W/cm2 and 2.5W/cm2 intensity, 5% and 80% duty cycle, and 5 minutes and 30 
minutes duration. The midpoint setti ngs generated by the DOE were 1. 5W/cm2 
intensity, 42.5% duty cycle and 17.5 minutes duration. However, 50% duty cyc le and 
18 minutes duration were used in this study as these were the closest setti ngs avai lable 
on the ultrasound unit. The ultrasound unit frequency of I MHz was used in the 
experiments. The complete DOE with random run order is shown in Appendix IV and 
summari sed in Table 15. Three SKN constructs were not stimulated by ultrasound and 
used as contro ls. 
Sample 1.0. Intensity Duty cycle Duration (w/cm') (%) (mins) 
2 6 25 2.5 5 30 
13 17 18 2.5 5 5 
3 8 10 2.5 80 5 
1 14 16 2.5 80 30 
5 9 21 0.5 5 5 
7 19 23 0.5 5 30 
4 15 22 0.5 80 5 
12 20 24 0.5 80 30 
11 - - 1.5 50 18 
26 27 28 0.0 0 18 
Table IS Summary of the DOE ultrasound pa rameters 
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4.2.2. Method 
28 SKN constructs were cast in the central four wells of seven culture di shes (Figure 
39). The water column and water tank were filled with sterile water 24 hours before 
each ultrasound stimulation sess ion to allow the water to de-gas . A culture dish was 
placed in the cradle which was then placed on the water tank location pins so that the 
base of the cu lture dish was in contact with the water below. The transducer was 
clamped to the water co lumn which was then placed on the water tank location pins so 
that the acoustic window was in contact with the media above the constructs. Care was 
taken to ensure that no bubbles formed between the base of the culture dish and the 
water in the water tank and between the acoustic window and the culture media to 
ensure homogeneous propagation of the ultrasound through the SKN constructs. The 
ultrasound parameters were set on the SonoPlus490 unit to stimulate the constructs. 
This was repeated for each construct in each culture dish and the contro l constructs for 
18 minutes (the midpoint duration) with no stimulation. 
Ultrasound stimulation was appli ed to the SKN constructs two days post casting and 
then prior to the media change every Monday, Wednesday and Friday to coincide with 
the current media feeding regime described in section 3.2.2. The media was changed 
after ultrasound stimulation was applied to each of the constructs in the culture dish. 
This was repeated for 2 1 days and the constructs were harvested two days after the last 
ultrasound stimulation on day 23 post casting. 
4.2.3. Cbaracterisation of the SKN Constructs 
On day 23 (023) a IOmm x 28mm section was cut from one end of the construct to 
form a 28mm2 square construct. Two 5mm x 5mm samples were then cut from the 
IOmm x 28mm section in a locat ion that avoided edge effects from the culture di sh. 
These samples were prepared for analysis by hi sto logy and SEM as described 
previously in sections 3.3.2 and 3.3.5 respectively . The shear storage modulus (G') and 
shear loss modulus (G") of the square constructs were analysed using a rheological 
strain sweep as described in section 3.5. 1. The number of cell s were counted using 
CEOEX after the rheological testing as described in section 3.4. 1. Finally, statistical 
analysis of the combinations of ultrasound parameters that cause a significant effect on 
G' was carried out using the Pareto Chart of Standardised Effects in MiniTab® 14. 
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4.2.4. Results and Discussion 
SKN construct samples 1-4 and 21-25 were removed from the study on day 18 due to 
the occurrence of bacterial contamination. At least one construct from each ultrasound 
group was not affected which allowed analysis of the DOE results to proceed (Table 
16). 
4.2.4.1. Cell Number 
The total number of cells 111 the ultrasound stimulated constructs ranged between 
3.4x 106 and 4.5x106 cells compared to the control which had an average of4.0x 106 (cr= 
4x I Os) . The cell viability ranged between 93% and 96% for the ultrasound stimulated 
constructs compared to 97% in the control (Figure 40). No stati stically significant 
differences in cell number were observed between the ultrasound groups (with n> I ) and 
the control. These results suggested that ultrasound stimulation did not affect the total 
number of HDF cells in the SKN constructs which is supported by similar findings in 
other studies (Ebisawa, !-lata et al. 2004, N ishikori , Ochi et al. 2002, Cui , Park et al. 
2006). In addition, there was no correlation between the shear storage modulus (section 
4.2.4.2) and the number of cells. 
oo ~---------------------------------------------
i G'>COO' '''i r--------- G' « Control --------, 
-0 
E 
0_: 2 SW ..... , ,~ ~ osw ...... : 05W'-2 0 _, J _, 2-'!NtI-.z ,~ 
s ... oe_ 5' OC_ ~DC , ... oc __ oes...- _DC "11(; __ oc_ _DC 
,- - -
Ultrasound Parameters 
Figure 40 The average number of viable and dead cells in each group of ultrasound stimulated 
constructs compared to the control. Error bars represent I standard error of the total number of 
cells where n> t 
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4.2.4.2. Microstructure and Mechanical Properties 
The Masson's Trichrome stained histological sections showed that the 023 control and 
ultrasound stimulated constructs were comprised of a collagen matr ix (Figure 41 ). 
Intense collagen staining was observed around the cell membranes and thin inter-
cellular collagen fibri ls were present. The ultrasound combinations of 1.5W/cm2 
intensity, 50% duty cycle and 18 minute duration and the combinations of 5% duty 
cycle and 5 minute duration for both 0.5W/cm2 and 2.5 W/cm2 intensity caused an 
increase in overa ll coll agen staining and deposi tion of inter-cell ular co llagen fibri ls 
(Figure 41 top) . Higher magnification SEM images showed that these construct a lso 
had a denser matri x compared to the contro l (Figure 42 top). These observations were 
supported by measurement of the shear storage modulus (G') and the shear loss 
modulus (G") which were greater than the control by up to 139% and 165% 
respectively (Table 16). 
In compari son, the other combinations of ultraso und parameters caused a decrease in 
co llagen stain ing in the histological sections (Figure 41 bottom) and a decrease in 
matrix density shown in the SEM images (Figure 42 bottom). G' and G" fo r these 
constructs was up to 64% and 50% less than the control respect ively (Table 16). 
However, the linear viscoelast ic region was greater (0%-5% strain) for the constructs 
with a G' less than the control compared to the constructs with a G' greater than the 
control (0%-3% strain, Figure 43). This suggested that the combination of ultraso und 
parameters may have affected the attachment of the cell s to the matrix, as descri be in 
section 3.9. 1, and that the ability of the HOF cells to adhere to the ultrasound stimulated 
constructs when subjected to shear deformation was less for the constructs with a 
greater G' than the contro l. 
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Sample I DC t Average Change Average Change (W/cm') (%) (min) G' (Pa) G' (%) G" (Pa) G" (%) 
11 
- -
1.5 50 18 251 139 34 165 
5 9 21' 0.5 5 5 230 119 31 146 
13 17 18 2.5 5 5 223 112 30 134 
Control 0 0 0 105 0 13 0 
12 20 24' 0.5 80 30 80 -23 12 
-5 
4 15' 22' 0.5 80 5 62 -41 9 -29 
2 6' 25' 2.5 5 30 37 -64 6 -50 
l' 14 16 2.5 80 30 72 -31 8 -36 
7 19 23' 0.5 5 30 81 -23 8 -36 
3' 8 10 2.5 80 5 75 -28 12 -7 
Table 16 Ave rage Cl and C" in the lin ear viscoelastic region and percentage change compared to 
the control for each co mbination o f ultrasound parameters. Shaded area: matrix density greater 
than control. *rem ovcd from study on day 18 days due to occu rrence of co ntam ina tion. 
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Figure 41 Exa mples of MT stained cross-section of SKN constructs with increased (top) and 
decreased (bottom) matrix density and concentration of inter-cellular fibri ls compared to the 
cont rol (middle). Collagen (blue), cell nuclei (dark blue). Ultraso und parameters on individ ual 
images 
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Figure 42 Examples of SEM Cross section of SKN constructs at 10000x magnification. Increased 
(top) a nd decreased (bottom) matrix density compared to control (m iddle). Ultrasound parameters 
on individual images 
134 
.-
!O-
0 
" • 
" 
[ 
o 
b 
• 
" 
looo .---------------------------------------------------~ 
6 G' ,SW/= 'SO'IIo l'lIWI 0 0-1SWIcm> 50% 11 ..... 
• G' OSWlc/II'S'IIo SIIWI G·O.SW/cm" 5'110 SIn;,. 
_ - G' 2SWlan' S'IIo s.... O" 2,SWIcm' 5'110 $mIrI 
• 0 ' C4nIrDi -+-G" C_oI 
666666.110_ 6, ~t=a .. III & :-1 
100 
• • 
-..-._--.--........  
•• +-
• 
• 
10~--=:::::::::::~~_~~ 
o 10 
Strain (%) 
100 1000 
looo .-------------------------------------------------------~ 
o 
6 G' Con~oI 0 " Control 
- 6 - G' 0 5 Wltrn' 8D'11o 30...... G- 0 5 W/c .... 80% 30tn1n 
_ - G· OSWJc .... 5'11. lOnm O· D.SWIc .... S'llo ).Q...., 
-6- G' O.S Wltm' 10'11. 5mon -9- 0"0 5 W/cm" D'IIo $mill 
6 G' 2 5 Witm' 5'110 lOm.. 0 0 - 2.5 Witm' 5'l!o 30 .... 
10 
Strain (%) 
100 1000 
Figure 43 Average G' ( A ) and G" (0) for each co mbina tion of ultraso und pa ra meters greate r (top) 
a nd less th an (bottom) than the control (green line) with in creasi ng strain 
135 
4.2.4.3. Effect of Ultrasound Intensity, Duty Cycle and Duration on G' 
The Pareto Chart of Standardised Effects was used to determine the ultrasound 
parameters that had a significant effect on the shear storage modulus (G') through 
analysis of the results from each ultrasound group. The analysis showed that the 
combination of duty cycle and duration caused a stati sticall y signifi cant effect (p<0.05) 
on G' (F igure 44). However, individual factors and other combinations of intensity, 
duty cycle and duration did not have a significant effect. 
The duty cycle controlled the time that the ultrasound was on and off in one ultrasound 
cycle and hence, the time that the HDF cells were stimulated and at rest. The duration 
controlled the tota l number of cycles that the HDF cell s in the construct experienced. 
The ultrasound combinations using 5% duty cycle and 5 minute duration, and 50% duty 
cycle and 18 minute duration were previously shown to improve the biochemical and 
mechanical properties of the SKN constructs. The Sonoplus490 ultrasound unit 
produced a cycle length of IOms (Enraf Nonius, Sonoplus490 User Manual) and 
therefore, application of caused the HDF cells in these construct to be subjected to a 
0.5ms on, 9.5ms off cycle for 3x I 04 cycles and 5ms on, 5ms off cycle for I 0.8x I 04 
cycles for the respecti ve combinations of duty cycle and duration (Figure 45) . 
Pareto Chart of the Standardized Effects 
(response is Storage Modulus, Alpha = .OS) 
2.776 
I 
Factor Name 
BC- A Intensity 
• Duly cycle 
I 
c Duration 
C-
B- I 
E AC- I " ~ 
A- I 
ABC - I 
AB -
O 1 2 3 4 
Standardized Effect 
Figure 44 Co mb inat ions of ult raso und parameters with a significant effect on Ihe shear storage 
modu tus of SKN constructs 
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Figure 45 Top: Relationship between Ihe combination of duty cycle and duration and the 
ultrasound stimutation (on) and rest (ofl) cycle a nd number of cycles experienced by the HDF cells 
in the S KN construct. Botto m: Schematic of the ultrasound pulse for two combinations of duty 
cycle and duration 
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In addition The SKN constructs subjected to 80% duty cycle (8ms on and 2ms off) 
resulted in a lower G' than the control regardless of the total number of pulses. 
Similarly, subjecting the cells to a total of 18x I 04 pulses (30 minute duration) 
regardless of the duty cycle caused a G' less than the contTo l. In contrast, the SKN 
constructs subjected to 5% duty cycle (O.Sms on, 9.Sms off) for 5 minutes (3x I 04 
pulses) and the midpoint settings of 50% duty cycle (Sms on, Sms off) fo r 18 minutes 
(10.8x l04 pulses) resulted in a greater G' than the control (Figure 46) . These results 
suggested that combinations of duty cycles between 5% and 50% and the stimulation 
durations between 5 minutes and 18 minutes could increase the properties of the SKN 
constructs. In compari son, duty cycles and durations greater than 80% and 30 minutes 
respectively caused a decrease in the properties of the SKN constructs. 
Since the SonoPlus490 ultrasound unit used in thi s study has a limited selection of duty 
cycles (5%, 10%, 20%, 50%, 80% and 100%), further investigation into improvements 
in the SKN construct properties is limited to combinations of duty cycle between 5% 
and 50% (Figure 46). A custom-built ultrasonic system would be required to investigate 
the affect of combinations of duty cycle between 50% and 80% (Figure 46). 
Signifi cantl y, the total time that the ultrasound was stimulating the constructs 
(calculated by multiplying the time the ultrasound was "on" by the total number of 
pulses) did not correlate with changes in the shear storage modulus (Figure 45). The 
total stimulating time for the constructs with a G ' greater than the control ranged 
between 15 seconds and 540 seconds but ranged from 90 seconds to 1440 seconds fo r 
constructs wi th a G' less than the control. This showed that the stimulation and rest 
cycle and number of cycles rather than the total stimulation time was responsible for 
causing a significant cellular response. 
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Finall y, the application of diffe rent combi nations of stretching and relaxation cycles on 
the ultimate tensile strength CUTS) of myofib roblast seeded fibr in gels subj ected to 
cyclic distension (lsenberg, Tranqui llo 2003) also supported the results in thi s study. In 
particular, duty cyc les of less than 12% improved the ultimate tensile strength CUTS) 
and collagen synthesis compared to duty cyc les greater than 40% which decreased the 
UTS compared to the non-stimulated control. However, thi s study did not investigate 
the effect of the combinations of duty cycle and duration which have been shown to be 
signifi cant in this study. 
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18xl0' cycles 
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G' < Control 
~~----------------------------.-------------------~ 
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with possible use of 
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Figure 46 S ummary o f results and co mbinations of du ty cycle and duration fo r furth er 
investiga tion fo r max imis in g the im provement of S KN co nstruct properties. Inserts: SE M and 
histo logy cross-sectio ns of S KN const ruct for G'>control and G'< control 
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4.2.5. DOE Conclusion 
This study demonstrated the use of a Design of Experiments (DOE) methodology to 
invest igate the effect of ultrasound stimulation on the biochemical and mechan ical 
properti es of the SKN constructs. The DOE methodology enabled efficient 
investigation of the effect of the combinations and range of ultrasound parameters 
compared to the affect of single parameters which is commonl y reported. 
This study showed that ultrasound stimulation can be used to influence the 
microstructure of the SKN constructs by stimulat ing or inhibiting the quantity of 
collagen synthesised from cell s and degree of inter-cellular collagen deposition. The 
changes in the microstructure were supported by measurements of the shear storage 
(0') and shear loss (0") modulus. Significant changes in 0 ' were caused by the 
combination of duty cycle and duration which were related to the ultrasound 
stimulation-rest cycle and number of cycles to which the cell s were subjected. 
Ultrasound stimulation did not affect the total number of cells in the construct which 
suggested that the changes in the microstructure and viscoelastic properties were 
primari ly a result of the quantity of collagen secreted by each cell. The DOE results 
identified the range in which the different combinations of ultrasound parameters could 
be used to improve the properties of the SKN construct and are further investigated in 
Chapter 5. 
140 
Chapter 5 Ultrasound Stimulation for Improvement of SKN 
Construct Properties 
5.0. Introduction 
This chapter describes the use of ultrasound stimulation to further improve the 
properti es of the SKN constructs. The design of experiments study identifi ed the range 
and combinations of ultrasound parameters that increased the shear storage modulus 
(G ') of the SKN constructs. The equation fo r calculation of G' was derived using the 
response optimiser function in M iniTab® 14 and is: 
G' = 275 + 0.1 3 (Duty Cycle • Duration) 
The ultrasound parameters of 1.5W/cm2 intensity, 42. 5% duty cycle and 17.5 minute 
duration were calculated to max imise G'. A duty cycle of 50% instead of 42.5% was 
used in the following experiments as it was the closest avai lable setting on the 
ultrasound unit. The duration used was decreased to 14 minutes to account for the 
change in the duty cycle. Non-stimulated control constructs were characteri sed on day 0 
(DO), day 23 (D23) and day 49 (049) of the manufacturing period and ul trasound 
stimulated constructs on 0 23. The effect of ultrasound on the SKN construct properties 
was compared between DO and 0 23. The 0 23 ultrasound stimulated constructs were 
compared with the 049 control constructs produced by the current manufac turing 
process to assess the use of ultrasound for improvement of the biochemical and 
mechanical properti es. 
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5.1. Method 
24 SKN constructs were cast as a batch in the centre four well s of six culture di shes. 18 
constructs were randomly chosen as controls and six of these constructs were harvested 
for characterisation on DO, D23 and D49 respectfull y. The remaining six constructs 
were stimulated by ultrasound, using the parameters stated in section 5.0, fo r 2 1 days 
and harvested on D23 , as described in section 4.2.2. Three sections (approx imately 
5mrn x 10mrn) were cut from the centre of one SKN construct from each of the 
ultrasound stimulated and contro l groups. The cut samples were prepared fo r SEM, 
TEM (D23 construct onl y), histology staining with Masson' s Trichrome (MT) and 
Alcian blue, and IHe for detection of co llagen type I and III (Figure 47) as described in 
sections 3.3.2 to 3.3 .6. 
The viscoelastic properti es (G' and G") of the remaining constructs from each group 
(n=5) were measured using the rheologica l strain sweep as descri bed in section 3.5. 1. 
Fo llowing rheological testing the constructs were placed in 2mL of 0.28U1mL of 
collagenase B, fo r measurement of the digestion time and the total number of cell s as 
described in section 3.4.1. The dry weight of the constructs was then determined by 
freeze drying the co llagenase digest for 96 hours and the digestion rate calcu lated by 
di viding the digestion time by the dry weight. This was repeated for 2 batches of SKN 
constructs labelled 2005 and 20 I 0 (batch reference number). 
SKN Construct 
SEM 
TEM 
Histology 
IHC 
( 
( 
28mm 
) 
10mm 
) 
tsmm 
38mm 
Figure 47 Sc hema tic of sections cut from SKN construct for characterisat ion by light and electron 
microscopy 
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5.2. Results 
The quantitative results for the DO, 0 23, 049 control constructs and the 0 23 ultrasound 
stimulated constructs are summarised in Table 17 and discussed in the following 
sections. 
023 DOE 
DO 023 Batch 2005 023 Batch 2010 049 Midpoint 
(n=10) (n=5) (n=5) (n=10) Settings 
(n=l) 
Control Control Ultrasound Control Ultrasound Control Ultrasound 
Average G' (Pa) 65 117 202 118 185 137 239 
Average G" (Pa) 7 19 33 19 30 21 34 
Total number of 1.54 6.68 7.26 5.78 7.54 3.70 4.52 cells (xl0') 
Average Dry 0.17 0.31 0.32 0.30 0.33 0.44 No data Weight (g) 
Average 
Digestion rate 1.46 1.60 1.47 1.43 1.42 3.29 No data 
(mg/min) 
Table 17 Summary of ultrasound improvement experimental results compared to the DOE 
midpoint setting results 
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5.2.1. DO Control Construct 
The DO SKN constructs for both the 2005 and 20 I 0 batches were similar in 
composition and structure. The quantitative data reported for the DO constructs is the 
combination of the data from both batches (n= IO). Masson's Trichrome staining of the 
DO SKN construct confirmed that the matrix was comprised of fib ri n (Figure 48 left). 
Higher magnifi cation SEM images showed that the DO construct was comprised of a 
highly cross-linked matrix of fibrils surrounding the ce lls (F igure 48 right). The 0' and 
0" of the DO construct was 65Pa (cr= 8) and 7 Pa (cr= I) respectively which was simi lar 
to the values reported for DO constructs in section 3.9. I. The cell viabi lity (Figure 49) 
was 95% and total number of viable cells in the construct was J.54xl06 (cr= 9.7x I04) . 
The average dry weight of the construct was O. I 7g (cr= 0.02) and average digestion rate 
was I .46mg/min (cr= O. I 2) as shown in Figure 56. 
J 
.. 
• 
• 
Figure 48 Cross-section of DO SKN constru ct. Left: MT sta in ed section with fibrin matri x (purple) 
and cell nuclei (da rk purple). Right: 10 OOOx magnification SEM image with huma n derm al 
fibrobla st cells (DF) embedded in a highly cross- linked fibrin matrix (F) 
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5.2.2. D23 Control and Ultrasound Stimulated SKN Constructs 
5.2.2.1. Cell umber and Viability 
The viability for both the ultrasound stimulated and control SKN constructs ranged 
between 91 % and 95%. The total number of viable ce ll s in the D23 ultrasound 
stimulated constructs was 7.2x 106 (cr= 7 .8x 1 05) and 7 .5x 1 06 (G= 6.9x 1 05) cell s for the 
2005 and 20 10 batches respectively compared to 6.6 x l06 ( G= 3.5x I05) and 5.7 x l06 
(0= 4.7x I05) cells in the respective contro l samples (Figure 49). However, there was no 
stati sticall y significant difference between the total number of cell s in the cont rol and 
ultrasound stimulated constructs which supported the DOE findings (section 4.2.4 .1 ). 
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DO Control 023 Ultrasound 2005 023 Control 2005 023 Ultrasound 2010 023 Control 2010 0<19 Control 
Figure 49 Co mparison of the number of viable and dead cells in the DO (n= IO), 023 (n=5), 049 
(n=tO) co ntrol and 023 (n=5) ultrasou nd stimulated co nstructs for the 2005 and 2010 batches. 
Error bars represent I standard error of the total number of cells 
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5.2.2.2. Microstructure and Mechanical Properties 
The Masson's Trichrome stained histology sections showed that the ultrasound 
stimulated and contro l constructs were compri sed of both co llagen and fibri n on 0 23 
(Figure 50) in comparison to the 00 construct which was comprised of fibrin only. The 
ultrasound st imulated constructs had more staining for co llagen and in parti cular, more 
inter-cellular co llagen fi bril s compared to the control (Figure 50). More intense 
co llagen staining was observed around the cell membranes fo r both constructs. 
However, more voids inside of these areas of denser staining were observed in the 
ultrasound stimulated constructs. Fi brin which stained purple was predominantly 
observed at the top of both the control and ultrasound stimulated constructs. 
The IHC sections showed that only co ll agen type I was present in both the ultrasound 
stimulated and contro l constructs on 023 and that more collagen type I was present in 
the ultrasound stimulated constructs (Figure 52). Collagen type III was not observed in 
the contro l or ultrasound stimulated constructs. This is in contrast to the previous 
observations on 0 21 di scussed in section 3.7.3 where both collagen type I and type 1Il 
were present. The histology sections stained with Alcian Blue showed that 
proteoglycans were present in the ultrasound stimulated constructs but not in the control 
(Figure 51) which supported the fi ndings of other authors that ul trasound stimulated 
cell s to secrete proteoglycans (Hsu, Kuo et al. 2006, Miyamoto, An et al. 2005, 
[washina, Mochida et al. 2006). 
Higher magnification SEM images showed that a layer of cells had fo rmed at the 
construct-media interface of the ultrasound stimulated and control constructs (Figure 53 
top row). The matrix density was greater around the membranes of the cells which 
supported the hi stological observat ions (Figure 53 middle row). The ultrasound 
stimulated constructs appeared to have a denser matrix than the control constructs and 
areas of thicker fi bres which, may have been formation of co llagen fi bril bundles 
(Figure 53 bottom row). 
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Figure 51 Alcian blue stained cross-sections of D23 co ntrol (left) and ultrasound stimulated (right) 
SKN constructs. Proteoglycans (b lu e), other cytoplasmic areas (purple) and cell nuclei (red) 
figure 52 Immunohistochemistry cross-sections of D23 control (left) and ultrasound stimulated 
(right) SKN const ructs. Collagen type I (green), cell nuclei (blu e) 
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Control Ultrasound 
Figure 53 SEM cross-sections of 023 control (left column) and 023 uUrasound stimu lated (right 
column) SKN constructs. Top: x2500. Middle: x10000. Bottom: x30000. CF=collagen fibril bundle, 
OF = Dermal fibroblast and C= collagen matrix 
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Measurement of the shear storage modulus (G') and shear loss modulus (G") supported 
the structural observations. Comparison of the DO control construct and D23 control 
and ultrasound stimulated constructs showed that G' increased by approximately 8 1 % 
for the contro l constructs but by 21 1 % (2005 batch) and 185% (20 I 0 batch) for the 
ultrasound stimulated constructs (Figure 55). 
Comparison of the D23 control and ultrasound stimulated construct strain sweep 
showed that for both the 2005 and 20 I 0 batches, the linear viscoe last ic region for the 
shear storage modulus (G') and shear loss modulus (G") was between approximately 
0% and 20% (Figure 54). G' and G" in the ultrasound stimulated constructs were 
greater than the control constructs up to 90% strain for both the 2005 and 20 I 0 batches 
and the cross-cover point of G' and G" was similar at approximately 120% strain 
(Figure 54). The contribution of the cells to the viscoelastic properties and the effect on 
cell detachment from the matrix on G' has been discussed previously (section 3.9.1 ). 
These results suggested that this combination of ultrasound parameters did not affect 
the strain at which the cell s detached fTom the matrix but did increase the degree of 
cross-linking and/or quantity of co ll agen in the constructs. These findings are supported 
by other studies which have also shown that ultrasound stimulation increased co llagen 
secretion from and cells and correlated with an increase in the mechanical properties of 
chrondocyte seeded in a collagen sponge in-vi tro and rat Achi lles tendon in-vivo 
(Takeuchi , Ryo et al. 2008, Yeung, Guo et al. 2006). 
In the linear viscoelastic region, the G' of the ultrasound stimulated constructs was 
202Pa compared to the control of 11 7Pa and equated to a 72% (p=O.O 13) increase for 
the 2005 batch. The control construct in the 20 10 batch had a similar G' of 118Pa and 
this increased by 56% (p=0.02) to 185Pa with ultrasound stimulation (Figure 55). 
Similarly, G" increased by 73% (p=0.0 I) and 59% (p=0.02) for the 2005 and 20 I 0 
batches respectively. For both batches of constructs, the G' and G" of the ultrasound 
stimulated constructs had a greater standard deviation (cr= 42Pa for G' and cr= 6.3Pa for 
G") compared to the control (cr= 8Pa for G' and cr= 1.6Pa for G") which suggested that 
the ultrasound stimulation process introduced variation into the SKN manufacturing 
process. 
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Figure 55 Co mpariso n of G' in the linea r viscoelastic region of 00 (n~ IO), 023 (n~5) and 049 
(n~ IO) co ntrol SKN co nstructs and 023 (n~5) ultrasou nd stimulated co nstructs for the 2005 and 
2010 batches. Error bars represent I standard error. * p~O.OI3 , ** p~0.02 
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5.2.2.3. Dry Weight and Digestion Rate 
The average dry weight of the 023 control and ultrasound stimulated constructs 
increased between 00 and 0 23. For the control constructs the dry weight increased by 
84% (2005 batch) and 78% (20 I 0 batch). For the ultrasound stimulated constructs the 
dry weight increased by 89% (2005 batch) and 100% (20 I 0 batch). However, 
comparison of the dry weight of the 0 23 control and ultrasound stimulated constructs 
was not conclusive. The average dry weight of the ultrasound stimulated constructs was 
greater than the control for both batches (F igure 56 top) but onl y significantly di fferent 
by 3% (p=0.04) for the 2005 batch. 
No significant diffe rence in digestion rate between 00 and 0 23 contro l and ultrasound 
constructs was observed and supported the findings of the characteri sation study 
(section 3.8.1). This suggested that ultrasound stimulation did not signi ficantly increase 
the rate of fibrin degradation or co llagen synthesis to alter the degree of cross-linking in 
the constructs during thi s period. Compari son of the 0 23 control and ultrasound 
stimulated constructs showed that the average digestion rate of the ultrasound 
stimulated constructs was slightly lower than the control (Figure 56 bottom). However, 
these results were not statistically different fo r either batch. These resul ts did not 
support the observations of increased collagen synthes is and cross-linking di scussed 
previously (section 5.2.2.2). However, the digestion assay may not have sufficient 
reso lution to detect changes in the degree of cross-linking between the control and 
ultrasound SKN constructs on 0 23 as it is reliant on operator judgement as discussed in 
section 7.2. 
152 
05 r---------------------------------------------------------~ 
0' 
§ 03 
• m ~ 
" C 02 1-------1 
01 
00 L-__ -=~=__1 ______ L_ 
DO Control 023 Con1rOl2005 023 Slimulated 2005 023 Control 2010 023 Shmutated 2010 049 COI'ltrol 
3 
C 
~ 
.s 
• ~ 2 
< 
~ 
li 
m 
" 
o L-________ L-__ ~L_ 
DO Conttol 023 Control 2005 023 SWnulBled 2005 023 Control 2010 023 Slmulloted 2010 [)oI9 ConIrOI 
Figure 56 Comparison of 00 (n= IO), 023 (n=5) and 049 control (n=IO) and 023 ultrasound 
stimulated (n=5) SKN constructs. Top: Dry weight. Bottom: Digestion rate. Error bars represent 
one standard error. * p=O.04 
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5.2.3. Comparison of D23 Ultrasound Stimulated Constructs and D49 Controls 
The 049 SKN constructs for both the 2005 and 2010 batches were similar ID 
composition and structure. The quantitative data reported for the 0 0 constructs is the 
combination of the data from both batches (n=I O). The 0 23 ultrasound stimulated 
constructs appeared to have more inter-cellular co llagen fibril s (F igure 57) and a denser 
matrix (Figure 58) compared to the 049 constructs. This was supported by a 123% 
(p=0.000) and 131 % (p=0.000) increase in the digestion rate of the 0 49 construct 
compared to the 2010 and 2005 ultrasowld stimulated constructs respecti vely (Figure 
56 bottom). This suggested that ultrasound stimulation caused an increase in cross-
linking in the constructs. 
These results also correlated with a 35% (p=0.047) and 48% (p=O.027) increase in G' 
for the 20 I 0 and 2005 ultrasound stimulated batches respecti vely (Figure 55). However, 
the dry weight of the 049 constructs was 38% (p=0.02) and 33% (p=0.01 ) greater than 
the 0 23 ultrasound stimulated constructs (Figure 56). This suggested that ultrasound 
stimulation of SKN constructs for 21 days resulted in increased cross-linking in the 0 23 
constructs but did not increase the quantity of co llagen synthesis by the ce ll s compared 
to the 049 control. These results are in contrast to the SEM and histology images and 
the greater G' of the ultrasound stimulated constructs compared to the 049 contro l. The 
reason for the contrasting res ults is unknown but a poss ible explanation may be that the 
total number of viable cell s in the D49 constructs decreased by approx imately 40% 
compared to the D23 constructs. This may have resulted in a greater vo lume fraction of 
the 049 construct to be occupied by a less dense co llagen matrix compared to the 0 23 
ultrasound stimulated constructs. 
It was suggested that by 0 49 the biochemical composition and mechanical properties of 
the construct were suffic ient for supporting the cells in the culture di sh and less cells 
were required to maintain the construct matrix (section 3. 10). Application of ultrasound 
stimulation to the SKN constructs fo r 49 days would demonstrate the effect of sustained 
mechanical signalling on cell proliferation as well as co llagen deposition compared to 
the 0 49 SKN construcls produced by the current manufacturing process. 
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Figure 57 MT stained cross-sections of SKN constructs with collagen (blue) and cell nuclei (dark 
blue) Left: 049 Cont rol. Right: 023 Ultrasound stimulated 
Figure 58 Comparison of SEM cross-section of 049 control (left) construct a nd 023 ult rasound 
stimu lated (right) SKN construct 
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5.2.3.1. Fibroblast Ultrastructure 
The TEM images showed that the live fibroblast cells in the D23 control construct had a 
smooth plasma membrane, extensive endoplasmic reticulum, long mitochondria and 
several secretory ves icles (Figure 59a). These features suggested that the cell was 
acti vely secreting collagen. It is known that proco llagen molecule chains are assembled 
in the endoplasmic reticulum and packaged into vesicles in the Golgi apparatus. These 
vesicles then move to the plasma membrane where the content is discharged (Ghosh 
2002, Fawcen 1994). In addition, the long mitochondria function to provide usable 
chemical energy for processes such as protein synthes is (Sadava 1993). 
In comparison, the fibroblast cell s in the ultrasound stimulated constructs had many 
blebs on the cell membrane (protrusions from the cell membrane), dilated endoplasmic 
reticulum, many vacuoles and secondary lysosomes (Figure 59b). The dilated 
endoplasmic reti culum and vacuoles have previously been observed in fibroblasts 
stimulated with hormones that up-regulated collagen synthesis (Lupulescu 1974). Also, 
similar di fferences in the morphology of the plasma membrane have been shown to be 
caused by mechanical stimulation in fibroblast seeded collagen constructs (Lee, Lin et 
al. 1993). However, the presence of numerous secondary lysosomes is characteristic of 
apoptos is (Formigli, Papucci et al. 2000, Kulkarni 1994). This suggested that the cell s 
had been mechanicall y stimulated by ultrasound but may also be undergoing apoptos is 
by D23. 
In the control and ultrasound stimulated constructs ce ll shrinkage away from the 
surroundi ng matrix, a characteristic feature of cell apoptosis (Formigli , Papucci et al. 
2000, Kulkarni 1994), was also observed in some cell s (Figure 59c and d). In the 
ultrasound constructs, cell necrosis was also observed (F igure 59d) which is 
characteri sed by an electron-translucent nucleus, disruption of the plasma membrane 
and cytoplasmic di scharge (Formigli , Papucci et al. 2000, Kul karni 1994, Tinari , 
Giammarioli et al. 2008). These results showed that the ultrasound parameters used in 
thi s experiment caused premature cell death as well as stimulating co llagen synthesis 
from the ce ll s. 
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The presence of dead cells in the SKN constructs is not a maj or concern as the SKN 
constructs are freeze dried for storage in subsequent steps of the manufacturing process. 
However, premature cell death by necrosis may reduce the that rate of collagen 
synthesis in the SKN constructs as there will be a smaller population of viable cell s that 
can secrete co llagen. 
157 
Figure S9 TE M Cross-sections SKN constructs. a: Live ce ll in control construct with a smooth plas ma membrane, extensive endoplasmic reticulum (ER), long 
mitochondria (M) and secretory vesicles (SV). B: Live cell in ultrasound stimulated construct with many blebs (B) on the plasma membra ne, dilated endoplasmic 
reticulum (ER) ma ny vacuoles (V) and seconda ry Iysosomes (Iy). c: Apoptotic cell ill control construct shrinking away from the matrix. d: Apopto tic (A) and 
necrotic cell (N) with cytoplasmic discha rge (D) in ultraso und stimulated construct 
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5.3. Conclusion 
Ultrasound stimulation of the SKN constructs for 2 I days at J.5W/cm2 intensity , 50% 
duty cycle and 14 minute duration caused a signi ficant increase in the shear storage 
modulus (G') and in shear loss modulus (G") compared to the non-stimulated D23 
contro l constructs. A 72% (p=0.013) and 56% (p=0.02) increase in G' and 73% 
(p=0.0 I ) and 59% (p=0.02) increase G" was observed for the 2005 and 20 I 0 batches 
respective ly. Qualitative observations of the hi stological and SEM images suggested 
that the increase in viscoelastic properties was due to an increase.in co llagen and inter-
cellular fibril deposition. However, comparison of the number of cells, dry weight and 
digestion rate showed that there was no significant di fference between the ultrasound 
stimulated and control constructs apart from a 3% (p= 0.04) increase in the dry weight 
of the 2005 batch. There was also no significant difference between the number of cells 
in the construct. This suggested that ultrasound stimulation did not promote cell 
proliferation and that the increases in G' and G" were not associated with the number of 
cells in the constructs. 
Comparison of the D23 ultrasound stimulated and D49 contro l constructs showed that 
ultTasound stimulation could be used to improve G' and G" of the SKN constructs 
through an increase in collagen cross-linking in the matTix. This was demonstrated by 
the significant increase of 123% (p=O.OO) and 13 1% (p=0.00) in digestion rate of the 
D49 constructs compared to the 2005 and 2010 batches respectively of the D23 
ultrasound stimulated constructs. However, ultrasound stimulation for 2 I days did not 
increase the quantity of collagen in the matrix compared to the D49 construct as the dry 
we ight of the D49 construct was 38% (p=0.02) and 33% (p=0.01) greater than the D23 
ultrasound stimulated constructs for the 2005 and 20 I 0 batches respectively. 
It was also shown that the ultrasound parameters used for product improvement 
( J.5W/cm2 intensity, 50% duty cycle for 14 minutes) caused premature cell death by 
necrosis. Further understand ing of the mechanisms by which ultrasound causes necros is 
would improve the selection of the ultrasound parameters so that cell viability can be 
maintained during the manufacturing period. A reduction in cell necrosis may lead to an 
increase in total co ll agen synthes is or the rate of collagen synthes is. 
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Further experiments are required to moni tor the effect of ultrasound on viscoelastic 
properties, quantity of ex trace llular matri x and cross-linking over the 49 day 
manufacturing period. This wou ld firstly provide an insight into the magnitude of 
improvement in SKN construct properties that cou ld be achieved using ultrasound 
stimulation. Secondly, ul trasound was applied 3 times/week for 3 weeks in this study. 
Further work is required to determine the frequency of each ultrasound session and the 
duration of the manufacturing period over which ultrasound wou ld maximise 
improvement in SKN construct properties . This may in turn lead to improvement of the 
efficiency of the manufacturing process through a reduction in manufacturing time. 
5.3.1. Variation Caused by the Ultrasound Stimulation Process 
Ultrasound stimulation of the SKN constructs improved the mechanical properties of 
the constructs but also increased the variati on in the mechanical properties compared to 
the control. The design of the ultrasound stimulation device was such that the alignment 
of the ultrasound transducer and the SKN constructs was repeatable for every 
ultrasound session. The most probable cause of the variation was the output from the 
ultrasound transducer itself and the homogeneity of the propagation of ultrasound 
through the SKN constructs due to locali sed variations in the cell density and 
extracellular matrix. Further work to reduce the variation in the ultrasound stimulation 
process, through improvements to the ultrasound stimulati on system and mapping of 
ultrasound propagation through the SKN constructs, is discussed in section 7.4. 
5.3.2. Improvement of Ultrasound Parameters 
This experiment used ultrasound parameters of I .S W/cm2 intensity and SO% duty cycle 
for 14 minutes and caused an increase in G' of up 72%. In comparison, the midpoint 
settings used in the DOE of I.SW/cm2 intensity and SO% duty cycle for 18 minutes 
resulted in an 16S% increase in G' (Table 17). The SO% duty cycle used in both 
experiments related to an ultrasound stimulation-rest cycle of Sms on and Sms off. 
However, the extra 4 minute duration used in the DOE increased the number of cycles 
the cell s were sUbjected to by 29%. This suggested that for a SO% duty cycle, and 
increase in G' through an increase in co llagen secreti on and cross-linking could be 
achieved by increas ing the number of ultrasound cycles to which the constructs were 
subjected. 
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However, comparison of the SEM images from the DOE and improvement studies 
showed that the matrix of the control construct from the DOE study was denser than the 
control matrix in the improvement study (sections 4.2.4.2 and 5.2.2.2 respectfull y). The 
di ffe rences between these batches may have also affected the ce llular responses caused 
by the ultrasound. Therefore, further work to investigate the source of the batch-to-
batch variation in the current process and procedures to minimise the variation is first 
required, and is di scussed in section 7.3 . 
In summary, ultrasound stimulation can be used to improve the shear storage and shear 
loss modulus of the SKN constructs through an increase in collagen cross- linking. The 
ultrasound stimulation caused increased variation in the viscoelastic properties of the 
construct which is likely to be caused by fluctuations in the transd ucer output. The 
ultrasound stimulation regime can be further improved to increase the biochemical and 
mechanica l properties of the SKN constructs but batch-to-batch variation in the current 
manufacturing process must first be controll ed. 
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Chapter 6 Conclusion 
6.0. Integration of Biologica l Science and Process Engineering 
The regenerative medicine industry is redirecting its focus from scienti fic research to 
translation of the research into commercially viable products (Mason 2007). There are 
many commercial issues which need to be met such as, regulatory, financial and suppl y 
chain, as well as building upon the 25 years of scientific research in th is fi eld (Mason 
2007, Kemp 2006). A key challenge is the development of cost-effective manufacturing 
processes that allows sufficient income from reimbursement and implementation of 
good manufacturing practice (GMP) standards to satisfy regulatory requirements of 
repeatable prod uct manufacture to predetenn ined specifications. Continuous product 
improvement to exceed customer and stakeholder expectations is also necessary for the 
reali sation of routine use of regenerative medicine products in pati ents. 
In this thes is, the value of the integration of biological research with manufacturing and 
process engineering principles in the development of ICX-SKN constructs was 
demonstrated. ICX-SKN is a dermal skin substitute fo r the treatment of acute wounds 
currently being developed by healthcare company Intercytex. ICX-SKN aims to provide 
an alternati ve to the current go ld standard treatment of skin grafting, eliminate the need 
of a donor graft site and reduce surgical time and cost. Phase I clinical trials 
demonstrated the safety of ICX-SKN and provided preliminary evidence of efficacy in-
vivo (Boyd, Flasza et al. 2007). However, further understanding of the processes that 
occur during manufacture of ICX-SKN was required to identify areas of process and 
product improvement. In thi s thesis, the constructs were produced using bovine 
fibrinogen instead of human fibrinogen for cost-effective research and were denoted 
SKN constructs. 
The first part of this thes is prov ided an increased understanding of 49 day 
manufacturing process through characterisation of the changes in the biochemical, 
mechanical and phys ical properties of the SKN construct and lead to identification of 
areas for process improvement. The second part of thi s thesis demonstrated the use of 
ultraso und stimulation in the manufacturing process to make a step-change in the 
properti es of the SKN constructs for product improvement. 
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6.1. Improved SKN Manufacturing Process Model 
The characterisation study in thi s thesis identified four phases 111 the SKN 
manufacturing process. Between 0-2 and 0 7, the manufactur ing process was 
dominated by HOF cell proliferation (397%) and matrix compaction (50%), and there 
was evidence of fibrin degradation and co llagen synthesis. Between 07 and 0 28, cell 
proliferation and matri x compaction ceased and the main processes were fibrin 
degradation and collagen synthesis shown by relati vely constant measurements of dry 
weight (13.9± lmg), digestion time (11 0± 10minutes) and shear storage modulus 
(72.5±6.5Pa) . Between 0 28 and 042, fibrin degradation ceased and collagen synthes is 
continued which was shown by significant increases in dry weight (16%, p=0.002), 
digestion time (48% p=0.002) and shear storage modulus (33%, p=0.006), and 
observations of increased matrix density in the light and electron microscopy sections. 
Finally, between 042 and 049, the dry weight, digestion time and shear storage 
modulus appeared to reach a plateau suggesting that remodelling of the matrix had 
begun or that the biochemical composition and mechanical properti es of the matrix 
were suffi cient to support the cell s in the culture dish . Changes in the physical, 
biochemical and mechanical properties of cellular fibrin gels have not been previously 
reported over a 49 day week period. 
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6.2. Development of Characterisation Techniques for Tissue-
Engineered Constructs 
The characterisation of ti ssue-engineered products with gel-like properties IS 
problematic as they are generall y fragile to handle and are composed of more than 50% 
water and less extracellular matrix when compared to ti ssue. Characteri sation 
techniques and methodologies were developed for such constructs in thi s thesis and 
demonstrated using SKN constructs. The methodologies developed fo r the preparation 
of the SKN constructs for structural characteri sation by light and electron microscopy 
enabled observation of the constructs with minimal damage to the native structure. The 
shear storage modulus (G') and shear loss modu lus (G") provided quantitative data to 
support the observed, qualitative structural changes and also refl ected the phys ical and 
biochemical changes that occurred during manufacturing. In particular, G' , 
representative of the elastic properties of the SKN constructs, correlated with the 
quantity of ex tracellular matri x and degree of cross- linking in the matrix as well as the 
degree of construct compaction. 
In addition, the novel application of automated, real-time, non-contact, non-destructive 
measurement systems was also demonstrated in th is thesis. Precision surface profiling 
was shown to provide models for the compact ion of cellular constructs over the whole 
surface compared to single point measurements previously reported (Robinson, Johnson 
et al. 2008). The potential use of Raman spectroscopy to determine the changes in 
biochemical composition of the SKN constructs during manufacturing was also 
demonstrated and has not been used for thi s application fo r ti ssue-engineered constructs 
previously. 
Further deve lopment of such non-contact, non-destructi ve techniques would be 
benefi cial in the development and commercialisation of tissue-engineered products. The 
key benefits include the ability to monitor the properties of a large sample of each batch 
of products during manufacturing. This would provide an increased understanding of 
the batch-to-batch and within batch process variation, identify areas for process 
improvement and minimise the production of out of specification product. In add ition, 
the cost-effecti veness of research and product testing would be improved through a 
reduction in samples required for destructi ve testing. 
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6.3. Batch-to-Batch Variation 
In the current SKN manufacturing process, greater batch-to-batch variation was 
observed in the structure, shear storage modulus and total number of HDF cell s of the 
non-stimulated SKN constructs compared to wi thin batch variation (section 5.3.1). Thi s 
suggested that there was variation in the process inputs and in parti cular, vari ati on in 
the activity of the cell population, components of the culture media and structure of the 
fibrin matrix. Further wo rk to control the pre-process ing of the raw material inputs and 
development of robust measurement systems to test the materials prior to use in the 
manufacturing process and is discussed further in sections 7.2 and 7.3. This work is 
important as it may lead to a reduction in the variation manufacturing process and final 
product and aid compliance with GMP standard of repeatable manufacture of product to 
predetermined specifications. 
6.4. DOE Methodology to Determine Cellular Responses to 
Ultrasound Stimulation 
The use of ultrasound stimulation in-vivo to accelerate wound hea ling and in-vitro to 
improve the properties and functiona lity of tissue-engineered constructs has been shown 
to produce both positive and negative results (Mendonya, Ferreira et al. 2006, Tsai, 
Pang et al. 2006, Takeuchi , Ryo et al. 2008, Noriega, Mamedov et al. 2007, Turner, 
Powell et al. 1989). Compari son of the contrasting results was problematic due to the 
large range of ultrasonic parameters used and the variations in response associated with 
the type of cells, matrix composition and tissues stimulated. This thesis demonstrated 
the use of a design of experiments (DOE) methodology to effIcientl y determine the 
range of each ultrasound parameter and the signifi cant combinations of parameters 
which elicited desired biological responses from the HDF cells in the SKN constructs. 
The use of such a methodology minimised the need for iterati ve experiments and 
reduced the labour time and costs which would be beneficial in an industrial setting. 
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The DOE results showed that the combination and magnitude of the ultrasound 
parameters affected the total quantity of collagen and depos ition of inter-ce llular 
collagen fibrils in the SKN constructs but did not affect the total number of ce ll s. In 
compari son to the non-stimulated contro ls, the shear storage modulus was increased by 
up to 139% and decreased by up to 64% using different combinations of ultrasound 
parameters within the range of the physiotherapy ultrasound unit used in this study. 
This suggested that therapeutic ultrasound could be used to promote or inhibit the 
amount of co llagen secreted by each HDF cell in the SKN construct. 
In add ition, the combination of the ultrasound duty cycle and duration was shown to 
cause a significant effect on the shear storage modulus. These parameters controlled the 
cell stimulation and rest time within each ultrasound cycle and the number of cycles to 
which the cell s were subjected. In comparison, the magnitude of the ultrasound 
intensity and other combinat ions of intensity, duty cycle and duration were shown to 
not have a significant effect. The use of an 80% duty cycle resulted in a decrease in the 
mechanical properties of the SKN constructs regardless of the duration. Similarly, the 
use of a 30 minute duration resulted in a decrease in the mechanical properties 
regardless of the duty cycle. Combinations of duty cycle between 5% and 50% and 
durations between 5 minutes and 18 minutes were shown to increase the mechanical 
properties of the SKN constructs. 
6.5. Product Improvement using Ultrasound 
Following the ICX-SKN Phase I study, it was hypothes ised that the mechan ism of 
act ion of the ICX-SKN constructs in-vivo was related to the biochemical composition 
and structure of the matrix (Boyd, Flasza et al. 2007). The ultrasound parameters of 
1.5W/cm2 intensity, 50% duty cycle and 14 minute duration were shown to improve the 
SKN constructs by increasing the viscoelastic properties and collagen deposition in the 
D23 SKN constructs after 2 1 days of stimulation. The shear storage modulus of two 
separated batches of SKN constructs was increased by 56% (p=0.02) and 73% (p=0.01) 
respectively in compari son with the 023 non-stimulated control. These results were 
supported by qualitative observations of increased co llagen deposition, matrix density 
and cross-linking in light and e lectron microscopy images. However, a significant 
166 
difference in dry weight and digestion rate was only observed for the dry weight of the 
2005 batch which was 3% (p=0.04). 
The D23 ultrasound stimulated constructs were also shown to have an improved shear 
storage modulus through an increase in cross-linking compared to the non-stimulated 
D49 SKN constructs produced by the current manufacturing process. The shear storage 
modulus was increased by 35% (p=0.047) and 48% (p=0.027) for the 2010 and 2005 
batches respectfully and the digestion rate decreased by 123% (p=O.OOO) and 131 % 
(p=O.OOO) respectfully. These results show that introduction of ultrasound into the SKN 
manufacturing process also has potential for reducing the total manufacturing time. 
Further studies using ultrasound stimulation over the 49 day manufacturing process 
would identity the period over which collagen deposition and viscoelastic properties 
were maxiinised. 
6.6.' Scale-up and Improvement of Ultrasound System 
The proof-of-principle, custom-built ultrasound stimulation device used in this study 
allowed repeatable and reproducible coupling of the ultrasound transducer to the SKN 
constructs in the optimum region of the ultrasound beam. This device demonstrated that 
ultrasound could be used to stimulate cellular responses in tissue-engineered constructs 
by coupling of the ultrasound through a liquid path. The elimination of the need for 
physical coupling to the constructs provides a system that is suitable for scale-up. 
However, ultrasound stimulation also increased the variation in the shear storage 
modulus of the SKN constructs compared to the controls. It is likely that the source of 
the variation was from fluctuations in the output from the ultrasound transducer. 
Replacement of the ultrasound unit with a higher specification, custom built ultrasonic 
system would provide a more stable output and is discussed further in section 7.4.1. 
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Chapter 7 Further Work 
7.0. Introduction 
This chapter describes key areas of further work with both an industrial focus to 
improve the SKN manufacturing process and an academic focus to further understand 
the relationship between cell responses to the surrounding extracellular matrix and 
external mechanical stimulation. 
This study provided an improved model of the SKN manufacturing process and 
identified areas for process improvement (Chapter 3). Section 7.1 describes further 
understanding of the interactions between the properties of the fibrin matrix, diffusion 
patterns of the culture media and cell responses required to enable process 
improvements. Research to improve the cost-effectiveness of the manufacturing 
process, build on the process model developed in this study and minimise the process 
variation are described in sections 7.1 to 7.3. 
Ultrasound stimulation of the SKN constructs was shown to cause a step-change in 
improvement of the biochemical and mechanical properties of SKN constructs. 
However, the use of ultrasound stimulation also increased variation in the properties 
compared to the control (Chapters 4 and 5). Section 7.4 describes further research to 
identify and minimise the sources of variation. In addition, further research to increase 
understanding of the homogeneity of ultrasound propagation though the. SKN construct 
and the resultant effect on cellular responses is discussed. Sections 7.5 and 7.6 describe 
further areas of research to improve the understanding of the physical and molecular 
mechanisms by which ultrasound is detected by the cells to elicit cellular responses. 
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7.1. Improvement of the SKN Construct Manufacturing Process 
The human dermal fibroblast (HDF) cells are responsible for the breakdown of the 
fibrin matrix and secretion of the collagen matrix. It is hypothesised that increasing the 
total number of cells in the SKN constructs will increase the rate of fibrin degradation 
and collagen synthesis and in turn reduce the manufacturing time and associated 
material and labour costs. Two key areas of further research required to enable an 
increase the number of HDF cells in the SKN constructs have been identified and are 
discussed below. These are firstly, understanding of the properties of the fibrin matrix 
that influence cell proliferation. Secondly, understanding of the diffusion patterns of the 
nutrients in the culture media through the SKN constructs. 
7.1.1. Relationship between the Fibrin Matrix and Cell Proliferation 
Other studies have shown that different formulations of fibrinogen and thrombin 
concentrations used to form the fibrin matrix influence the rate of cell proliferation and 
the total number of cells in the fibrin matrix (Cox, Cole et al. 2004). In particular, 30% 
more HDF cells were reported using concentrations of Smg/mL fibrinogen and 1 U/mL 
thrombin and 17.3mglmL fibrinogen and 167U/mL thrombin after 7 days (Cox, Cole et 
al. 2004) compared to the number of cells in the SKN construct which used SmglmL 
fibrinogen and 2SU/mL thrombin formulation. The cell seeding density has also been 
shown to influence the rate of cell proliferation and the total number of cells in a 
fibroblast seeded fibrin matrix after 21 days (Duong, Wu et al. 2009). 
The porosity and stiffness of the fibrin 'matrices formed by different formulations have 
been suggested to influence cell proliferation (Duong, Wu et al. 2009, Collet, Park et al. 
2000). The porosity of the matrix affects the diffusion of nutrient from the media 
through the matrix which in turn affects cellular processes such as proliferation (Collet, 
Park et al. 2000). Fibrin matrices with low porosity have also been shown to inhibit cell 
spreading and rounding which has been suggested to be necessary for cell proliferation 
(Duong, Wu et al. 2009). The stiffness of the matrix has been shown to affect the 
locomotion of the cells and rate of proliferation (Yeung, Georges et al. 2005, Lo, Wang 
et al. 2000). The porosity and mechanical properties of the fibrin matrices can be 
changed using different formulations of fibrinogen and thrombin (Duong, Wu et al. 
2009, Mooney, Costales et al. 2008, Wolberg 2007). However, the mechanisms by 
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which these factors affect cell proliferation are not fully understood. Further 
understanding of the biochemical and mechanical signalling of the cells from the fibrin 
matrices associated with cell proliferation would allow optimisation of the fibrin matrix 
for cell seeded fibrin constructs. 
7.1.2. Relationship between the Distribution of Media in the SKN Constructs and 
Cell Proliferation 
Secondly, analysis of the cell distribution through the thickness of the SKN constructs 
showed that the cells were evenly distributed in the fibrin matrix after casting. 
However, 7 days post casting, the cell density towards the top of the constructs was 
greater compared to the bottom. In addition, it was shown that the cells migrated to the 
. surface of the construct to form a cell layer at the construct-media interface (section 
3.7.5). There are a number of factors that may have caused the inhomogeneous cell 
distribution. 
Firstly, passive diffusion of the culture media may have resulted in a greater 
concentration of nutrients towards the top of the constructs which stimulated the HDF 
cells either to migrate or proliferate more in this region. Secondly, the volume of media 
(2mL) supplied to the constructs 3 times/week may not have been sufficient for the 
requirements of all of the cells in the construct. The cells present at the top of the 
constructs may have used the majority of nutrients in the media before it could diffuse 
to the bottom. Finally, the compaction of the top of the SKN constructs described in 
section 3.7.1 may have also contributed to the increased cell density. 
Further understanding of the contribution of each of these factors to the increased cell 
density at the top of the constructs would allow for process improvements to increase 
the number of cells that could be supported at the bottom of the constructs. 
Mathematical and experimental models to assess the diffusion of the media through 
matrices with different porosity and structure could be used to improve understanding 
of the distribution of the media through the thickness of the constructs. The use of an 
automated, continuous feeding device such as those described for other tissue-
engineered constructs (Portner, Nagel-Heyer et al. 2005, Schulz, Wustneck et al. 2008) 
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would provide understanding of whether th" supply of media was the limiting factor for 
cell proliferation and collagen synthesis. 
Finally, other studies have used apparatus to physically compress HDF seeded collagen 
matrices (Brown, Wiseman et al. 2005). Controlled compression of the cell seeded 
matrices using such apparatus would provide further understanding of the affect of 
compaction on cell distribution. 
7.2. Improvement of the SKN Construct Model 
This study provided a semi-quantitative model of the current SKN manufacturing 
process and increased the understanding of interactions between the physical, 
biochemical and structural changes. However, this model can be improved further 
through development of quantitative assays to support the qualitative changes observed 
in the composition and structure of the matrix and in turn provide further understanding 
of the changes in the shear storage modulus reported in this study. In particular, the 
development of an assay to quantify the concentration of collagen and fibrin and 
improvement of the repeatability and reproducibility of the digestion assay is required 
and candidate approaches are discussed below. 
7.2.1. Development of a Quantitative Collagen Assay 
In this study, the collagen type I ELISA used to quantify changes in collagen in the 
SKN constructs was not conclusive as the absorbance signal from the constructs was 
very low and outside of the standard curve. Further work into the extraction of collagen 
from the SKN constructs and suitability of the antibodies used for detection of the 
collagen may improve the absorbance signal. Alternatively, other studies have reported 
the use of hydroxyproline based assays, such as Chloramine T, for detection of collagen 
secreted by cells in fibrin matrices (Ross, Tranquillo 2003, Grassl, Oegema et al. 2003) 
and could be assessed for suitability of use in SKN constructs. Although it was shown 
that fibrin matrices caused positive readings using this type of assay (Marshall 2005), 
further work to identify methods of removing the fibrin before testing maybe an option. 
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7.2.2. Development of a Repeatable and Reproducible Assay for Quantification of 
Cross-linking 
The digestion assay used in this thesis was reliaot on operator judgement to determine 
the point at which the SKN the construct was fully digested in the collagenase B 
solution. A methodology aod measurement system to remove the need for operator 
judgement would increase the resolution of the assay aod achieve more reproducible 
aod repeatable results. In addition, the digestion solution should be developed to 
incorporate other enzymes present in wound sites, such as MMPs (Gilliver, 
Ruckshaothi et al. 2007), as this may provide a more realistic measure of the rate of 
degradation of SKN constructs in-vivo. 
7.2.3. Quantification of the Fibrin Degradation Rate 
The development of ao assay to quaotify the rate of fibrin degradation in the SKN 
constructs may improve the understaoding of the influence of biochemical signalling 
from the fibrin matrix on collagen synthesis by the cells. This study showed by 
histological analysis that fibrin was still present in the matrix after 21 days. However, it 
could only be inferred from the increases in dry weight, digestion rate aod shear storage 
modulus that the fibrin matrix was fully degraded between D21 aod D28 of the 
maoufacturing period. Other studies have shown that fibrin stimulates collagen 
synthesis from cells (Grassl, Oegema et al. 2002, Neidert, Lee et al. 2002, Tuao, Song 
et al. 1996, Ng CP, Swartz MA 2006). Further understaoding of the volume fraction of 
fibrin in the SKN construct matrix required to stimulate collagen synthesis would 
enable optimisation of the digestion rate of the fibrin matrix. Measurement of the fibrin 
digestion rate in SKN constructs could be achieved through measurement of the 
intensity offluorescently labelled fibrinogen as described by Grassl, E.D. 2002. 
7.3. Reduction in Batch-to-Batch Variation 
7.3.1. Control of Human Dermal Fibroblast Cell Population 
The humao dermal fibroblast (HDF) cells were confirmed to be responsible for the 
processes that occurred in the SKN maoufacturing process to produce the final product. 
In this study, a semi-automated process was used to produce master aod working HDF 
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cell banks to reduce the variation in the cell culture process and cell population used in 
the manufacture of SKN constructs when compared to manual cell culture. The use of a 
fully automated cell culturing process would be beneficial to further reducing process 
variation and variation in the cell population (Liu, Chandra et al. 2008). 
Development of a fully automated protocol using the CompacT SelecT requires 
changes to the manual trypsinisation process. In the manual cell culture process, trypsin 
is used to enzymatically detach cells from the culture flask for passaging of the cells but 
is then removed from the cell suspension by centrifugation and aspiration to minimise 
damage to the cells through prolonged exposure to the trypsin. However, the current 
automated cell culturing system (CompacT SelecT, TAP, UK) does not have the facility 
to centrifuge the cell suspension and remove trypsin. A fully automated cell culture 
process where trypsin enzymatica1ly detaches cells from the culture flask but minimises 
damage to the cells is required. This could be achieved through investigation of the 
volume of media required to reduce the concentration and activity of trypsin once the 
cells were detached from the flask. The concentration and incubation time of the trypsin 
on the cells required for enzymatic digestion could also be investigated. 
In addition, cell damage and therefore variation in the cell population, is most likely to 
be caused by cryopreservation and recovery of the cells from cryopreservation as well 
as trypsinisation during cell culture. Optimisation of these processes to minimise cell 
damage would improve cell viability and potentially improve the suitability of the cells 
for their function in the SKN manufacturing process. The processes could be optimised 
using a design of experiments methodology to analyse the interactions between the key 
parameters of each process as well as individual parameters. For the trypsinisation 
process, the key parameters include trypsin concentration and temperature, volume of 
dilution media and incubation time. For the cryopreservation and recovery processes, 
the key parameters include the cell density and volume, rate of freezing and rate of 
thawing when recovering cells from cryopreservation. 
Finally, development of a measurement system that would improve the understanding 
of the suitability of the cell population for the SKN manufacturing process would allow 
for optimisation and selection of cell populations prior to use. The identification of 
specific cell surface markers that are indicative of the optimum cells for use in SKN 
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constructs is many years away. However, assays such as Alarnar Blue are readily 
available for analysis of metabolic activity of cell populations. The coupling of cell 
viability, cell yield and metabolic activity would provide an improved profile of the 
cells used in the manufacturing process and provide a better understanding of the 
variation in the manufacturing process that is caused by variations in cell populations. 
7.3.2. Control of Culture Media 
The culture media is composed of 18 different supplements and is currently used for a 
maximum of 30 days before disposal. The stability ofthe components in the media over 
time and the effectiveness of each of the supplements with respect to maximising 
collagen synthesis and cell proliferation should be investigated to potentially reduce 
process variation and cost of goods through the removal of ineffective supplements. It is 
suggested that the effectiveness of the media supplements is investigated using a design 
of experiments as described previously for. the optimisation of the trypsinisation 
process. 
It is recognised that changes to the media formulation would also cause further 
expenditure as regulators would require evidence that there was no change in efficacy 
of the SKN product compared to that used in the Phase I clinical trial. The cost of such 
a study and magnitude of the potential savings needs to be balanced with the regulatory 
costs. It is suggested that such a study is conducted in collaboration with an applied 
manufacturing academic research group to generate preliminary evidence for a business 
case. 
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7.3.3. Control of the Fibrin Matrix 
The fibrinogen and thrombin used to produce the fibrin matrix for ICX-SKN constructs 
has inherent variation due to its human source (bovine source for SKN constructs). It is 
not currently known if this causes variation in the fibrin matrices as the biochemical and 
mechanical properties of the fibrin matrix are not measured before used in the SKN 
manufacturing process. The fibrin matrix may be a source of process variation as it has 
been shown that cell proliferation is affected by the properties of the matrix (Cox, Cole 
et al. 2004). Development of a measurement system that to test the biochemical and 
mechanical properties would provide an understanding of the variation and allow 
development of specifications for the matrix prior to use in the manufacturing process. 
The rheological method developed in this thesis in a potential candidate system to test 
the viscoelastic properties of the matrix. Further development of this methodology to 
assess the repeatability and reproducibility of the measurement system is first required 
and could be analysed using a nested Gauge R&R study (Mason, Gunst et al. 2003). 
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7.4. Improvement ofUItrasound Stimulation Process 
7.4.1. Reducing Variation in Ultrasound Stimulation Process 
The SonoPlus490 ultrasound unit provided a cost-effective, off-the-shelf system for 
ultrasound stimulation of the SKN constructs. However, assembly of a custom-built 
ultrasonic system would provide greater control of the ultrasound output and reduce 
variation in the ultrasound stimulating the HDF cells in the SKN constructs. The main 
components of an ultrasonic system are the pulser/receiver, transducer and associated 
communications and application software which provides the user interface for control 
of the ultrasound parameters (National Instruments Ultrasonic Developer Zone, 
http://zone.nLcornl). The pulser/receiver generates a high-voltage pulse that vibrates the 
piezoelectric ceramics in the transducer to generate an ultrasonic wave. The 
pulser/receiver controls the intensity, and frequency of the voltage as well as the pulse 
length, damping and band filter pass settings received by the transducer. Use of a 
pulser/receiver that allows greater control of these settings compared to the 
SonoPlus490 unit will allow optimal excitation of the transducer and greater output 
stability. In addition, coupling the pulser/receiver to a transducer with unifonn output 
across the whole face will provide more homogeneous stimulation of the HDF cells in 
the SKN construct. The cost and suppliers of the components required for such a system 
is detailed in Appendix V. Such a system could be used to investigate the effect of the 
ultrasound duty cycle between 50% and 80% which is not possible with the 
SonoPlus490 unit. 
7.4.2. Improvement in Understanding ofUltrasonnd Ontput and Propagation 
The force balance used to measure the output of the transducer in this study provided an 
average output power measurement over the whole transducer face. However, further 
understanding of the homogeneity of the output across the transducer face and the 
. propagation of ultrasound through the construct is required to improve understanding of 
the cellular responses reported in this study. Spatial mapping of the ultrasound field 
using a hydrophone (which converts acoustic pressure to a measurable output voltage) 
would allow measurement of variation in output across the transducer face of the 
SonoPlus490 or custom-built unit. In addition, a needle hydrophone can used to map 
the ultrasound output in the SKN constructs. This would provide an understanding of 
176 
the homogeneity of the ultrasound propagation through the construct and the effect on 
cellular responses as the extracellular matrix composition changes during 
manufacturing. 
7.4.3. Improvement of the Ultrasound Stimulation Parameters and Regime 
This study identified the range and combinations of ultrasound parameters that could be 
used to improve the biochemical and mechanical properties of SKN constructs. Further 
experiments to optimise the ultrasound parameters for maximum collagen synthesis and 
shear storage modulus are required. This can be achieved using a design of 
experiments, as described in section 4.2.1, with maximum and minimum duty cycles of 
20% and 50%, durations of 5 and 18 minutes and intensities of 0.5W/cm2 and 
1.5W/cm2 for the current experimental set-up with the SonoPlus490 ultrasound unit. A 
custom-built ultrasonic system (section 7.4.1) would allow optimisation at duty. cycles 
between 20% and 50% as well as between 50% and 80%. 
In addition, increasing the levels of ultrasound stimulation during the manufacturing 
process could be investigated as this has been reported to increase collagen synthesis 
from cells in fibrin gels subjected to stepped increases of uniaxial strain compared to 
the gels stimulated by the same magnitude of strain (Syedain, Weinberg et al. 2008). 
For instance, using the DOE results in this study, ultrasound parameters of 2.5W/cm2 
intensity, 5% duty cycle and 5 minute duration which increased G' by 112% could be 
used between DO and D7. Between D7 and D14, 0.5W/cm2 intensity, 5% duty cycle and 
5 minutes duration which increased G' by 119% could be used and between DI4 and 
D21, 1.5W/cm2 intensity, 50% duty cycle and 18 minute duration which increased G' 
by 139% could be used. 
Finally, mathematical modelling programs can be used to support optimisation of the 
ultrasound parameters and stimulation regime. Modelling programs such as Field II 
(http://server.elektro.dtu.dklpersonal/jaj/fieJd/) are commercially available and can be 
used to simulate the ultrasound output from the transducer and propagation through the 
SKN constructs in a similar mariner that describe for simulation of ultrasound 
propagation through bone (Kaufman, Luo et al. 2008). 
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7.5. Ultrasound Induced Mechanisms Affecting Cell Responses 
It has been widely reported that ultrasound stimulation increases collagen synthesis 
from cells and the mechanical properties of cell seeded matrices. These findings were 
confirmed in this study using human dermal fibroblast seeded fibrin matrices. The 
phenomena that occur when ultrasound propagates through materials is well established 
(ChaIlis, Povey et al. 2005). There are also many studies on the safety of ultrasound 
propagation through tissue when used for imaging of foetuses (Duck 2008). However, 
the mechanisms by which ultrasound stimulate cell responses, such as collagen 
synthesis, in-vitro are not fully understood. 
There are a number of mechanisms that may cause cell responses when stimulated by 
ultrasound. Firstly, the propagation of ultrasound may improve the availability of 
oxygen and nutrients to the cells through physical diffusion of the media through the 
cell seeded matrices. A system to assess fluid flow through matrices with different 
matrix densities, with and without ultrasound stimulation, would improve the 
understanding of the effects of ultrasound on media distribution. 
Secondly, the propagation of ultrasound through materials is known to cause physical 
deformation through compression and expansion of the materials as described in section 
2.8.3. Optical techniques such as holography and interferometry can been used to 
measure sub-micron deformation of materials and observe changes in the morphology 
of cell surface (Joeris, Frerichs et al. 2002, Neto, Agero et al. 2006, Cuche, Bevilacqua 
et al. 1999). These techniques could be used to understand the effect of ultrasound on 
the compression and expansion of cells in mono layers. This would provide further 
understanding of the relationship between cellular responses, such as cell proliferation 
and collagen synthesis, and the degree of cell deformation caused by ultrasound. 
178 
Thirdly, the velocity of ultrasound propagation differs through the cells, extracellular 
matrix and fluid in cell seeded matrices. This causes the cells to be subjected to shear 
forces at the interface between the cell membrane and surrounding extracellular matrix. 
Studies of the effect of interstitial flow through cell seeded collagen matrices showed 
that shear forces could stimulate collagen synthesis from the cells (Ng, Hinz et al. 
2005). Application of different combinations of ultrasound parameters, measurement of 
the shear force and cellular responses such as collagen synthesis would provide further 
understanding of the mechanisms by which ultrasound causes cellular responses. In 
addition, it has been shown that cells detect ultrasound through integrin receptors on the 
cell membrane (Zhou, Schmelz et al. 2004). These receptors detect mechanical 
stimulation and analysis of the activation of the integrin receptors, as described by Zhou 
et al 2004, could be used to provide further understanding of the contribution of the 
effect of cell deformation and shear force on cell responses. 
Finally, there is currently much debate on the acoustic conditions required for the 
formation of cavitation bubbles and the effect of cavitation in cell mono layers and cell 
seeded matrices. In this study, there was evidence of some cell necrosis together with 
collagen synthesis when the SKN constructs were stimulated with ultrasound. The 
formation and collapse of cavitation bubbles on the cell membrane has been suggested 
to cause cell necrosis through penetration of the membrane (Miller 2007). However, it 
has also been shown that ultrasound improves the permeability of cell membranes for 
the uptake of drugs (Husseini, Diaz de la Rosa et al. 2005). The degree of cavitation 
induced by ultrasound in these studies may account for the different cellular responses 
reported. 
Further understanding of the acoustic conditions that cause the formation of cavitation 
bubbles could be studied through use of time-lapse microscopy. Calculation of the 
magnitude of the force of impact of bubbles with the cell membrane would provide an 
understanding of the effect of cavitation on cell responses and would allow for better 
selection of the ultrasound parameters to elicit desired cell responses. 
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7.6. Molecular Mechanisms Affecting Cell Responses 
The processes of mechanotransduction whereby mechanical stimuli are converted by 
cells into intracellular chemical signals have been widely reported and have been 
recently reviewed (Chiquet, Gelman et al. 2009, Wang, Tytell et al. 2009, Ingber 2006). 
Cells bind to the surrounding extracellular matrix through formation of focal 
complexes, focal adhesions and fibrillar adhesions (Chiquet, Gelman et al. 2009). These 
matrix adhesions contain integrin receptors as their main transmembrane proteins. The 
integrins bind to specific extracellular matrix molecules and to adaptor proteins in the 
cell which are linked to the cell actin cytoskeleton (Wang, Tytell et al. 2009). The 
detection of mechanical stimuli by the integrin receptors causes reorganisation of the 
actin cytoskeleton and in turn activates signalling pathways which lead to cell responses 
such as collagen synthesis (Chiquet, Gelman et al. 2009). Methods to measure 
cytoskeletal forces have been demonstrated by a number of studies (Choquet, 
Felsenfeld et al. 1997, Spudich, Pelham et al. 1999, Schwarz, Balaban et al. 2002, 
Sniadecki, Anguelouch et al. 2007). However, the degree of cytoskeletal reorganisation 
caused by mechanical stimulation, to elicit desired cell responses requires further 
investigation. A study which applied cyclic strain to cardiac fibroblasts showed that the 
COLlAI gene associated with synthesis of collagen type I was regulated by a 
signalling pathway dependent on TGF-~ (Lindahl, Chambers et al. 2002). However, it 
has also been shown that over stimulation of cells causes disassembly of focal 
adhesions and can lead to undesired cell responses such as apoptosis (Kearney, 
Prendergast et al. 2008). 
The selection of appropriate combinations of ultrasound intensity, duty cycle and 
duration to elicit desired cell responses requires further research. Firstly, an 
understanding of the magnitude of mechanical force on the cell caused by ultrasound 
stimulation required to activate integrin receptors and the associated cytoskeletal force 
is required. Secondly, understanding of the optimum frequency and duration over which 
integrin receptors can respond to mechanical stimuli would enable optimisation of 
mechanical stimulation regimes and aid the choice of the most suitable combinations of 
ultrasound parameters. 
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Finally, it has been shown that cells respond to changes in the stiffness of the 
extracellular matrix through formation and disassembly of focal adhesions (Chiquet, 
GeIman et al. 2009, Discher, Janmey et al. 2005). An understanding of the whether the 
matrix stiffness is altered as ultrasound propagates through it would provide an insight 
in to whether this is also a mechanism by which ultrasound stimulation elicits responses 
from cells seeded in matrices. 
In summary, there· are three key areas of further work required to develop 
manufacturing processes and products that meet business and customer needs for the 
realisation of the routine use of regenerative medicine products in patients. Firstly, 
improved understanding of current manufacturing processes and development of 
repeatable and reliable measurement systems is required to identify areas to improve the 
cost-effectiveness of the process. Secondly, research into minimising the variation in 
the process input raw materials is required to reduce the variation in the manufacturing 
processes and improve product quality. Finally, further understanding of the effect of 
the type, magnitude,· frequency and duration of mechanical stimulation on cell 
responses will enable a step-change in improvement of product properties through use 
of mechanical stimulation. 
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Experimental Operating Procedure EOP012 Manual Culture of Human Dermal 
Fibroblasts 
1. PURPOSE 
This document describes the procedure for the manual culture of human dermal 
fibroblast cells grown in monolayer in culture vessels. 
2. SCOPE 
This EOP is intended to describe specific protocol for the manual culture of human 
dermal fibroblasts grown in monolayer culture for creating a master and working cell 
bank. It should be read in conjunction with SOP 012 "Manual Culture of Human 
Osteoblast like cell line" and relevant local SOPs 
3. SPECIAL NOTES - HEALTH & SAFETY 
3.1. Risk is low when work involves authenticated cell lines derived from pathogen 
free animals or cell lines which are known to be free of adventitious agents 
3.2. HOWEVER, ALL WORK WITH HUMAN CELLS MUST BE CARRIED 
OUT UNDER THE ASSUMPTION THAT THE SPECIMIN MAY CARRY 
AN INFECTIOUS AGENT. 
3.3. Human-derived cells may be carrying adventitious agents. Treat as potentially 
hazardous. Inoculation against Hepatitis B may be appropriate. 
3.4. Wear lab coat and gloves. 
3.5. Work in a Microbiological Safety Cabinet (MSC). 
3.6. Most gases used in cell culture (C02, 02, N2) are not harmful in small amounts 
but can be dangerous if handled improperly. When a major leak occurs, there is 
a risk of asphyxiation from C02 and N2. and a fire hazard from O2. evacuation 
and ventilation are necessary in each case. 
4. REFERENCES 
EOP008 Recovery of Human Dermal Fibroblasts from cryopreservation 
EOP013 Trypsinisation of Human Dermal Fibroblasts 
SOP003 Disposal and Disinfection of Biological Waste 
SOP009 Use and Maintenance of BSC-G2000 Vertical Laminar Airflow Cabinet 
SOP020 Use and Maintenance of Water Bath 
SOPOl5 Use and maintenance ofthe BOECO U032R 
SOP022 Use and maintenance of Microscope 
SOP025 Use and Maintenance of C02 Incubator 
SOP034 Cell Counting and Viability Assessment 
School Risk Assessment SAFIMM/1638 Processes of Cell Culture 
Biological Risk Assessment BRAlMM/0003 Isolation, culture and 
cryopreservation of human, neonatal dermal fibroblasts (HDFs) 
5. RESPONSIBILITIES 
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5.1. This process is for use in the Loughborough University Cell Culture laboratory, T208b, 
and should be used according to the general rules and local SOPs for using T208b and 
with good laboratory practice. 
5.2. It is the responsibility of the person performing the operation and of their supervisor to 
ensure that adequate training has been received and that this document is followed as 
written. 
6. EOUIPMENT AND MATERIALS 
Equipment 
o Biological Safety Cabinet 
o Centrifuge (capable of centrifuging IS or 50ml tubes at 500g) 
o Water bath 
o Aspirator and pump 
o Haemocytometer with cover glass 
o Microscope inverted 
o Culture flasks (size and quantity as required) 
o Pipettes (5ml- 50ml) 
Materials 
o DMEM-IO media (prepared according to EOP Preparation of DMEM-I 0) 
7. PROCEDURE 
7.1. Obtain a cell suspension by trypsinisation according to EOPOl3 Trypsinisation 
of Cells, or from recovery from cryopreservation according to EOP008 
Recovery of Human Dermal Fibroblasts from Cryopreservation. 
7.2. Count cells in suspension according to SOP034 Cell Counting and Viability 
Assessment" to obtain the cell density 
7.3. Calculate the volume of cell suspension required for each flask to be plated by 
multiplying the surface area of the plating flasks (cm2) by the required cell 
density (2500-6000cells/cm2). Then divide the total number of cells required by 
the concentration of cells in the cell suspension (cells/ml) 
7.4. In the BSC, dilute the stock cell suspension with DMEM-IO if necessary so that 
at least lml of cell suspension can be used in each new culture flask to be 
plated. The new cell suspension volume required can be calculated as follows. 
Calculate the new concentration of stock required by dividing the total number 
of cells required for plating (0.45 x 106) by the desired volume of the cell 
suspension for plating (e.g. Iml). Then calculate the new volume of stock 
required by dividing the total number of cells in the original cell suspension, by 
the new required concentration. Finally, calculate the additional volume of 
DMEM-IO required by subtracting the new volume required, by the volume of 
original cell suspension. 
7.5. In the BSC, place sufficient DMEM-IO to the culture flasks to be plated, see 
table I, and then the appropriate volume of the new cell suspension prepared in 
step 7.4. 
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DMEM·10 Cell Minimum Seeding Flask Size Suspension (mL) (mL) Volume (mL) 
T25 5-6 1-2 6 
T75 15-20 . 1-2 16 
T175 30-40 1-2 31 
Table 1 - Guide to the volume of media and cell suspension to use when culturing 
HDFs 
7.6. Incubate the flasks at 37°C according to SOP025 Use and Maintenance of C02 
Incubator. 
7.7. Every 2-3days, transfer the flasks to the BSC and change the DMEM-IO media, 
by aspirating the media and replacing with new DMEM-IO, until cells are 
confluent as seen under a microscope (according to SOP022 Use and 
maintenance of Microscope). See Table 2. Dispose of the used media according 
to SOP003 Disposal and Disinfection of Biological Waste . 
7.8. When the cells become confluent, transfer the flasks to the BSC and trypsinise 
the cells (according to EOP013 Trypsinisation of Human Dermal Fibroblasts). 
Obtain an appropriate cell suspensions for further cell culture by repeating steps 
7.1 - 7.7; for casting of SKN constructs (according to EOPOl4 Casting of SKN 
Constructs), or for freezing and storage (according to EOPOII Cryopreservation 
and Storage of Human Dermal Fibroblasts). 
8. DOCUMENTATION 
All results should be recorded in the Laboratory note book 
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Experimental Operating Procedure EOP008 Recovery of Human Dermal 
Fibroblasts 
1. PURPOSE 
This document describes the procedure for the recovery of viable human dermal 
fibroblast cells that have been cryopreserved in liquid nitrogen. 
2. SCOPE 
This EOP is intended to describe specific protocol for recovering human dermal 
fibroblasts that have been cryopreserved in liquid nitrogen and must be read in 
conjunction with SOP 0032 "The Resuscitation of Cryopreserved Mammalian 
Cell Lines" and other relevant local SOPs 
3. SPECIAL NOTES - HEALTH & SAFETY 
3.7. Human-derived cells may be carrying adventitious agents. Treat as potentially 
hazardous. Inoculation against Hepatitis B may be appropriate. 
3.8. Wear lab coat and gloves. 
3.9. Work in a Biological Safety Cabinet (BSC). 
3.10. See Safety Issues as detailed in SOP032 "The Resuscitation of Cryopreserved 
Mammalian Cell Lines" and . 
3.11. Personnel who use liquid nitrogen are required to be trained, and familiar with 
SOPOI3 "Use and Maintenance of Liquid Nitrogen Stores". PPE including 
thermally insulated gloves (able to withstand temperatures from -160°C to 150°C), 
lab coat and face shield are required 
4. REFERENCES 
SOP003 Disposal and Disinfection of Biological Waste 
SOP009 Use and Maintenance of BSC-G2000 Vertical Laminar Airflow Cabinet 
SOPOI3 Use and Maintenance of Liquid Nitrogen Stores 
SOP020 Use and Maintenance of Water Bath 
SOPOl5 Use and maintenance of the BOECO U032R 
SOP025 Use and Maintenance of C02 Incubator 
SOP034 Cell Counting and Viability Assessment 
Biological Risk Assessment BRAlMMl0004 Isolation, culture and cryopreservation 
of human, neonatal dermal fibroblasts (HDFs) 
5. RESPONSIBILITIES 
5.1. This process is for use in the Loughborough University Cell Culture laboratory, T208b, and 
should be used according to the general rules and local SOPs for using T208b and with 
good laboratory practice. 
5.2. It is the responsibility of the person performing the operation and of their supervisor to 
ensure that adequate training has been received and that this document is followed as 
written. 
6. EOUIPMENT AND MATERIALS 
Equipment 
o Biological Safety Cabinet 
o Centrifuge (capable of centrifuging 15 or 50ml tubes at 500g) 
o Water bath 
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o Liquid nitrogen store 
o Aspirator and pump 
o Haemocytometer with cover glass 
o Microscope inverted 
o Plastic Serological Pipettes (1-50ml) 
o 50ml Falcon tube 
o Appropriate culture flasks 
Materials 
o DMEM-10 prepared according to EOP Preparation ofDMEM-10 
o Cryovial of Human Dermal Fibroblasts 
7. PROCEDURE 
7.1. Remove DMEM-10 from the fridge and allow to reach room temperature. 
7.2. In the BSC, place 40ml ofDMEM-10 into a 50ml falcon tube 
7.3. Remove the cryovial containing human dermal fibroblasts from the liquid 
nitrogen store according to SOP013 Use and Maintenance of Liquid Nitrogen 
Stores 
7.4. Rapidly thaw the cryovial in a 37°C water bath by swirling the cryovial but 
ensuring that the cryovial cap remains dry (according to SOP020 Use and 
Maintenance of Water Bath) 
7.5. Once fully thawed, transfer the cryovial to the BSC and place the cell suspension 
into the 40ml of DMEM-l 0 using a pipette. 
7.6. Place lml of the DMEM-lO from the falcon tube into the cryovial to recover any 
cell from the surface and replace the solution back into the falcon tube using a 
pipette. 
7.7. Count the cells according to SOP034 Cell Counting and Viability Assessment and 
calculate the required volume of DMEM-l 0 to suspend the cells at the required 
density for further manual culture (according to EOPOl2 "Manual Culture of 
Human dermal Fibroblasts''). 
7.S. Replace the cap on the falcon tube and centrifuge at 500g for 5mins to obtain a 
cell pellet according to SOP015 Use and maintenance of the BOECO U032R 
7.9. Transfer the tube back to the BSC and aspirate the supematant and dispose of 
according to SOP003 Disposal and Disinfection of Biological Waste. Replace cap 
and flick the bottom ofthe falcon tube to distribute the cells in the pellet 
7.10. Resuspend the pellet in the required volume of DMEM-10 as calculated in step 
7.6 
7.11. Mix the cell suspension to obtain a homogeneous single cell suspension by 
drawing up and expelling the suspension with a pipette 
7.12. Use the cell suspension to culture the cells according to EOP012 Manual Culture 
of Human Dermal Fibroblasts 
8. DOCUMENTATION 
All results should be recorded in the Laboratory note book 
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Automated CompacT SelecT Program for Cell Seeding and Counting 
This program measures the cell concentration of a human dermal fibroblasts suspension 
in a T175 flask (assigned the name "pool") imported into the CompacT SelecT for 
passaging. The appropriate volume of media is added to the flask to achieve the desired 
cell concentration (875000cells/mL) and new flasks are seeded from this cell 
suspension. 
<properties> 
<description> Seeding <ldescription> 
<flaskingtirne units="s">O<lflaskingtirne> 
<platingtirne units="s">O<lplatingtirne> 
<lproperties> 
<steps> 
<fetch> 
<putdown name = "pool"!> 
<mix name = "pool" 
volume = "1 Oml" 
repeat = "2" 
frornheight = "2mrn" 
toheight = "50mrn" 
mixspeed = "2mVs" 
finaldispensespeed = "I rnlls" 
newtip = "yes"!> 
<count name = "pool" 
frornheight = "2mrn" 
aspiratespeed = "SmUs" 
dispensespeed = "5rnlls"/> 
<pickup name = "pool"/> 
<dispense liquid = "DMEMlO" 
volume = "OmI" 
cellconc = "875000" 
minvolume = "Oml" 
maxvolume = "1 OmI"/> 
<putdown name = "pool"/> 
<new repeat = "27" 
flasktypegroup = "Single"> 
<dispense liquid = "DMEMlO" 
volume = "29ml"J> 
<putdown name = "output"/> 
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<mix name - "pool" 
volume = "IOml" 
repeat = "211 
fromheight = "2mm" 
toheight = "2mm" 
mixspeed = "2mlls" 
finaldispensespeed = "2mVs"!> 
<pipette fromname = "pool" 
toname = "output" 
volume = "I.Oml" 
fromheight = "2mm" 
toheight = "50mm" 
aspiratespeed = "I mlls" 
dispensespeed = "lmlls"!> 
<pickup name = "output"!> 
<store passage = "yes" robotspeed = "I OO%"/> 
<!new> 
<pickup name = "pool"!> 
<dispose!> 
<!fetch> 
</steps> 
<!SelecT Protocol> 
Automated CompacT SelecT Program for Media Change 
This program disposes of the culture media in the flasks and adds fresh culture media 
<properties> 
<description> Media Change <!description> 
<tlaskingtime units="s">O<!tlaskingtime> 
<platingtime units="s">O<!platingtime> 
<!properties> 
<steps> 
<fetch> 
<dump pause = "2s"!> 
<dispense liquid = "DMEMIO" 
volume = "30ml"!> 
<store passage = "no"!> 
<!fetch> 
</steps> 
<!SelecT Protocol> 
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Automated CompacT SelecT Program for Cell Harvesting 
This program detaches adherent cells from the flask using trypsin and combines the cell 
suspension from individual flasks into a "pool" flask. Nine individual flasks are pooled 
before export of the pool flask for cryopreservation of further passaging. Two flasks are 
processed during the trypsin incubation period of another flask (interleave=3) 
<SelecT_Protocol> 
<properties> 
<description> Pool and Harvest </description> 
<tlaskingtime units="s">O<ltlaskingtime> 
<platingtime units="s">O<lplatingtime> 
<lproperties> 
<steps> 
<new tlasktypegroup = "Single"> 
<putdown name = "pool"!> 
<lnew> 
<fetch maxrepeat = "9" staggertime = "Os" interleave = "3"> 
<dump pause = "2s"/> 
<dispense liquid = "PBS" 
volume = "IOml"/> 
<swirl repeat = Ill" speed = "100%" pause = "Os" capped = "no"/> 
<dump pause = "2s" robotspeed = "100%"/> 
<dispense liquid = "JASTRYPSIN" 
volume = "6ml" 
robotspeed = "IOO%"/> 
<swirl repeat = "1" speed = "100%" pause = "Os" capped = "yes"/> 
<incubate period = 116m"j> 
<shake repeat = "6" speed = "50%" pause = "Os" capped = "yes"/> 
<dispense liquid = "DMEMIO" 
volume = "6ml" 
robotspeed = ''100%''/> 
<swirl repeat = "1" speed = "100%" pause = "Os" capped = "no"/> 
<pour name = "pool" pause = "4s" robotspeed = "100%"/> 
<dispose robotspeed = "IOO%"/> 
<lfetch> 
<mix name = "pool" 
volume = "tOml" 
repeat = "6" 
fromheight = "2mm" 
toheight = "2mm" 
mixspeed = "SmUs" 
finaldispensespeed = "SmVs" 
newtip = "yes"/> 
<count name = "poo)" 
fromhei~ht = "2mm" 
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newtip = "no"/> 
<pickup name = "pool"!> 
<outfeed passage = "no"/> 
<lsteps> 
<lSelecT Protocol> 
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Appendix 11 Protocols for the Preparation and Staining of 
Paraffin Wax Histology Sections 
Leica TP 1020 Automatic Tissue Processor reagents and timings for preparation of wax 
embedded samples for histology and immunohistochemistry 
Reagent Duration (hour) 
10% Formal Saline 1 
10% Formal Saline 1 
70% Ethanol 1.5 
80% Ethanol 1.5 
96% Ethanol 1.5 
100% Ethanol 1 
100% Ethanol 1 
100% Ethanol 1 
Xylene 1.5 
Xylene 1.5 
Paraffin Wax 2 
Paraffin Wax 2 
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Masson's Trichrome Histological Staining Protocol (reproduced with permiss ion 
from the Advance Microscopy Unit, Nottingham University) 
Method developed for the staining of fibrin , co llagen and cell nuclei in SKN constructs: 
• Rehydrate cut section in a series of decreasing ethanol concentrations (100% 
three times, 90%, 70%, 50%) and then in water. 
• Stain with 4%lron Alum for 5 minutes 
• Wash in tap water 
• Stain wi th Mayers Haematoxyli n for 1 minute 
• Wash in tap water until nuclei appear blue 
• Stain with Ponceau Acid Fuschin for 5 minutes 
• Wash in tap water 
• Differentiate in 1% Phosphomolybdic acid , observe under microscope unti l 
collagen appears clear 
• Stain in 0.2% li ght green in 0.2% acetic acid for 2 minutes 
• Dehydrate, clear and mount 
Collagen stains blue/green 
Nuclei stain blue/black 
Fibrin and cytoplasm stain red 
Figure 60 Cross-section of human liver stained with Masson's Trichrome as a co ntrol. Colla gen 
fibres (blue), fibrin fibres (purple/red) and cell nuclei (dark blue blac k) 
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Alcian Blue Histological Staining Protocol (reproduced with permission from the 
Advance Microscopy Unit, Nottingham University) 
Method developed for the staining of proteoglycans in SKN construct 
• Rehydrate cut section in a series of decreasing ethanol concentrations (100% 
three times, 90%, 70%, 50%) and then in water. 
• Stain with Alcian Blue pH 2.5 ( I g Alcian Blue in 100ml of 3% acetic acid) for 5 
minutes 
• Wash in tap water 
• Counterstain in 0.1 % nuclear fast red fo r 5 minutes 
• Dehydrate, clear and mount 
Proteoglycans stain bright blue 
Nuclei and other cytoplasmic areas stain red 
Figure 61 Cross-section of hum an intestine stained with Alc ian blue as a co ntrol. Cytoplasmic 
regions (red) a nd proteogtycans (blu e) 
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Elastic Van Giesson 's Histological Sta ining Protocol (reproduced with permiss ion 
from the Adva nce Microscopy Unit, Nottingham University) 
Method developed for the staining of elastin in SKN constructs: 
• Rehydrate cut section in a series of decreasing ethanol concentrations (100% 
three times, 90%, 70%, 50%) and then in water. 
• Treat with 0.5% acidified potassium permanganate fo r 3 minutes 
• Wash in tap water 
• Bleach sections with I % oxalic acid to remove brown colouration 
• Rinse in Industria l Methylated Spi rit (lMS) 
• Place secti ons into Millers elastin for I hour 
• Wash in tap water 
• Differentiate in IMS until the background is co lourless 
• Wash in tap water 
• Stai n with Van Gieson so lution for 5 minutes 
• Blot sections and rinse quickly in IMS 
• Clear and mount 
Elastin stains blue/black 
Collagen sta ins dark red 
Figure 62 Cross-section of hunUlIl dermis stained with Elastin Van Cicso n's as a co ntrol. Collagen 
fi bres (da rk rcd), elastin (b lack) 
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Immunohistochemistry and Con focal Laser Fluorescent Microscopy Negative 
Controls 
Negative controls used to assess the fluorescence of the secondary anti body to the in the 
absence of the primary anti body. 
Figure 63 Immunohistochemistry nega tive co ntrol with no primary co llagen type I or CO llagen type 
III anti body. No cross reactivity between th e seco ndary antibod ies and section observed. Cell nuclei 
sta ined blue wi th DAPI 
Figure 64 C LFM nega tive co nt ro l with no collagen type I p rim a ry a ntibody. No cross react ivity 
between the seconda ry antibod ies and section observed. Cell nuclei stained blue wi th OAPI 
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Appendix III Assumptions for the Calculation of the Volume 
Fraction of Cells in SKN Constructs 
• The vo lume fraction of the fibroblast cell s was approximated by multi plying the 
volume of the cell by the total number of ce ll s in the construct. 
• The vo lume of the cells was calculated assuming that the cells were cy lindri cal 
and using an average length of 1 50~m and diameter of 8~m measured from the 
CLFM and SEM images (Figure 65). 
• The contribution of the cell membranes to the dry weight was assumed to be 
negligi ble and therefore the total cell vo lume was calculated as a percentage of 
the vo l ume fraction of water in the constructs. 
Figure 6S Exa mplc of C LFM (top) and SE M (bottom) imagcs from which cell dim ensions wcre 
measured 
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Appendix IV Ultrasound Calibration Curve and 
Experimental Design 
Power balance reading for SonoPlus490 Ultrasowld Unit at different duty cycles. CW = 
100% duty cycle. 
~ 
S 
-Cl 
c 
"0 
III 
Q) 
a: 
Q) 
() 
C 
III 
III 
(l) 
'-
Q) 
~ 
0 
a.. 
16 
14 
12 
10 
8 
6 
4 
2 
--cw 
..... 5 % Duty Cycle 
.. .. . .. 10 % Duty Cycle 
...... - 20 % Duty Cycle 
50 % Duty Cycle 
.... ..... 80 % Duty Cycle 
US Setting x ERA 
..-
.. 
o· 
... 
.' 
... 
. ' 
- '- -
. . '
.' 
.-.--
'- '- '-
- .--
- .- '-
.-. -
.. ' 
_. - '-
.- .- -
- - .-
.-'-- ,- ,'-
,- ,,-
------
./ ----_.---- - - - - - - - - - - - - - -O ~~-~·-~::~~~~O~~ ·O~.~O.~-_ .. _.~·_· _··~ __ ~~ __ ~ __ ~ __ ~~ 
0.0 0.5 1.0 1.5 2.0 2.5 3.0 
Ultrasound Power Setting (W cm·2) 
212 
Calculation of the Distance between the Ultrasound Transducer and SKN 
Construct 
The optimum distance between the ultrasound transducer and SKN constructs to enable 
positioning of the SKN constructs in the most homogeneous but least divergent 
ultrasound stimulation was calculated as follows: 
Optimum distance from transducer face = a 2fA 
Where, 
a = radius of transducer face 
A = ultrasonic wavelength 
Effective radiating area of Sonoplus490 transducer = 5cm2 
Radius of transducer = 12.6mm 
In soft ti ssue, A = 1.50mm (Duck 1990) 
Optimum distance from transducer face = (l2.6il1.s 
= 105.8mm 
In water, A= 1.48mm 
Optimum distance from transducer face = (12.6)2/1.48 
= 107.3mm 
Assuming that the propagation of ultrasonic waves through ICX-SKN constructs is 
between that of soft tissue and water, the optimum distance from the transducer face is 
between 105 .8mm and 107.3 mm. 
Reference 
DUCK, F.A., 1990. Physical Properties of Tissue, A Comprehensive Reference Book. 
London: Academic Press Inc. 
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Design of Experiments (DOE) Run Order for Ultrasound Stimulation Study 
The random run order used in the DOE study minimise variation in the results caused 
by the ultrasound stimulation process such as, time-dependent effects. 
Run Order Sample Intensi~ Duty cycle Duration 
number (W/cm' ) (%) (mln) 
1 2 2 .5 5 30 
2 21 0 .5 5 5 
3 4 0 .5 80 5 
4 13 2 .5 5 5 
5 23 0 .5 5 30 
6 7 0 .5 5 30 
7 8 2 .5 80 5 
8 1 2 .5 80 30 
9 24 0 .5 80 30 
10 3 2 .5 80 5 
11 22 0 .5 80 5 
12 10 2 .5 80 5 
13 11 1.5 42.5 17.5 
14 6 2 .5 5 30 
15 5 0 .5 5 5 
16 15 0 .5 80 5 
17 9 0 .5 5 5 
18 17 2.5 5 5 
19 20 0 .5 80 30 
20 14 2.5 80 30 
21 25 2.5 5 30 
22 19 0 .5 5 30 
23 12 0 .5 80 30 
24 16 2 .5 80 30 
25 18 2.5 5 5 
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Appendix V Costing for Custom-built Ultrasonic System 
Costing fo r an upgraded ultrasonic system ( 0 deliver a more homogeneous output 
Description Supplier Manufactured Cost 
Videoscan Contact Transducer Olympus NOT UK £1 ,500 
UT320 Pulser Receiver Utex Scientific Canada £5,450 Instruments Inc. 
Hydrophone & accessories Precision Acoustics UK £4,305 Lld 
Wavesurfer 104XsOscilloscope l eCroy Switzerland £7,013 
Software for Oscilloscope LeCroy Switzerland £319 
PC £1 ,250 
Subtotal for £19,836 priority Itoms 
Acoustic Materials (Aptflex tiles , Precision Acoustics UK £500 Acoustic Putty) Lld 
Stepper Motor/Scanning Frame £2,500 
Ultrasound transducer array £10,000 
150A 1 OOB RF power amplifier AR Worldwide USA £6,520 
Total £39,356 
Compiled by Dr.M .Mather, Nottingham University 
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